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Abstract
Vector-borne diseases have a profound impact on world health. The two most well-known
and costly diseases are dengue fever and malaria, both spread by mosquito vectors. In
the last decade, many new solutions to halting the spread of these diseases have been
sought, including vector-mediated disease suppression. The work presented here seeks to
generate alleles to e↵ect this suppression, and engineer a drive system to replace the native
population. Additional work on systems to keep engineered organisms genetically isolated
from native populations has also been carried out. Initial studies in C. elegans investigated
use of the transitive nature of RNAi in this species to genetically isolate one population
from another. This type of speciation could be used in plant populations to limit gene flow
of engineered crops into local environments.
The next series of studies details work on engineering of refractoriness alleles. Dengue
virus has several enzymatic activities that are essential for its replicative cycle, including an
RNA-dependednt RNA polymerase (RdRp) responsible for synthesizing both the sense and
antisense viral genomes and a protease responsible for several essential cleavages of the viral
polyprotein. Artificial substrates for these proteins were created to act as sensors, triggering
an apoptotic response when viral infection occurs. Several generations of constructs were
tested, but so far no completely functional sensor has been generated.
Lastly, a series of underdominant gene drive architectures were built and tested in
Drosophila melanogaster. Initial systems utilized a Drosophila cell death protein, Hid, as
toxin, and engineered microRNAs designed to target the Hid proteins as antidote. Two
toxin-antidote pairs were mismatched and positioned on separate chromosomes so that
an organism carrying both chromosomes survives, but an organism carrying only a single
chromosome is unviable. Construction of a proof-of-principle in the eye was successful, but
work in essential tissues is ongoing. Systems using engineered microRNAs as toxins and
vii
resupply of the native protein as antidote were tested in essential tissues. Testing of many
components has contributed to the development of these systems, but a complete system
has not yet been constructed.
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1Chapter 1
Introduction
I decided on Caltech for my Ph.D. after an April visit filled with sunshine and calm—
something of a miracle coming from a Boston not-quite-spring. When I began this adventure
almost 7 years ago, I knew I wanted to work on research that was somewhat applied. Given
that, I really wasn’t sure where to settle until I heard Bruce give his research preview talk
for the first-year students, presumably to lure us in. I was sold then and there. I was
enchanted by the clever projects, but also by the chance to work on something that had a
direct application to the lives of those in need.
Fighting Dengue with Mosquitoes
Medea, a powerful gene drive system, was almost complete when I joined the lab, so I leapt
at the chance to work on her cargo, the genes that would do the disease fighting in the
wild. There were so many ideas and so much work to be done. In my first year in the lab I
worked in C. elegans and Drosophila, with mosquito and fly cell lines, and with dengue and
yellow fever—all of this with no prior experience in any of those systems. Aedes and mice
were to be added to my repertoire later on. The first two years were a battle to keep up
with the possibilities of what to work on, and to keep a realistic check on what had to be
learned just to get started on the projects. It was a trial by fire, and an empowering time
to realize there is knowledge in this community that is there for the asking.
My primary objectives in the first few years were to design and test dengue refractoriness
alleles. As I worked in the lab, I also learned about the financial and social costs of the
virus: almost a third of the world’s population lives in dengue-endemic areas and it is
considered a neglected disease by the WHO. Further, the range of the main vector, Aedes
2aegypti, has been increasing since the 1960s due to many factors including urbanization
and globalization, but also possibly due to the loss of DDT as a powerful pesticide and
global warming (Wu et al., 2009; Knobler et al., 2006). The four related serotypes have
made vaccine generation di cult and slow (Coller and Clements, 2011; Murrell et al., 2011),
giving traction to alternative disease-fighting methods. Broad use of genetically modified
crops have opened the door to the possibility of releasing engineered organisms into the
wild; hopefully one day soon we will use insects to fight the battles against dengue and
malaria. I am excited to be part of the team breaking that trail.
Drive
As the field of genetically modified insects has grown and evolved—and it has significantly
during my time in the lab—demand for additional drive systems has increased. Eventually,
my focus shifted to exploring new methods of delivering these disease-resistance alleles into
native, na¨ıve populations.
Refractoriness alleles penalize the animal carrying them by forcing the organism to
perform an additional task that is above and beyond their basic genetic mandate of living
and reproducing. This fitness cost prevents the alleles from spreading in natural populations:
A gene-drive system is required. Some communities may want drive systems that spread
beyond their release area, and others may not. Drive should be quick, but many communities
may not want irreversible population replacement. This kind of flexibility has not yet been
developed, so my work on gene drive aims to expand and diversify the drive systems available
to our ‘customers’, the people living with vector-borne disease.
Genetic Isolation
With the advent of genetically engineered organisms, concerns have arisen about the flow of
genes between engineered individuals and the native species from which they were derived.
In particular, the plant community has found that public concerns have profound e↵ects on
their ability to deliver important products to both first-world businesses and third-world
populations in need of better crop yields and nutritionally supplemented foods (Hails, 2000).
Community-wide resistance to plants with exogenous genetic material has resulted in bans
in some countries and widespread skepticism among the general public domestically (Gaskell
3et al., 1999; Fernandez Cornejo and Caswell, 2006). Going forward, it will be increasingly
important to have engineered organisms that are tightly genetically isolated if they will be
cultivated or released into the wild. Generating fully genetically isolated synthetic species is
of increasing interest to many including biologists, agriculturists, and even epidemiologists.
Here I detail work on engineering refractoriness alleles for use in Aedes aegypti targeting
dengue virus, progress in the development of an underdominant gene drive system, and
a small piece on the use of RNAi-based approaches to reproductively isolate genetically
modified organisms.
4Chapter 2
Harnessing Transitive RNAi to
Generate Genetically Isolated C.
elegans
2.1 Introduction
Project Motivations
The goal of this project is the creation of a genetically isolated C. elegans line through
creation of an engineered line able to detect wild-type chromosomes and selectively kill
heterozygous progeny. The approach is based on the observed phenomenology of transitive
RNAi, which a↵ords silencing of genes upstream of the original target through unprimed
generation of ⇠ 22nt RNA molecules by endogenous RNA-dependent RNA polymerases
(RdRps) (Alder et al., 2003). The spreading of silencing was first observed bidirectionally in
plants through introduction of vectors containing exogenous, promoterless DNAs (Voinnet
et al., 1998; Vaistij et al., 2002), but has since been observed in C. elegans (Sijen et al.,
2001, 2007), and shown to be triggered by shRNAs, including microRNA (miRNA) mimics
(Shimamura et al., 2007; Poethig et al., 2006; Manavella et al., 2012). Transitive RNAi is
not triggered in either Anopheles or Drosophila (Roignant et al., 2003; Hoa et al., 2003),
however if the proof of principle were accomplished, the strategy could be used in the
generation of genetically isolated plants as a method of gene flow control.
Due to its broad existence in eukaryotes (Shabalina and Koonin, 2008), post-transcriptional
silencing has become a powerful tool in studying higher-order biological systems. Theoret-
ically, any transcript can be targeted specifically provided it has some unique sequence in
5its spliced mRNA, and this provides a wide range of potential toxins in the form of lost
essential transcripts. In practice, there seem to be a large variety of factors that influence
the ability of a gene to be targeted using a specific sequence and approach. The transitive
nature of RNAi-induced silencing in C. elegans further expands the flexibility of RNAi-
based knockdown by allowing the targeting of a downstream sequence to e↵ect silencing of
an upstream target (Figure 2.1).
Figure 2.1: (a) Initial studies using long dsRNA-targeting GFP showed that silencing of
upstream transcripts, most often an uncoordinated (Unc) gene, was a result of specific
targeting of downstream regions (Alder et al., 2003). (b) Later on, shRNAs were used and
functional RNAi molecules were detected which targeted upstream regions. This transitive
behavior was shown to be unprimed generation of ⇠ 22 nt RNAs (Sijen et al., 2007).
The challenge inherent in generating a genetically isolated population is the sensing of
the individuals’ genetic makeup as self or other. The result of this detection must then
trigger a switch that allows viability of those found to be self, and destruction of those
progeny which are other. Nature does this continually in the sense that most animals
cannot mate outside their own species and create viable, fertile o↵spring, although vigorous
hybrids do exist and may contribute to evolution in their own right (Rieseberg et al., 2003).
The courses nature takes for this detection are often complex and not well understood (Kao
et al., 2009). For our purposes, however, the population should be as closely related as
possible to its parent. Ideally, it will fill an identical biological niche, mate freely with its
wild counterpart, and compete well enough to ultimately replace the native population if
population replacement is desired. At a minimum, gene flow between engineered and wild
populations will be prevented. Key to our approach is the use of RNAi to detect a small
di↵erence in a single mRNA such that if an animal bears a single copy (is heterozygous
wild type) it will be detected. If the targeted region is not present, RNAi targeting it will
6be unable to e↵ect a phenotype, but if one copy of the gene bears the target, both will be
silenced, as the upstream siRNAs generated from the target-bearing transcript silence the
non-bearing allele via transitive RNAi.
Target Selection
A mutant allele (ok825) of cdc-42, a cell-division cycle gene in C. elegans containing a 632bp
deletion beginning in the 3’UTR of the gene. was identified as an appropriate target for
this project. MiRNAs designed to target a site within the deletion are innocuous in the
mutant strain, but should cause suppression of cdc-42 in a wild-type background. Loss
of Cdc-42 results in disruptions in cell polarity (Etienne-Manneville, 2004). Crossing an
ok825 strain bearing the miRNAs to the wild-type N2 strain should generate lethality in
trans-heterozygous progeny (Figure 2.2) if expressed broadly, as with the 858 promoter, or
movement defects if expressed under myo-3, a body-wall-muscle promoter.
Figure 2.2: (a) In a wild-type animal, silencing of the essential transcript will occur through
both sequence-specific targeting and via 5’ transitive silencing. (b) In a mutant, the miRNA
will be unable to target the transcript and the animal will remain viable. (c) Heterozygous
animals will have their wild-type transcript silenced normally, while the mutant chromosome
will be silenced only via transitive RNAi produced from the wild-type transcript.
72.2 Results and Discussion
The first task was to generate a male-enriched ok825 line so that once transgenics were
obtained, crosses could be carried out. Attempts were made to generate an ok825; him-
5(e1490) strain. ok825 hermaphrodites were mated to him-5 males. Cross-progeny herma-
phrodites, ok825+ ;
him 5
+ , were self crossed. These self crosses were predominantly sterile.
Of the few progeny that did survive, all lacked the ok825 allele as scored by PCR. It ap-
pears that the him-5 and ok825 alleles somehow interact, resulting in sterility or embryonic
lethality. This was not pursued, although in future other male-enriched lines could be
tested for compatibility with the ok-825 allele. This approach was abandoned and males
were generated post transformation through either heat shock or simple collection of nat-
urally occurring male individuals. The ok825 line obtained from the stock center may be
slightly male-enriched based on the ease of finding males when required.
I next assembled a miR targeting the native Cdc-42 sequence. The site targeted is
CGATGAGCATGATTCCAGAATT and begins 9bps inside of the ok825 deletion region.
Ten transgenic lines were isolated using the bombardment protocol. These carried a myo2::
GFP marker (pharyngeal cells) and the Cdc-42 targeting miR in the pPD95.86 backbone
(pPD96.86-Cdc42miR), which drives expression in the body wall muscles under the myo-3
promoter. Unfortunately, no F1s gave F2 GFP positive progeny. Personal communication
from John DeModena indicated that use of GFP as a positive marker for transformation via
bombardment has not been successful. GFP-positive individuals generated in this way are
usually mosaics and the transgene is not heritable. Additionally, isolating transformants
is very di cult because of the numbers of progeny generated that must be screened from
the bombardment protocol. In the future, the unc-119 movement-based scoring protocol
should be used. For this experiment it was not feasible because it was essential to generate
transformants in the mutant background.
The myo2::GFP marker and construct pPD95.86-Cdc42miR were co-precipitated with
pBluescriptSK+ as carrier DNA and injected by Harmonee Kim. I screened progeny from
these worms and isolated high transmission array lines. Three integrated lines were gener-
ated through  -irradiation. When outcrossed to unc-119 and N2, no genetic isolation was
observed. Progeny were healthy, carried one copy of the deletion, one of the wild-type gene,
and the transgene.
8I next tried using a di↵erent miR backbone that targeted the same site. The let-7
backbone was selected because of its demonstrated e cacy in generating transitive RNAi
in C. elegans (Sijen et al., 2007). The myo-2::gfp and pPD118.25-Cdc42/let-7 DNAs were
prepped and delivered to Steven Kuntz, who did one round of microinjection. pPD118.25
contains the let-858 promoter and is broadly expressed. The resulting worms yielded several
high-transmission lines.  -irradiation yielded two integrated lines that were crossed to unc-
119. Again, these yielded healthy, mobile, GPF-positive progeny, indicating the transgene
was being transmitted without killing the heterozygous progeny.
2.3 Future Implementations
Due to increasing interest in genetic isolation in plants and a dearth of truly flexible, modular
systems to accomplish it, reopening this project in C. elegans or even A. thaliana may be
worthwhile. Demonstrating genetic isolation via a pathway known to function in plants
may o↵er a viable alternatives to approaches in use that rely on imperfect phenotypes like
seed shattering, or physical methods like barrier crops.
MiRNA Design
The biggest unknowns with respect to these results are the e cacy of the miRNAs and the
suitability of cdc-42 as a target. Neither miRNA was tested in a homozygous wild-type
background, so it may be that they fail to target e ciently in the first instance, or the
transitive nature of the response is weak, or both.
A great deal of work has been done using the let-7 backbone in vitro since this project
was set aside, and it might be possible to design improved miRNAs based on this backbone.
Probably due to the ease of feeding long dsRNA to elicit phenotypes in C. elegans, not
much work has been done optimizing miRNA function, but lessons might be learned from
better-studied systems like Drosophila. The testing of multiple backbones targeting a single
site known to work might be called for.
Target Selection
Target selection in Drosophila seems to be one of the most sensitive parameters in suc-
cessfully targeting a gene with miRNAs, and this may hold true for C. elegans as well.
9Phenocopying a known loss-of-function phenotype might be an important control for as-
sessing miRNA e ciency as a function of target site. Additionally, if a haplo-insu cient
target could be selected, this would increase the sensitivity of the system immensely, and
might reduce the level of knockdown necessary for a functional system.
Knock-in technology also broadens the range of targets available. We worked with an
extant mutant, but this is not necessarily the best way to approach target selection at the
gene level. Many changes to UTRs can be tolerated, and even changes to the coding region
can be benign if the transcript is not especially sensitive to codon bias e↵ects. A best case
scenario would involve the targeting of the coding sequence of a gene that is mutated at
the DNA level to preserve wild-type protein function but leave it vulnerable to targeting
by engineered miRNAs. The modified transcript could be knocked-in to its native locus,
thereby creating an ‘invisible’ change where health and behavior are concerned. The new
strain would be wild type in all but its response to the presence of the engineered miRNAs.
This type of engineering would also allow the incorporation of a fluorescent marker, and
the linking of the miRNA to the un-targetable target.
Unfortunately, work is just beginning on the development of knock-in systems in plants
and C. elegans. The closest the worm field seems to get is an e↵ort at site-specific in-
tegration using a Drosophila class II transposon Mos1. Even with the planned insertion
library, the type of knock-in required for this project is not possible (Robert and Bessereau,
2007). The field is interested in directed gene manipulation in worms, with FLP-based and
Mos1–transposon-based systems recently described (Robert and Bessereau, 2011; Vazquez-
Manrique et al., 2010). According to Wormbook, low levels of true knock-in intergrations
have been observed via bombardment, but the documentation is minimal. In plants, the
situation is better with actual fusions to endogenous genes having been produced in rice
(Yamauchi et al., 2009), so perhaps studies would proceed more fruitfully in A. thaliana.
2.4 Materials and Methods
C. elegans culture and strains
Worms were cultured according to standard methods (Brenner, 1974) at 20 C on E. coli OP-
50. Strain RB942, bearing the ok825 allele, was obtained from the Caenorhabditis Genetics
Center. Additional strains used in this study—wild-type N2, him-5(e1490) (Hodgkin et al.,
10
1979), and unc-119(ed3) (Maduro and Pilgrim, 1995)—were generously provided by the
Sternberg laboratory.
The GFP marker, myo-2::gfp, was observed on a fluorescence stereomicroscope in the
Sternberg laboratory. Phenotypes induced by miRNA expression were scored based on
movement and viability of L3, L4, and adult worms.
Plasmid Construction
Four plasmids were constructed each containing a single miR6.1 miRNA targeting cdc-
42. The miRNA was constructed through two rounds of PCR. First, two inner primers
were annealed and amplified. A second round of PCR was carried out to add either an
NheI/KpnI or EcoRI/NotI pair of restriction digest sites to the flanks. These primers also
carried internal BglII and BamHI sites for construction of a doublet, but this miRNA was
used singly. The miRNA assembly procedure is further documented in Appendix D. Primers
are shown below with restriction sites underlined. Primers for EcoRI/NotI cloning are not
shown. The site targeted is CGATGAGCATGATTCCAGAATT and begins 9bps inside of
the ok825 deletion region. Cloning of the synthetic miRNA into a vector was carried out
via traditional methods following digestion of Fire lab plasmids pPD95.86 (NheI/KpnI),
pPD118.25 (NheI/KpnI), pPD134.96 (EcoRI/NotI), and pPD134.99 (EcoRI/NotI) obtained
from Addgene (Cambridge, MA). A second generation of plasmid was constructed using a
C. elegans let-7 backbone in place of Drosophila’s miR6.1, and the same target. Strategic
mispairings in the stem were intended to help preserve stem structure. This miR was cloned
into the pPD118.25 backbone (NheI/KpnI).
Generation of Transgenics
Transgenics were generated through bombardment (Wilm et al., 1999) and microinjection
(Mello et al., 1991). Steven Kuntz’s bombardment protocol (see Appendix A) was adapted
for use with the ok825 strain. 6µgs of DNA consisting of a 1:1 ratio of myo2::gfp and
pPD95.86-Cdc42miR were used for bombardment. Instead of screening for rescue of the
uncoordinated phenotype, as is usual for locating bombardment transformants, screening for
GFP-positive transformants was carried out on a fluorescence stereoscope in the Sternberg
lab.
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Primers for the Assembly of cdc-42 miRNAs
Inner Primers miR6.1 Fwd 5’ - GGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTCGAT
GAGCATGATTCCAGACTTTAAGTTAATATACCATATC
Rev 5’ - AATAATGATGTTAGGCACTTTAGGTACCGATGAGCATGAT
TCCAGAATTTAGATATGGTATATTAACTTAAAGT
Outer Primers miR6.1 Fwd 5’ - GGCGGTACCGCCAGATCTGTTTAAAGTCCACAACTCATC
KpnI/BglII AAGGAAAATGAAAGTCAAAGTTGGCAGCTTACTTAAACTTA
Rev 5’ - GGCCGCTAGCACGGATCCAAAACGGCATGGTTATTCGTG
NheI/BamHI TGCCAAAAAAAAAAAAAATTAAATAATGATGTTAGGCAC
Inner Primers let-7 Fwd 5’ - GAAAGTTGTGAGAGCAAGACGACGCAGCTTCGTAAGAGT
CTGTCTCCGGCGACGAGCATCACCCCAATAATTTCACCGGTG
GTAATATTC
Rev 5’ - AGGCAAGCAGGCGATTGGTGGACGGTCTACACTGTGGAT
CCGGCGATGAGCATGATTCCAGAATTTTTGGAATATTACCAC
CGGTGAAAA
Outer Primers let-7 Fwd 5’ - GGCGGTACCGCCAGATCTAAAATAAAGAAAAACAAAGAG
KpnI GTGAAAGTAAGAGGAGGAAGAAAACGAAAAGAAAGTTGTGA
GAGCAAGACG
Rev 5’ - GGCCGCTAGCCACATCTCCCTTTGAATTTATATGTCTAAT
NheI TTAACAACAAGTACTAATCCATTTTTCAGGCAAGCAGGCGAT
TGGTGG
Two rounds of microinjections were also carried out by Harmonee Kim and later Steven
Kuntz. The first round utilized the same DNAs as above, but the second round utilized
the second-generation let-7 based miRNA in the pPD118.25 backbone. Transformants were
isolated and  -irradiation integrations were performed using a Cs137 source. Integrated
transformants were outcrossed to wild-type N2 and unc-119(ed3) strains to assess genetic
isolation characteristics. Worm genotypes with respect to the ok825 allele were confirmed
via PCR using primers KJD7 and KJD8.
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Chapter 3
Engineering Refractoriness to
Dengue Virus
3.1 Introduction
Project Motivations
Myriad pathogens are spread to humans via arthropod hosts. This study focuses on dengue
virus (DENV), an important reemerging pathogen in tropical regions, and its main insect
vector, Aedes aegypti. The fight against dengue in humans has mainly focused on vaccina-
tion, an approach which often presents an e cient and (relatively) cost-e↵ective method of
controlling viral pathogens and the diseases they cause. The creation of a DENV vaccine
has proven di cult and, and while there are good candidates in development, there are
none ready for deployment. Presented here are e↵orts to develop a new mode of control
for the suppression of insect-borne disease while circumventing the need for vaccine devel-
opment, individualized vaccine delivery or medical care, and chemical suppression of vector
populations which have this far failed to break the transmission cycle and slow the spread
of dengue virus.
The project goal is to use endogenous insect proteins, or other engineered biomolecules,
to detect the presence of DENV. Coupled with, or integral to, the sensor is an apoptotic sig-
nal that triggers cell death only in infected cells. There are two main families of approaches
here, the first focusing on using the viral protease to activate components of the cell death
pathway and the second using the RNAi pathway coupled with the viral RdRp to induce
an apoptotic response. We used Drosophila as our model because many of the cell death
components are well characterized in that system and because culture and transgenesis are
better developed than in Aedes aegypti.
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Dengue Virus
DENV, which causes dengue fever, is a member of the family flaviviridae, that also includes
yellow fever virus, Japanese encephalitis, tick-borne encephalitis, and West Nile virus. In-
fection with DENV is typically characterized by fever, headache, nausea, vomiting, and
joint pain. The World Health Organization estimates that there are approximately 50
million cases of dengue fever each year. Of those, 1% result in dengue hemorrhagic fever
(DHF) or dengue shock syndrome (DSS), much more serious conditions that require medical
intervention and result in death ⇠ 2.5% of the time (WHO, 2012).
The virus is largely transmitted by the Aedes aegypti mosquito in urban and semi-urban
environments. It breeds predominantly in man-made containers, and increased urbaniza-
tion and reduced e cacy and use of pesticides have increased the spread of the virus.
Current methods of controlling the virus include chemical suppression of mosquito pop-
ulations during outbreaks and educating the public to reduce man-made standing water
breeding environments such as flower pots. These methods work with only limited success
as the virus continues to emerge and become endemic over larger geographic areas.
DENV circulates as four serotypes and exposure to one confers only partial, temporary
immunity to any of the other three. Exposure to one type can also cause a more severe
infection upon exposure to the other serotypes due to antibody-dependent enhancement.
Currently, no vaccine is available and treatment mainly consists of clinical management of
symptoms. With proper care, even DHF and DSS are rarely fatal, although the level of
treatment required is not always available in areas where dengue is endemic (WHO, 2012).
Viral Features
The DENV genome consists of a single, positive-stranded RNA of ⇠ 11 kb that encodes 5’
and 3’ untranslated regions (UTRs) and a single precursor polyprotein. The polyprotein
consists of the membrane, envelope, and capsid proteins in addition to seven nonstructural
proteins, NS1-NS5 (Chambers et al., 1990). During maturation, the polyprotein under-
goes a series of proteolytic cleavages carried out by the viral protease and several cellular
proteases (Falgout and Marko↵, 1995; Falgout et al., 1991). The other main enzymatic
function of the virus is carried out by its RNA-dependent RNA polymerase (RdRp) which
is responsible for making both positive and negative strands of viral RNA for replication
and packaging (Chambers et al., 1990).
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Figure 3.1: (a) The DENV RNA consists of 3 structural, capsid (C), membrane (prM),
and envelope (E) proteins, and seven nonstructural (NS) proteins, as shown. They are
translated as a single polyprotein that is then cleaved by a combination of viral and cellular
proteases. (b) The four cleavage sites in the DENV polyprotein in each of the four serotypes.
The residue N-terminal to the cleavage site is shown in red and the residue C-terminal is in
orange.
The Viral Protease
The DENV protease is encoded in the 180 amino terminal amino acids of the NS3 protein
and it cleaves both in cis and in trans. It must cleave multiple target sites, all of which
share certain sequence characteristics, including charged residues N-terminal to the cleavage
site and small uncharged residues C-terminal to it (Figure 3.1). The protease functionality
requires NS2B as a cofactor. It is autolytically cleaved from the NS2A and NS3 proteins.
NS2B is largely hydrophobic and embeds in the endoplasmic reticulum (ER) as a trans-
membrane protein. A set of 40 amino acids of NS2B compose a hydrophilic domain that is
necessary and su cient as a cofactor to the NS3 protease (Falgout et al., 1991; Preugschat
et al., 1990; Zhang et al., 1992).
A recombinant protein has been constructed fusing, via a flexible linker, the 40 amino
acid hydrophilic region, NS2B40, to the NS3 protease, and it cleaves successfully in vitro
(Leung, 2001). A cleavage consensus sequence was determined using the cleavage sites of all
four serotypes (Li, 2005), and it was adapted for use in this work. Some of the viral protease
is sequestered out of the cytoplasm in viral replication complexes that are closely associated
with cellular membranes derived from the endoplasmic reticulum (Mackenzie et al., 1998;
Westaway et al., 1997). Some studies indicate, that the bulk of the protease is found in a
cytoplasmic fraction accessible to trypsin digestion (Uchil and Satchidanandam, 2003).
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The Viral RNA-Dependent RNA Polymerase
The RdRp is one of the functionalities of NS5, the largest and most highly conserved of
the viral proteins (Chambers et al., 1990). It synthesizes the viral RNA e ciently and
specifically, to the exclusion of cellular mRNAs (Grdzelishvili et al., 2005; Ranjith-Kumar
et al., 2003). Cyclization of the viral genome is required for replication and is believed to
be accomplished by long-range RNA-RNA interactions through highly conserved sequences
on either end of the RNA molecule, and a conserved stem-loop on the 3’ end as shown in
Figure 3.2 (Alvarez et al., 2005). Additionally, it has been shown that when these elements
alone are present at the ends of non-viral RNA sequences, the viral RdRp will perform
negative strand synthesis (Filomatori et al., 2006). A cytoplasmically expressed mRNA
containing the conserved cyclizing sequences has the potential to be transformed into a
double-stranded intermediate by the viral RdRp upon viral infection. Studies carried out
in vitro have shown that the 3’ terminal region of the (–) strand alone is su cient for RNA
synthesis as well (Nomaguchi et al., 2004).
NS5 has two other functions: it is a methyl transferase and a guanylyl transferase (Zhou
et al., 2007). Like the protease, the majority of the RdRp protein exists cytoplasmically, but
enough is sequestered in or near the ER in replication complexes to allow viral replication.
Drosophila as a model
Drosophila has served for over 100 years as a model organism in biology, but has not yet
proven its utility as a model for disease-bearing arthropods. For these studies, Drosophila
is used as a model of one of its own order, diptera. While great di↵erences exist between
mosquitoes and flies, we have chosen to work in the better-understood insect. The two
species diverged approximately 250 million years ago, as opposed to the most divergent
Drosophila species that diverged from one another 40–60 million years ago (Severson et al.,
2004).
Elements of the Cell Death Pathway
The two classes of sensors explored here take advantage of the known components of the
Drosophila apoptotic pathway. The initial designs for the protease-based sensors centered on
the e↵ector (downstream) caspase, drICE, a protein that carries out the cell death process
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Figure 3.2: Reproduced above is a figure from Alvarez et al. (2005) showing two possible
folding structures of a circularized DENV genome. That study also shows that mutations
in the 5’ end resulting in loss of pairing with the 3’ end abolish function that can be rescued
by compensatory mutations, indicating it is the structure that the viral RdRp recognises
and the exact sequence is somewhat plastic.
by cleaving many cellular proteins. drICE is produced in the cell as a zymogen and is
activated upon cleavage by an initiator (upstream) caspase, Dronc (Hawkins et al., 2000).
drICE activity can be suppressed by an inhibitor of apoptosis protein, DIAP1, but only after
drICEs 20 amino terminal residues have been removed (Yan et al., 2004). Based on tissue
culture studies in Drosophila S2 cells, drICE has been shown to sensitize cells to apoptosis
when overexpressed and to be required for apoptosis (Fraser and Evan, 1997; Fraser et al.,
1997; Muro et al., 2004). No phenotype is observed when drICE is overexpressed in the fly
eye. Control of drICE cleavage, and thus activation, in vivo is a step toward controlling the
apoptotic response.
Upstream of both DIAP1 and drICE are Reaper (Rpr), head involution defective (Hid),
Grim and Sickle (SKL), the RHG proteins. The RHG proteins are pro-apoptotic and induce
caspase-dependent death by disrupting the interactions between the IAPs and initiator
and e↵ector caspases (Bergmann et al., 2003; Hay and Guo, 2004). The N terminus of
Hid carries a conserved IAP binding motif, AVPF, that has been shown to interact with
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DIAP1 and be required for its pro-apoptotic activity (Hay, 2000). If the N-terminal motif
is not exposed, the ability of Hid to induce cell death is compromised. Normally, Hid is at
least partially inhibited by the Ras pathway, through MAPK-dependent phosphorylation.
Figure 3.3: This a partial repro-
duction of a figure from Hay and
Guo (2004) showing the cell death
pathway in Drosophila. Circled in
green are the proteins targeted in
the RdRp-based approaches and in
purple the proteins targeted with
the protease-based approaches.
A mutant form lacking the five natural MAP Ki-
nase phosphorylation sites that evades inhibition by
Ras and exhibits a much greater killing activity was
used in this study (Bergmann et al., 1998). If the
activity of Hid can be precisely triggered, the cell
death response can be controlled. A schematic of
the Drosophila cell death pathway is shown in Fig-
ure 3.3.
Mosquito Mediated Pathogen Control
For over a decade, the scientific community has been
working toward the genetic engineering of mosquitoes
as a possible method of disease control, mainly focus-
ing on malaria (James and Collins, 1996), although
there has been more work done with dengue and
Aedes aegypti of late. Fewer than ten years ago, A.
aegypti was successfully transformed using a method
similar to the P-element transformation common in
Drosophila, allowing the introduction of new traits
(Coates et al., 1998; Spradling, 1986). Shortly there-
after, A. aegypti was engineered to express an anti-
bacterial factor, Defensin A, under the control of the
promoter of a bloodmeal-activated gene, vitellogenin.
The expression resulted in antibacterial activity and
persisted for at least 20 days (Kokoza et al., 2000).
Since the early work, a great deal more progress has
been made. Franz et al. (2006) engineered an RNAi
based refractoriness cassette and showed suppression
of DENV infection in the laboratory, but there may
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be issues with the stability of that line. After more than 17 generations, the expression of
the RNAi cassette seems to be suppressed and DENV is able to replicate and be detected
in the salivary glands of the insects (Franz et al., 2009). Ongoing work may answer ques-
tions about how and why this happened, but it certainly must be addressed before this
strategy could be implemented in the wild. The other, and most successful, approach is
the use of a Wolbachia infected line of mosquitoes. These not only spread Wolbachia, but
the bacterial infection itself suppresses DENV replication. The authors do note that the
Wolbachia strains that give the best Dengue protection also bear the largest fitness cost,
so this must be addressed, but field trials are going forward (Ho↵mann et al., 2011; Walker
et al., 2011). This stain also side steps the hurdles of public acceptance of genetically modi-
fied (GM) animals because the infection of the mosquitoes with a Drosophila endosymbiant
is not characterized as genetic modification. The insects are not subject to the regulatory
frameworks being developed to handle releases of GM animals into the wild (Barro et al.,
2011).
Creation of a Genetic Driver
An essential component to the concept of GM mosquitoes fighting disease is the ability to
push the genetic components into the insect population to fixation quickly, even if their
presence results in a fitness cost. The mainstay of gene drive in the Hay lab is Maternal
E↵ect Dominant Embryonic Arrest (Medea), a selfish genetic element that can drive to
fixation in Drosophila populations (Chen et al., 2007). I did participate in Medea based
projects, but they will not be discussed here. My work on a separate gene drive system,
Underdominance, can be found in Chapter 4.
3.2 Results and Discussion
3.2.1 Viral Protease-Based Sensing & Killing
Fly Results
The first pair of flies generated were GMR-drICEvp and GMR-NS2B40/NS3185. The down-
stream caspase, drICE, was modified to contain a viral protease consensus sequence LKRR-
SGSG (Li, 2005) where its endogenous Dronc cleavage site is located. The natural drICE
cleavage sites (D217 and D230) and its IAP binding site (A29) were mutated away to render
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it insensitive to IAP-dependent inhibition. This drICEvp was cloned into a transformation
vector containing the eye-specific GMR promoter. A fusion of the viral protease domain
of NS3, NS3185, and its cofactor, NS2B40, joined by a flexible linker was also cloned into
the GMR vector. The injection of GMR-drICEvp resulted in the generation of 15 lines,
and all the flies had healthy, wild-type eyes. From the GMR-NS2B40/NS3185 injection,
19 lines were isolated, but only 5 showed mild or no phenotype in the eye. Most of the
lines gave small-eye phenotypes and were so sick as to be unmaintainable. I worked with
lines with wild-type eyes, as we wanted to see the e↵ect of our sensor, not e↵ects of over
expression of the protease. When the GMR-drICEvp and GMR-NS2B40/NS3185 flies were
crossed together, death was observed (Figure 3.4), but, as evidenced by the full sized eye,
was occurring post-di↵erentiation and only in some cells. This indicated that the pro-
tease was able to trigger a drICE-induced cell death phenotype, but that the e↵ect was not
Figure 3.4: Shown in (a) are the three proteases expressed under the GMR promoter. (b)
The four substrates tested. (c) Phenotypes of some of the constructs in (a) and (b). Killing
late in eye development was achieved with drICE alone, and improved with a Hid fusion.
strong. This e↵ect was observed when protease-bearing flies were crossed to several di↵erent
GMR-drICEvp lines, so it is unlikely that it was a function of too little sensor in a specific
line. Killing could be limited by amount of protease, because I intentionally selected lines
with lower and more-specific expression patterns, but I did not assess the level of protease
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expression compared to that in a native viral infection in a mosquito.
To improve killing, a second round of flies were generated: GMR-NS2BfAVPFhid, the
NS2B co-factor’s hydrophilic domain alone fused via a flexible linker containing viral cleav-
age sites to the cell death protein Hid, GMR-drICEvpAVPFhid, the modified drICE caspase
fused via the same linker to Hid, and GMR-pdldrICEvp, a modified drICE that also lacked
its prodomain, as sensors, GMR-NS2B/NS3FL, a full-length fusion of the NS2B co-factor
and the NS3 protease, and GMR-NS2Bf, the hydrophilic fragment of the NS2B co-factor,
as proteases. Schematics of these constructs are shown in Figure 3.4. The flies carrying
a full-length NS2B-NS3 fusion surprisingly gave no phenotype, perhaps because the intact
protease sequesters itself in the ER membrane and therefore is not damaging to the cell. This
was also true of the NS2B hydrophilic fragment alone. The GMR-drICEvpAVPFhid did give
some enhancement of the eye phenotype when crossed to the original GMR-NS2B40/NS3185
protease line, but I never achieved a Hid-like small-eye phenotype from crossing any of the
modified drICE constructs to the viral protease lines.
To achieve a more realistic model, I attempted to infect adult D. melanogaster through
feeding of DENV2-laden media. Both wild-type and Dcr-2 mutant strains were evaluated.
If infection was successful, I expected to see viral-infection-induced death in the Dcr-2 mu-
tants, but there was no significant di↵erence in the survivorship of virally exposed flies
compared to flies fed only serum after 12 days of observation (Table 3.1).
w/ virus w/o virus
Dcr-2 Dcr-2/+ w- Dcr-2 Dcr-2/+ w-
Day 0 97 98 100 98 100 100
Day 1 96 97 100 98 100 100
Day 2 91 97 99 95 99 96
Day 3 90 97 98 96 99 95
Day 4 86 97 98 92 99 93
Day 5 81 96 93 90 99 93
Day 6 80 96 88 85 99 90
Day 7 75 93 88 77 99 88
Day 8 73 91 87 74 92 84
Day 10 71 83 82 65 83 72
Day 12 62 75 72 57 83 66
Table 3.1: Survivorship of flies fed viral-laden MEM
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Tissue Culture Studies
I also attempted to infect Drosophila S2 cells with DENV2. Infection was monitored via im-
munofluorescence assay. Initially, infections were carried out identically to those for C6/36
cells. Schneider’s media was removed and replaced with 200 µl of virus containing MEM.
The cells were incubated for an hour and then the viral media was removed and the cells
returned to Schneider’s media. Attempts to assay for viral infection were unsuccessful be-
cause the less-adherent S2 cells were lost using the extant staining procedures for C6/36
cells. To improve adherence, I treated small, circular glass coverslips with Concanavalin
A solution, as described in Appendix B (Sabatini, 2004), and then cultured S2 in wells
containing these slides. The slides allowed the cells to adhere and were retained through
the staining procedure. Initial immunofluorescence procedures created a great deal of back-
ground, but blocking with BSA reduced the autofluorescence or nonspecific binding. The
final staining procedure is documented in Appendix B. Unfortunately, no staining was ob-
served, indicating that viral replication was not occurring at significant levels in the S2 cells
after 48 hours. I attempted culturing the S2 cells in 1XMEM, but they were not viable
in that media. I then reversed the experiment and cultured the C6/36 cells in Schneider’s
medium, infected with virus-containing MEM media, and replaced the Schneider’s media.
The cells were not very healthy under this condition, but developed a robust viral infec-
tion, so I ruled out Schneider’s media as limiting viral competence. Ironically, the C6/36
cells did not adhere well to the Concanavalin-A-treated slides, but I don’t believe that the
Concanavalin A interfered with infection. In an attempt to sensitize the S2 cells to infec-
tion, I pretreated with Dcr-2 dsRNA. The success of the Dcr-2 knockdown was evaluated
by co-treatment with DIAP1 dsRNAs, which normally results in massive apoptotic death,
but this was suppressed by the Dcr-2 knockdown (Figure 3.5). I was unable to achieve a
robust DENV2 infection, even with the knockdown of the RNAi machinery, so I shifted my
approach to focus on detecting the viral infection in C6/36 cells.
Tissue culture of Aedes albopictus cells (C6/36) was also explored as a method to assay
constructs in the presence of a native DENV infection. Transfections were carried out using
lipofectin, cellfectin, lipofectamine, and FuGENE6 along with a GFP marker, but I only
had good success with FuGENE6. I surveyed ratios of FuGENE to DNA ranging from 2:2
to 9:2. Optimal transfection e ciency of around 15–20% was achieved using a ratio of 3:2.
This is not a high enough transfection e ciency to use loss of cells an an accurate assay
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Figure 3.5: Cells were treated with dsRNAs targeting Dcr-2 in an e↵ort to sensitize them
to DENV2 infection. (1) On the first day, cells were treated with 40 µg of dsRNA. (2)
On day 2, a second dsRNA treatment with or without a subsequent DENV2 infection was
carried out. (4) On day 4, cells were observed and immunostained. No evidence of DENV2
infection was found in either Dcr-2-dsRNA-treated cells or untreated cells.
readout. A loss of 15% of the cells, the best case if the killing was absolute, is too subjective
an analysis to be reliable. Instead, a GFP co-transfect with any of the sensors allowed us
to use GFP as a marker of successful transfection, and then see its loss (dependent on the
sensors) as the readout for a successful trial. Transfections shown as part of this study
have variable FuGENE ratios as they were conducted as I was still optimizing the system,
but no transfection represented had a transfection e ciency below 10–15%, and each was
representative of the results I achieved.
I began the testing the same constructs that I had tested in the fly eye in C6/36 tissue
culture. The proteases and drICE sensors were cloned into a heat shock plasmid for use
in C6/36 cells kindly gifted by Bart Bryant in the Clem lab at Kansas State University
(designated KHS in these studies). A sample transfection is shown in Table 3.2. No killing
was observed before or after viral infection when using the contructs KHS-drICEvpAVPFhid
and pAc5.1-drICEvp. I tried triggering them with both KHS-NS2B40/NS3185 and a native
viral infection. The constructs themselves were well tolerated, but neither co-expression of
the viral protease fusion nor infection with DENV2 instigated killing of transfected cells.
Staining of cells after scoring for killing indicated that a robust viral infection had been
achieved in wells that were treated.
Our first concern was that perhaps D. melanogaster cell death proteins were not e↵ective
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a. Marker DNA KHS-drICEvp Balance DNA FuGENE Ratio GFP signal
KHS-GFP (µg) (µg) pBSK+ (µg) (µl) upon infect
1 0.4 1.6 9 9:2 +++
2 0.4 1.6 9 9:2 +++
KHS-drICEvp
AVPFhid
3 0.4 1.6 9 9:2 +++
4 0.4 1.6 9 9:2 +++
KHS-NS2B/ GFP signal
NS3 No Infect
5 0.4 1.6 9 9:2 +++
6 0.4 1.6 9 9:2 +++
KHS-NS2B/ KHS-drICEvp
NS3 AVPFhid
7 0.4 0.8 0.8 9 9:2 +++
8 0.4 0.8 0.8 9 9:2 +++
b. Marker DNA KHS-RHG Balance DNA FuGENE Ratio GFP signal
KHS-GFP (µg) (µg) pBSK+ (µg) (µl) No infect
1 Ctrl 0.4 1.6 9 9:2 +++
2 Rpr 0.4 1.6 9 9:2 -
3 Hid 0.4 1.6 9 9:2 -
4 Grim 0.4 1.6 9 9:2 -
Table 3.2: Tissue culture results for transfections using (a) fly-eye protease targets and (b)
testing of RHG proteins in C6/36 culture
toxins in Aedes albopictus cells, so I took a step back and tested the ability ofD. melanogaster
cell death proteins Rpr, Hid, and Grim to kill in C6/36 cells. Transfection of KHS driving
each of the RHG proteins individually gave complete ablation of GFP positive cells in
repeated transfections. DNAs were carefully cleaned several times so that I could be sure
the DNA treatment itself was not inducing death, and the cell culture itself looked healthy,
indicating to us that only the transfected fraction was being killed. This led me to conclude
that the RHG proteins as toxins would work in C6/36 cells, but that there was another
barrier to killing. The next hurdle was making sure the sensors were exposed to the viral
protease, so I made constructs targeting the sensors to the ER.
Initially, two synthetic transmembrane domains were synthesized, and each was fused
via a flexible linker containing synthetic protease target sites to either Gal4 or FLP. The
first domain, prMcleave, was a fragment of the virus itself, comprised of a small piece of
the capsid, the entire prM protein and a small piece of the M protein. This fragment con-
tains the first transmembrane domain of the virus. A fully synthetic fragment, p450cleave,
was designed containing the N-terminal signal sequence and ER localization signal from
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Figure 3.6: (a) This schematic shows the design rationale of the membrane-tethered tran-
scription factor sensors. (b) The transcription factors Gal4 and LexA::VP16 are fused to
transmembrane domains meant to target them to the endoplasmic reticulum via a flexible
linker containing viral cleavage sites. (c) The toxin, expression of a cell death protein,
is only expressed when the transcription factor is cleaved from its membrane tether and
activates its UAS in the nucleus.
cytochrome p450, a highly conserved protein (Szczesna-Skorupa and Kemper, 2000). Both
of these domains were intended to help the sensors co-localize with the replicating virus,
thereby bringing the protease and sensor together. The linker contains multiple cleavage
sites, and cleavage would result in the release of either FLP or Gal4 to travel to the nucleus,
and by di↵erent mechanisms trigger a cell death response. These systems are more complex
than the drICE-hid system because they require both the cleavable component and a down-
stream activity. For the Gal4 constructs, KHS-prMcleave::Gal4 and KHS-p450cleave::Gal4,
the downstream activity is simply the expression of a cell death protein driven by Gal4’s
UAS once they are cleaved by the virus, as shown in Figure 3.6a. The UAS-RHG constructs
are quite toxic to the cells when transfected at high concentrations, probably due to leakage
from the basal promoter attached to the Gal4 UAS which is derived from hsp70 and known
to express in C6/36 without any heat shock. I titrated the doses down to a level where no
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killing was detectable, but no lower, as I wanted to use the highest dose possible. I observed
no enhancement of killing when cells transfected with KHS-prMcleave and UAS-Hid were
subjected to a DENV2 infection (Table 3.3). The trials with p450cleave produced identical
results.
a. KHS-GFP UAS-Hid prM- Balance DNA FuGENE Ratio GFP signal
(µg) (µg) Gal4 (µg) pBSK+ (µg) (µl) upon infect
1 0.4 1.6 3 3:2 +++
2 0.4 1.6 3 3:2 ++
3 0.4 1.6 3 3:2 -
4 0.4 0.2 0.4 1.0 3 3:2 ++
5 0.4 0.15 0.4 1.05 3 3:2 +++
6 0.4 0.1 0.4 1.1 3 3:2 +++
b. KHS-GFP KHS-Gal 4 UAS-GFP UAS-Rpr pBSK+ FuGENE GFP signal
(µg) (µg) (µg) (µg) (µg) Ratio No infect
1 0.4 1.6 3:2 +++
2 0.4 0.4 1.2 3:2 +
3 0.4 1.6 3:2 -
4 0.4 0.4 1.2 3:2 +
5 0.4 0.2 1.0 3:2 +++
Table 3.3: (a) On its own, UAS-Hid is toxic in high concentrations, although this e↵ect can
be neutralised through the use of less DNA per transfection. The KHS-prMcleave::Gal4
construct can also confer some toxicity on its own. This is consistent with reports that Gal4
is not a neutral molecule and induces phenotypes in adult D. melanogaster as well. When
the two molecules are co-transfected and then an infection is performed, no enhancement
of killing is observed. (b) Gal4 fails to drive GFP or Rpr significantly in C6/36 cells
I then set out to test the function of Gal4 in C6/36 cells because I could not distinguish
from our results whether we were getting cleavage and no UAS activation or whether cleav-
age was not occurring. I therefore expressed Gal4 on its own from KHS plasmid and used
this to drive the RHG proteins and also GFP. Unfortunately, I found that Gal4 functions
only very weakly in C6/36 cells (Table 3.3). This result is consistent with a report from
the James lab at UC Irvine that Gal4 functions poorly in Aedes, although a more recent
paper refutes this (Kokoza and Raikhel, 2011). Even if cleavage was occurring, very little
cell death protein would be produced and I would observe no killing. I learned very little
from this system because I had no way to determine whether no cleavage was occurring,
whether cleavage was happening and the Gal4 was unable to reach its target, or whether
everything was functioning, but expression o↵ the UAS was just weak.
To circumvent the possible Gal4-UAS system failure in C6/36 cells, I replaced the Gal4
with a LexA::VP16 (LV) fusion, and changed to an 8LexA UAS fused to either a bottleneck-
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supercore (bnkSCP) fragment as basal promoter or a fragment of the UASp promoter. The
8lexUASp promoter was leaky in C6/36 cells, resulting in uncontrollable killing, and so I
focused my attention on the p8lexbnkSCP promoter driving Rpr and Hid. As a control,
KHS-LV was transfected with 8lexbnkSCP and this yielded killing, indicating to us that the
LexA::VP16 fusion I was using worked in the C6/36 cells and that I could test the function of
our sensor because the output was sound. I carried out a series of control transfections and
found that KHS-prMcleave::LV and KHS-p450cleave::LV constructs were well tolerated by
the cells and did not result in death on their own as the Gal4 versions had. Co-transfections
of the sensors with their targets, however, revealed that killing was occurring even without
the addition of virus. It appeared that the LexA::VP16 was not being retained in the ER,
but instead was localizing to the nucleus and activating transcription of Rpr. No matter
how little of the KHS-prMcleave::LV or KHS-p450cleave::LV was used, killing still resulted.
The p450 versions were more toxic than the prM versions.
Concurrently, I was testing the KHS-prMcleave::FLP and KHS-p450cleave::FLP con-
structs against a di↵erent type of reporter showed in Figure 3.7. Work had just begun in
the lab on engineered underdominance, and Chun-Hong Chen had built a test construct
consisting of a pair of FRT sites flanking a miRNA and two target sites for that miRNA.
Downstream of the second FRT and the miRs, was space for an open reading frame to
be cloned. I cloned wild-type Rpr and RrpKR which contains no lysines and cannot be
ubiquitylated (Vernooy et al., 2002), downstream of the miR and its targets (See Figure
3.6). The design of this substrate ensures that if it is expressed without FLP, the miR
is processed, and targets the same transcript it is processed from, ensuring that any ex-
pressed mRNAs are cleaved and targeted for degradation. Processessing of the miRNA
will also cleave the cap o↵ the transcript, destabilizing it. If flipping occurs, the mRNA
produced will carry no miR and no targets and so, a capped, stable mRNA that bears the
Rpr ORF is produced, resulting in cell death. Both KHS-synRprWT and KHS-synRprKR
were slightly toxic, but could be transfected at reasonable levels (0.2 µg) without observ-
able killing. As with the LV constructs, killing occurred when the KHS-prMcleave::FLP or
KHS-p450cleave::FLP construct was co-transfected with its Rpr-bearing target. This also
suggests that the transmembrane domains are not retaining the fusion proteins anchored
to the ER.
Improved transmembrane targeting seemed to be the next logical improvement as killing
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Figure 3.7: (a) This schematic shows the design rationale of the membrane tethered FLP-
based sensors. (b) FLP is fused to transmembrane domains meant to target them to the
endoplasmic reticulum via a flexible linker containing viral cleavage sites. (c) The KHS-
synRprWT and KHS-synRprKR constructs, which bear the toxin, are benign before flipping
because a miRNA that targets the transcript it is processed from is placed upstream of the
toxin ORF. Once FLP excises the miRNA, expression of the toxin is free to occur.
and the targets were both functional. I again used a transmembrane domain, either from
the prM or the envelope protein (E), and fused it downstream of CD4 which has been shown
in D. melanogaster to keep cleavable fusion tethered to the membrane (Hawkins et al., 1999;
Op De Beeck et al., 2004). The use of viral transmembrane domains was intended to help
with colocalization of my transcripts with the viral protease. The same linker and LV as
in the previous round were used. The function of these constructs is as described in Figure
3.6. The last membrane-targeting strategy I tried was a much smaller fusion of amino acids
1–29 of a protein called Erlin-1 (Browman et al., 2006). This fragment was fused N-terminal
to a new set of viral cleavage sites and a LexA::VP16 fusion that had been codon optimized
for insects and had several inconvenient restriction sites removed.
This round of transfections yielded us the most perplexing results yet. The Erlin con-
struct activated the 8LexbnkSCP at even minuscule concentrations and so it was abandoned.
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a. GFP 8lexbnk Erlin:: CD4E:: CD4prM pBSK+ GFP signal GFP signal
(µg) SCP (µg) LV (µg) LV (µg) ::LV(µg) (µg) No infect Upon infect
1 0.4 1.6 +++ +++
2 0.4 0.4 1.2 +++ ++++
3 0.4 0.4 0.1 1.1 + +
4 0.4 0.4 0.1 1.1 +++ ++++
5 0.4 0.4 0.1 1.1 +++ ++++
b. GFP 8lexbnk NS2bf CD4E:: CD4prM pBSK+ GFP signal GFP signal
(µg) SCP (µg) LV (µg) LV (µg) ::LV(µg) (µg) No infect Upon infect
1 0.4 1.6 ++ ++
2 0.4 0.4 1.2 ++ +++
3 0.4 0.4 0.2 1.0 ++ ++
4 0.4 0.4 0.4 0.2 0.6 + +
5 0.4 0.4 0.2 1.0 + ++
6 0.4 0.4 0.4 0.2 0.6 + ++
Table 3.4: (a) The KHS-Erlin::nLV construct is toxic when co-transfected with 8lexbnkSCP-
rpr, indicating it is not being sequestered in the membrane prior to cleavage. The CD4E
and M constructs do not localize to the nucleus precociously, but also do not kill upon
infection. An increase of GFP signal results, possibly due to stress on the cells activating
the KHS promoter, which is responsive to heat shock. (b) Adding a KHS-NS2bf construct
to try to increase cleavage did not result in more killing.
In D. melanogaster the very N-terminal fragment of Erlin-1 is not enough to localize and
retain the protein in the ER. The CD4 constructs were well tolerated, but no killing was
induced upon infection. In fact, infection significantly increased our GFP signal. Upon
reading more about historical usage of the hsp70 fragment, certain kinds of non-heat shock
stress increase expression o↵ these fragments. It is possible that something about these
membrane-targeting constructs induces stress in the presence of a viral infection. I still
wanted to test whether or not cleavage could be induced and the transcription factor could
be released and get to the nucleus, so KHS-NS2bf (which does not carry the NS3 domain)
was added to the transfections. This was meant to increase our odds of cleavage. The same
result was obtained, however, with an increase in GFP signal upon infection with DENV2.
It is important to note that NS2bf transfected alone also induced an increase in GFP and
did not seem to be toxic, so it is unclear whether this fragment would cleave the targets in
the cells.
At this time, we still do not fully understand these results. It may be valuable to go back
to using the CD4-based constructs in D. melanogaster S2 cells because progress has been
made in achieving infection of both S2 cells and adult Drosophila (Chotkowski et al., 2008;
Mukherjee and Hanley, 2010). The strategies used in those studies to sensitize Drosophila to
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flaviviral infection are not very di↵erent from those approaches I tried. Knockdown of Dcr-
2, Argonaut, and a healthy dose of patience resulted in success where I failed. There is even
a flaviviral strain that is adapted to S2 cells and di↵ers at only a few amino acids from the
native virus. The better-understood pathways in S2 cells may still make them a fruitful test
bed, especially now that the staining protocols and strategies to make them more adherent
have been developed. It should be noted that assaying for virus was done more rigorously
via plaque assay in both of these studies. Also, in light of the Dcr-2 deficiency of the C6/36
cell line (personal communication, Ken Olson), it may not be a good choice for the testing
of our constructs, although this is more true of the constructs in the next section.
3.2.2 RdRp-Dependent Sensing & Killing
Fly Results
A family of constructs designed to be substrates for the viral RdRp were generated. The
5’ and 3’ ends of dengue virus (D5 and D3), responsible for circularizing and allowing
initiation of transcription, were used to flank an antisense fragment of the DIAP1 (D)
coding sequence. A HDV ribozyme (R) was cloned downstream of the D3 fragment to
cleave it specifically at the known 3’ end of the viral RNA genome, and a tubulin 3’UTR
was used to help with proper transcription. This generated the construct D5DD3RT, meant
to act as a stable mRNA bearing both the 5’ and 3’ ends of the dengue genome that would
be a substrate for minus strand synthesis by the NS5 RdRp expected to be floating in the
cytoplasm during a dengue infection. It was cloned into the same GMR promoter bearing
transformation vector used previously for expression in the fly eye, producing construct
pGMR-D5DD3RT. The 5’ end of the mRNA would bear the 5’UTR normally downstream
of the GMR transcription start site. The rationale behind these constructs was that the
DIAP1 antisense, when transcribed by the RdRp, would produce a fragment of the sense
strand of DIAP. Together with the original mRNA produced from the D5DD3RT, this
would generate dsRNA molecules of DIAP1. Knockdown of DIAP in Drosophila results in
e cient apoptotic killing of cells. Individually, the NS5 and its substrate should be benign.
Over ten lines of each GMR-NS5 and GMR-D5DD3RT were generated, and all of them
had healthy, wild-type eyes. When crossed together, there was no change in eye size, health
or patterning. Tissue culture studies were beginning at that point, and so I focused on those.
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Figure 3.8: A schematic of the proposed function of the RdRp sensor
Cell Culture Results
Versions of the RdRp substrate described above were made for testing in tissue culture.
As I was working it C6/36 cells, the anti-sense fragment used was from Aedes albopictus
IAP (A). They were cloned into the KHS vector used in the viral protease studies and also
utilized the 5’ and 3’ ends of dengue. The pGMR-D5DD3RT was modified so that when
cloned into KHS the dengue 5’ fragment initiated precisely at its 5’ end without any extra
nucleotides, producing construct KHS-D5AD3RT. A second construct, KHS-AD3(–)R, was
built that carried the AAIAP fragment, a dengue antisense 3’ fragment (D3’(–)) and the
HDV ribozyme. These constructs rely on the production of dsRNAs that are processed and
induce RNAi-based suppression of the AAIAP to kill cells (Figure 3.8). We carried out a
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large number of transfections, but never observed killing from these transcripts.
I built and evaluated miRs against AAIAP (targeting sites TCACCGATAACAAAGT-
TAAAGA and GAAGATGAACCAAATAGAAAAC) to test whether or not suppression of
IAP in Aedes albopictus cells had the same e↵ect as in S2 cells, but only saw weak induc-
tion of apoptosis. I also used stabilized antisense fragments of AAIAP to carry out this
investigation, but I will not report the full details of what we did because about two years
after these studies were put on hold, we received information from a collaborator, Dr. Ken
Olson at Colorado State, about the competence of C6/36 cells for RNAi. He indicated
that the cell line has a defective Dcr-2 gene and does not generate the 21 bp dsRNAs
characteristic of the RNAi response. Even our miRNAs may have been hampered by the
lack of a functioning Dcr-2, despite normal processing of miRs by Dcr-1. Because of their
complete pairing through the middle of the stem, they may be loaded preferentially into
the Dcr-2 RISC complexes. Mis-pairing in the middle section is thought to direct miRNAs
to the Ago1/Dcr-1 machinery (Lee et al., 2004). Some work has been done in the lab to
understand how the miR6.1 synthetic miRs are processed, but the data are not clear.
In any case, the experiments would best be repeated using the Aag2 cell line, although
it also has limitations. Aag2s are persistently infected with cell fusing agent virus, which
incites a large RNAi response of its own, even before a hengue infection is initiated. Al-
though the Aag2 is competent for dengue infection, a deep sequencing run on an Aag2
sample infected with both viruses yielded about 40-fold more small RNAs against CFA
virus compared to dengue. Titers of dengue from Aag2 infections 5 days post infection are
around 105 as compared to C6/36 which are around 107. Additionally, the IAP in Aedes
aegypti has not been identified, although other targets could be utilized. Constructs tar-
geting GFP could o↵er a way of testing the ability of the Dengue RdRp to replicate the
artificial ‘genomes’ we created without having an apoptotic protein to target.
I also generated a set of RdRp substrates that would not be dependent on the action of
the RNAi machinery, but instead would rely on the viral RdRp synthesizing a sense-strand
mRNA of a toxic transcript. I used the bacterial toxin, Barnase, as my lethal transcript.
Barnase and Barstar are a toxin-antidote pair produced by Bacillus amyloliquefaciens. Bar-
nase is a ribonuclease meant to be excreted and Barstar is its intracellular inhibitor that
keeps Barnase from killing the cell producing it (Hartley, 1989). The design of these con-
structs depended on transfection with a reverse-complement of Barnase being innocuous
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until the viral RdRp created a sense strand that would be competent for the translation of
a functional Barnase molecule, leading to cell death.
Figure 3.9: The initial Barnase construct was designed to produce a capped mRNA car-
rying a full-length reverse complement of Barnase that can be reverse transcribed by the
viral RdRp, making a protein coding transcript. If the cellular machinery produces the
complementary strand, however, the sense strand of Barnase, competent for translation,
is produced. By putting an intron in the forward direction with respect to the promoter,
any spurious transcription of the ‘wrong’ strand results in an mRNA without a functional
Barnase open reading frame.
The initial design, which relied on the 3’ end of the (–) strand of the dengue genome
acting as an attractive initiation site for the viral RdRp, carried the full length reverse-
complement of Barnase. In concept, this was predicted to be tightly ‘o↵’, that is, not
expressed, until a viral infection occurred. In practice, transfection of DNAs result in
multicopy arrays of DNAs entering the cell, and it appears that expression of both sense and
antisense occurred, because a great deal of killing was observed when the original Barnase
sensor was transfected. Enough Barnase protein was produced to kill the transfected cells,
even when introduced as a small fraction of the transfection mixture.
We never tested this theory directly, but we did synthesize a new Barnase construct. It
also carried the 3’(–) strand of the the DENV2 and a full length Barnase reverse complement,
but an intron was inserted in the Barnase reverse complement such that if produced from the
plasmid in the correct direction (making an mRNA with the reverse complement of Barnase)
the intron would be spliced out and a viral sensor would be produced. If, however, spurious
transcription occurred which would produce a sense strand of Barnase, the transcript would
contain a stretch of nonsense coding RNA with stops and random amino acids produced
so that no functional protein would result. A schematic of the two constructs is shown in
Figure 3.9.
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Transfection of this construct was nontoxic, giving some indirect evidence that expres-
sion of a sense mRNA from the first generation Barnase sensor had been produced. dengue
infection did not trigger killing of the cells, when an infection was carried out 24 hours post
transfection of the new Barnase sensor. In my hands, the 3’(–) fragment of dengue was
insu cient for the RdRp to initiate synthesis of the negative strand. A simple further test
would be to clone the intron bearing Barnase between the dengue 5’ and 3’ ends to see if
together enough of the (–) strand could be produced to allow translation of Barnase and kill
cells. Testing of the RdRp on this substrate in vitro would answer the question of whether
or not the substrates can be recognized and used by the virus. If they were, the only hurdle
remaining would be bringing the NS5 protein and the sensor into contact.
3.2.3 PKR-Mediated Killing
A study in mammalian tissue culture showed that a fusion between the dsRNA binding
domain of PKR and apaf-1 resulted in apaf-1 proteins able to be brought into close proximity
when dsRNA is present due to the PKR dsRNA binding domain. The binding of apaf-1 to
procaspases allows them to reciprocally cleave one another, activating the hand triggering
cell death. Viral infections, including a dengue infection, in the presence of this fusion PKR-
apaf-1 induced apoptosis in infected cells while leaving uninfected cells untouched (Rider
et al., 2011). I built a similar set of constructs including the fusion of the D. melanogaster
homologue of apaf-1, ark, and the dsRNA binding domain of PKR and both the components
separately. Viral infection did not kill the transfected, infected cells. While the cell death
pathway architectures are very similar between mammalian systems and Drosophila, there
does seem to be a di↵erence in which components dominate the function of the pathway,
and where in the pathway the key decision points are located (Hay and Guo, 2006). In
Drosophila IAP1 is a powerful regulator of cell death, and as part of the normal functioning
system, suppresses the somewhat constitutive activity of Dronc, the caspase ark activates.
Therefore, it may not be surprising that further activation of ark, and therefore Dronc is
not enough of a signal to induce apoptotic death in mosquito cells. Figure 3.10 shows how
these constructs were expected to function and a summary of the fly cell death pathway.
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Figure 3.10: Infection with dengue results in dsRNA production. The PKR dsRNA binding
domain fused to the ark protein instigates co-localization of multiple arks. These bind the
procaspase form of Dronc and allow the molecules to reciprocally cleave each other. This
should induce apoptosis. DIAP1 is the master regulator of D. melanogaster cell death, and
may not allow activation of Dronc to induce apoptosis in the absence of other signals.
3.3 Future Directions
Protease approaches
In light of the advances in S2 and adult D. melanogaster infection (Chotkowski et al., 2008;
Mukherjee and Hanley, 2010), I think future work on the protease approaches should be
continued in S2 cells. Based on the information available, a reliable infection protocol can
be developed, and a wide variety of designs could be tested readily because S2 cells are
more easily and reliably transfected. Any design that worked in S2 cells would have to be
moved to either C6/36 or Aag2 cells for final testing before a mosquito was built, but with
both cell lines available in the lab, this should not present a problem.
I believe that the biggest hurdle to the protease approach will be achieving co-localization
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of the sensor and the viral protease. The di culty of tethering the transcription factor to
the membrane has been solved by use of the CD4 domain, but with the system I had
previously developed, separating the behavior of the other parts of the system was not
possible. If GFP were cloned in downstream of the linker with a nuclear localization signal
on it, its localization to the membrane and then release upon infection could be monitored.
The localization and cleavage could both be monitored using that single construct, and
hopefully improved. Once those two variables are sorted out, then the transcription factors
could be substituted in for the GFP and the sensor would have a good likelihood of working.
RdRp approaches
For the RdRp approaches, the first and easiest step lies in testing all the constructs that are
extant in the Aag2 cell lines. Literature shows that the RdRp is competent to replicate arti-
ficial substrates in vitro (Nomaguchi et al., 2003, 2004) and produces subgenomic fragments
in vivo (Pijlman et al., 2008; Li et al., 2011; Pesko et al., 2012). This implies that it should
be possible to create an artificial fragment that is able to be amplified in tissue culture.
Putting a GFP fragment as the RNAi inducing moiety would give a simple read out that
would not be expected to be toxic. It would be worth while to try both sense and antisense
between the dengue fragments as its unclear which would be most e cacious. In S2 cell
studies, expression of antisense alone has not triggered an RNAi response so it should be
‘safe’ for tests and with the virus producing both strands it may ultimately induce better
suppression.
The Barnase construct bearing the intron would be especially interesting to pursue
because the protein is toxic in such low doses and the current construct is tolerated well
by the cells. Even a small amount of reverse transcription by the virus might be enough
to trigger death. Trying a variety of dengue fragments to elicit reverse transcription by the
virus should o↵er a short term set of trials that could yield a functional sensor and killer in
one, small construct.
Additionally, NS5 is known to exist broadly in the cytoplasm, but a significant fraction
also localizes to the nucleus (Pryor et al., 2007) and so it could be that trying to retain
our sensors in the nucleus is also a viable route toward getting the RdRp to replicate them.
Getting the virally produced transcripts to then export for processing would then become
a key step, however.
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PKR approach
The PKR approach is also worth a little more e↵ort and creativity. While the dimerization
of ark may not prove toxic in insects, there are other proteins whose functionalities require
dimerization. One class that comes to mind is restriction enzymes. Class II restriction
enzymes are often homodimers, and some, such as FokI, require dimerization for function.
There is a crystal structure of FokI that shows its dimerization surface (Wah et al., 1998)
and there is a known mutant that can no longer dimerize. The cleavage of this mutant
is greatly compromised (Bitinaite et al., 1998). If the dsRNA binding domain from PKR
were fused to a dimerization deficient version of FokI, this could serve as a sensor and killer.
The trouble with this approach is that the enzyme once dimerized would need to be able
translate to the nucleus, bind and cleave DNA. There are probably many other candidates,
such as RNases, out there that could prove toxic when dimerized as a function of PKR
binding of dsRNA.
To test directly the ability of PKR to dimerize protein domains in insect cells in the
presence of a viral infection, there is a split GFP that could be utilized (Ghosh et al., 2000).
It has been used with small, artificial coiled-coils, but it would be an empirical question as
to whether or not it would tolerate the larger PKR dsRNA binding domain.
Despite not succeeding in creating a functional sensor, the field has advanced since I
last worked on most of these designs. I think each of the approaches has a way forward
that is worth exploring.
3.4 Materials and Methods
Vector Construction: Viral Protease-Based Approach
A modified drICE (drICEvp) with three point mutations, A29V, D217A and D230A, and
the region around its endogenous cleavage site (TMQRSQ) replaced with the viral cleavage
site consensus (LKRRSGSG) was generated by fusion PCR and site-specific mutagenesis
(primers shown in Table 3.5) and cloned into pGMR-1N using EcoRI and NotI restric-
tion sites. The previously described NS2B40/NS3185 fusion protease (Li, 2005) derived
from DENV2(TSV01) was PCRed to add restriction sites and cloned into pGMR-1N and
pCaSpeR-hs using EcoRI and NotI restriction sites. The NS2B40 (NS2Bf) cofactor and
drICEvp were each fused via PCR to a short linker containing half the viral protease consen-
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sus sequence (G4S-LKRR-AVPF) and a hid gain-of-function allele, HidAla3, from Bergmann
et al. (1998), and cloned into pGMR-1N using EcoRI and NotI restriction sites. A full length
NS2B-NS3 fusion (NS2B-NS3FL) was assembled from plasmids kindly gifted from Richard
Kuhn’s lab at Purdue (Bera et al., 2007), and cloned via a three piece ligation into the HpaI
and NotI sites of pGMR-1N. NS2Bf was also cloned into GMR-1N on its own. A prodomain-
less version of drICEvp that lacks amino acids 1-28 of endogenous drICE was cloned between
the BglII and NotI restriction sites in pGMR-1N. All of the constructs described above
were used to generate germ line transformants by standard methods (Spradling and Ru-
bin, 1982) producing flies GMR-drICEvp, GMR-NS2B40/NS3185, hs-NS2B40/NS3185, GMR-
NS2BfAVPFhid, GMR-drICEvpAVPFhid, GMR-NS2BNS3FL, GMR-NS2Bf, and GMR-
pdldrICEvp.1 Schematics of the constructs are shown in Figure 3.4.
A series of constructs for use in Drosophila S2 and Aedes albopictus C6/36 tissue culture
were also built. drICEvp and drICEvpAVPFhid were cloned into pAc5.1/V5-HisB (Invitro-
gen, Carlsbad, CA) and an Aedes albopictus expression vector, pHsp70 (designated KHS in
this work), from the Clem lab at Kansas State University (Clem and Miller, 1994).
Two artificial proteins were synthesized. prMcleave and p450cleave and their sequences
can be found in Appendix B. These were cloned into KHS using EcoRI and BglII. Fused
in-frame downstream of each were Flippase (FLP), Gal4, and LexA::VP16 (LV) (from the
University of Massachusetts Medical School) using cloning sites BglII and NotI yielding con-
structs KHS-prMcleave::FLP, KHS-prMcleave::Gal4, KHS-prMcleave::LV, KHS-p450cleav::FLP,
KHS-p450cleav::Gal4, and KHS-p450cleave::LV. H. Huang originally cloned prMcleave::Gal4
and p450cleave::Gal4 into pCaSpeR-HS Actin, but they were then sub cloned into KHS.
FLP was PCRed from BH1465. The LV transcription factor binds to an 8LexA enhancer
which was PCRed from pSH18-34 (Invitrogen, Carlsbad, CA) and fused to a fragment of the
bottleneck promoter. A basal super core promoter (SCP) (Juven-Gershon et al., 2006), was
fused downstream of this fragment generating p8LexbnkSCP. Another 8Lex promoter was
constructed by the fusion of the UASp promoter element fused to the 8Lex sites and cloned
into KHS XbaI and ApaI with a PstI site between the 8LexA and downstream elements.
Rpr and Hid were cloned downstream using restriction sites ApaI and NotI.
The second generation ER targeting proteins were designed to carry amino acids 1-371
of CD4, either a prM or E transmembrane domain and a flexible linker with viral protease
1The GMR-NS2B40/NS3185 line used in crosses has been lost, as have the original GMR-drICE
vp lines.
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cleavage sites fused in frame with a recoded LexA::VP16 (nLV) protein. The final construct
in this series carried amino acids 1-29 of Erlin-1, a modified linker and nLV which was
synthesized. Each of these ORFs was cloned into KHS. The sequences for the components
used are given in Appendix B.
Gal4 and LexA::VP16 were cloned EcoRI/NotI and blunt/NotI, respectively, into KHS.
GFP was cloned into the pUASt vector (BH1517) EcoRI/NotI. Rpr, Grim, and Hid were sub
cloned EcoRI/NotI into KHS from BH stocks 1482, 1483, and 1484 respectively. H.sapiens
PKR, a kind gift of the Pierce lab at Caltech, was blunt/NotI cloned into KHS, pGMR-
1N and pUASt. A portion of the Dcr-2 ORF was cloned into pBlueScriptKS(+) (pBSK)
EcoR1/NotI for generation of dsRNA using the Epicentre AmpliScipe High Yield Tran-
scription Kits (Epicentre, Madison, WI).
Name Sequence 5’ to 3’
drICEvp 5’ Frag F GCG GAA TTC CAA CCA AAA TGG ACG CCA CTA ACA ATG GAG AA
drICEvp Viral Site R GCC GGA GCC GGA GCG CTT CAG CAC TCC GCC AGC CAA TCT
GTC GCC CTG GCA GGC CT
drICEvp Viral Site F CTG AAG CGC CGC TCC GGC TCC GGC ACG GAA ACC GCT GGC
GAC TCC TCG ATG AGC TAC AAG
drICEvp 3’ Frag R GCG GCC GCT CAA ACC CGT CCG GCT GGT GCC AA
drICEvp Site specific mut F CAG CCC AAC GAT CAC ACA GAT GTG CTG GGC TCC GTG GAT
CCG GAG
drICEvp Site specefic mut R CTC CGG ATC CAC GGA GCC CAG CAC ATC TGT GTG ATC GTT
GGG CTG
NS2B40/NS3185 F CGC GCG AAT TCC AAC CAA AAT GGC TGA TTT GGA ACT GGA
GAG
NS2B40/NS3185 R CGC GCG CGG CCG CTT ACT TTC GAA AGA TGT CAT CTT CA
NS2B Full length F GGC GCG GTT AAC CAA CCA AAA TGA GGA GCT GGC CAT TAA
ATG AGG CTA TC
NS3 Full length (fusion) R CCG GGG CGG CCG CCT ACT TTC GGA AAA TGT CAT CTT CGA
TCT C
NS2B/NS3 Full length internal F GCG GCA AAG AAG GAA CAT TCC ATA CAA TGT GG
NS3 Full length R GGC GGC GGC CGC CTA TTT CTT CCG GCT GCA AAT TCC TTA A
NS2B40 fragment F GGC GAA TTC AAC CAA AAT GGC CGA TCT GGA ACT AGA GAG
AGC
NS2B40 fragment R GGC GCG GCC GCC TAC AAT GTT TGC TCT TCC TCT TC
Prodomain(–) drICEvp F CGC AGA TCT CAA CCA AAA TGG TGC TGG GCT CCG TGG GAT
CC
drICEvp (hid fusion) R GGC GCT TCA GGG ATC CGC CTC CGC CAA CCC GTC CGG CTG
GTG CCA ACT G
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Name Sequence 5’ to 3’
hid (drICEvp fusion) F GGG AGG CGG ATC CCT GAA GCG CCG CGC CGT GCC CTT TTC
TTT GCC CGA
hid R GCG GCG GCC GCT CAT CGC GCC GCA AAG AAG CCA CA
NS2Bf (hid fusion) R GCG CTT CAG GGA TCC GCC TCC GCC AGT CAA TGT TTG CTC
TTC CTC TTC
Gal4 F (EcoRI) GGC GAA TTC ATG AAG CTA CTG TCT TCT ATC G
Gal4 R (NotI) GCG GCG GCC GCT TAC TCT TTT TTT GGG TTT GGT GGG GTA
TCT TCA TC
GFP F (EcoRI) GGC GAA TTC ATG GTG AGC AAG GGC GAG GA
GFP R (NotI) GCH GCG GCC GCT TAC TTG TAC AGC TCG TCC A
FLP F (BglII) GGC AGA TCT ATG CCA CAA TTT GGT ATA TT
FLP R (NotI) GCG GCG GCC GCT TAT ATG CGT CTA TTT ATG T
LexA F (BglII) GGC AGA TCT ATG AAA GCG TTA ACG GCC A
SCP Den 5’ F GCG CGG GTA CCG TAC TTA TAT AAG GGG GTG GGG GCG CGT
TCG TCC TCA GTT GTT AGT CTA CGT GGA CCG ACA
Den 5’ R CCC CCC TCG AGG AGG TCC TCG TCC CTG CAG CAT TCC
DIAPI Frag F GCC GCC TCG AGG CGC AGG CGT GCC GTC TCG ATG GCG
DIAPI Frag R CCG GGA AGC TTT CAA AAA TAA TAT AAA CAA AAC CAG
Den 3’ F GGC CGA AGC TTA GAT TCA GAA AAG AAG AGG AAG AGG
Den 3’/Ribo R CCC TCG GAA TGT TGC CCA GCC GGC GCC AGC GAG GAG GCT
GGG ACC ATG CCG GCC AGA ACC TGT TGA TTC AAC AGC ACC A
Ribo Rev 2nd Frag CCG CCG AAT TCT GGG TCC CAT TCG CCA TTA CCG AGG GGA
CGG TCC CCT CGG AAT GTT GCC CAG CCG GCG
Tubulin F CGC GGG AAT TCG CGT CAC GCC ACT TCA ACG CTC GAT
Tubulin R CGG CCG CGG CCG CAA AGA AAA ACA GTG GGG TTT TCT TA
hsp70 F ATA AAG AAA TTT CCA AAA TAA AGC G
hsp70 (Den 5’) R CTT TGT CGG TCC ACG TAG ACT AAC AAC TCC GTC GAC GAA
GCG CCT CTA TTT ATA
Den 5’(hsp70) TAT AAA TAG AGG CGC TTC GTC GAC GGA GTT GTT AGT CTA
CGT GGA CCG ACA AAG
AAIAP F GCG GCA AGC TTT GTG GGA ACA GAA CGA TAA TGT CCT
AAIAP R GGC GGC TCG AGT ACT CAC AGT TAC TAT ACC ACA TGG
3’(–) F GCG CGT CTA GAG AGG TCC TCG TCC CTG CAG CAT TCC
3’(–) R Ribo CCC TCG GAA TGT TGC CCA GCC GGC GCC AGC GAG GAG GCT
GGG ACC ATG CCG GCC AGT TGT TAG TCT ACG TGG ACC GAC
AAA G
Ribo R 3’(–) Build GGC GGG AGC TCT GGG TCC CAT TCG CCA TTA CCG AGG GGA
CGG TCC CCT CGG AAT GTT GCC CAG CCG GCG
Table 3.5: Oligonucleotide primers used in this study. This is not a comprehensive list, but
defines fragments used repeatedly and not fully annotated elsewhere.
Other constructs used in this study, KHS-synRprWT and KHS-synRprK!R(RprKR)
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were derived from Chun-Hong Chen’s constructs and subcloned into the KHS vector. UAS-
superHid (BH932), UAS-RprKR (BH979), pCaSpeRhsAct-GFP, pBSK and pBKS-IAP1
were pulled from lab stocks.
Vector Construction: Viral RdRp-Based Approach
Two constructs were built for testing in the fly eye, GMR-NS5, the full RdRp and methyl-
transferase protein from DENV2 and a substrate for it to act on consisting of the DENV2
5’ and 3’ ends terminated by a self-cleaving ribozyme and then the tubulin 3’UTR. These
frame a piece of DIAP1 antisense, and the whole cassette (D5DD3RT) is also driven by the
GMR promoter. The DENV2 5’ and 3’ ends were PCRed from pSY2-pSP64, a gift from R.
Padmanabhan at Georgetown. The super core promoter and HDV ribozyme (Walker et al.,
2003) were added via PCR. The fragment of DIAP1 was PCRed from BH1091. The tubulin
3’UTR was PCRed from a template provided by Haixia Huang and cloned EcoRI/NotI into
pGMR-1N. The remainder of the pieces were ligated together and PCRed to generate a
single PCR fragment that was cloned KpnI/EcoRI into pGMR-tubulin. The complete con-
struct D5DD3RT was subcloned into pBSK to allow for the changing out of the antisense
fragment. NS5 was subcloned from a vector provided by the Kuhn lab at Purdue. NS5 was
cut XbaI, blunted and then cut BamHI to drop it out of the pET15 vector it was in and
pGMR-1N was cut BglII/StuI to accept the fragment. These two constructs were used to
generate germ line transformants.
Tissue culture constructs were also generated. The pGMR-D5DD3RT was modified so
that when cloned into KHS the Dengue 5’ fragment initiated precisely at its 5’ end without
any extra nucleotides and so that the antisense fragment targeted Aedes albopictus IAP (AA-
IAP), producing construct KHS-D5AD3RT. A second construct, KHS-AD3(–)R, was built
that carried the AAIAP fragment, a dengue antisense 3’ fragment (D3’(–)) and the HDV
ribozyme. A pair of miRs targeting AAIAP at sites TCACCGATAACAAAGTTAAAGA
and GAAGATGAACCAAATAGAAAAC were designed using the miR6.1 backbone and
cloned into KHS.
Designed for another project that required the stabilization of noncoding RNAs, I had
synthesized a construct that carried the Kunjin and dengue 3’ ends which are known to
be highly structured and resist nuclease degradation (Pijlman et al., 2008), and an intron
to help expedite transport to the cytoplasm. Between the two viral fragments are cloning
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sites to allow placement of the desired antisense fragment. More information about this
sca↵old is provided in Appendix B. I cloned in and antisense fragment of AAIAP to generate
KHS-TSAAIAP. The addition of a stem loop to prevent 5’ to 3’ exonuclease activity was
included in a separate version of the construct, KHS-SLTSAAIAP. These were designed
to help evaluated the e↵ect of knockdown of AAIAP in Albopictus cells. A final antisense
construct, pU6-D5GFPD3 was built up in the pAc5.1 backbone. The Actin promoter was
removed by digesting BglII/KpnI and the components, including the Dengue 5’ and 3’ ends,
GFP, and the U6 promoter and terminator, were PCRed and cloned in a single enzymatic
assembly (EA) cloning reaction (Gibson et al., 2009).2
The final set of constructs are Barnase (Hartley, 1989) derived. The reverse complement
of Barnase was cloned upstream of the D3’(–) and the HDV ribozyme in KHS. EcoRI and
Xbal were used to clone Barnase and XbaI and SacI to clone the Den3’(–)R fragment into
pBSK and the completed fragment was subcloned into KHS producing KHS-RCBarnD3’(–
)R. The cloning of even the reverse-complement of Barnase required cotransformation with
a Barstar expressing plasmid to suppress the toxicity of the Barnase bearing plasmids.
Barstar was cloned into pRSF-1b (Novagen, Madison, WI) KpnI/NotI. This backbone was
selected because it allows IPTG-inducible expression of Barstar during culture and has a
RSF origin allowing both it and the pBSK or KHS plasmids to be concurrently expressed.
The cloning was carried out in T7 Express Iq cells (New England BioLabs, Ipswich, MA)
using kanamycin, ampicillin and IPTG. A separate Barnase construct carrying the reverse-
complement of the Barnase ORF with an intron was synthesized.
Vector Construction: PKR Designs
A set of three constructs, pAc-PKRdbd, pAc-PKRaaArk, and pAc-aaArk were built by one-
step cloning. PKR was PCRed from the KHS-PKR construct and aaArk was RT-PCRed
from a C6/36 RNA preparation.
Cells and Transfections
Drosophila S2 cells were maintained in Schneider’s medium 10% FBS, 1% penicillin and
streptomycin (P/S) at 27.5 C, passaged every 3-4 days. The Aedes albopitus C6/36 cell line
from the Strauss Lab was cultured in Dulbecco 1XMEM supplemented with nonessential
2See Chapter 4 and referenced appendices for further information on our use of EA cloning techniques.
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amino acids, L-glutamate, 10% FBS, and 1% P/S at 29 C with 5% CO2. Cells were
trypsinized when passaged. A culture of C6/36 received from the Clem lab at Kansas State
University were cultured in Liebovitz L-15 medium supplemented with 10% FBS and 1%
P/S at 29 C without CO2. KSU-C6/36 can be dislodged physically, so trypsinization is not
required for passaging.
C6/36 transfections were carried out using the FuGENE6 reagent. The most successful
ratio of FuGENE:DNA was 3µl:2µg. A GFP marker was often used, and always as 20%
of the DNA transfected. Use of endotoxin-free DNAs was essential for good transfection
e ciency. S2 cell transfections were optimally transfection using FuGENE6 at a ratio of 2.5
µl FuGENE:1 µg DNA. Immunofluorescence assays were carried out to assess viral infection
as described in Appendix B.
Drosophila Culture
Fly crosses were carried out under standard conditions at 25 C. Viral infections of D.
melanogaster were attempted through feeding. Extra Thick Blot Paper (Bio-rad, Hercules,
CA) cut to ⇠ 0.75 cm2 were soaked in viral containing media supplemented with 10%
glucose and provided to adult flies as their only food for 24 hours. The flies were then
returned to normal fly diet and rearing conditions.
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Chapter 4
Underdominance
4.1 Introduction
Project Motivations
Hand-in-hand with the need to engineer refractoriness cassettes to fight vector-borne disease
goes the need to deliver these systems into wild populations. Releases of engineered, lab-
reared animals carrying a refractoriness allele alone will not replace native populations of
insects. Generation of a genetically diverse laboratory strain has attempted to equalize
some of the fitness disparity between wild and lab-reared individuals (Valdez et al., 2010),
but with only limited success. This is partly due to the fitness costs associated with the
refractoriness alleles, but also because populations of lab-reared individuals (even genetically
diverse ones) are no longer as fit for wild survival. To address this problem, refractoriness
genes need to be carried by a drive system that will push the engineered chromosomes into
wild populations, despite their associated fitness costs.
Naturally occurring selfish genetic elements o↵er intriguing clues about the best ways of
accomplishing gene drive, but for the most part require engineering a priori, or at least re-
purposing to function in the target organism. Some, like Wolbachia, have a known agent and
can be translated across species (Ho↵mann et al., 2011; Walker et al., 2011), despite their
mode of action at the molecular level remaining mysterious. Others, like homing endonu-
clease genes and transposons, are understood at the molecular level and can be transferred
into organisms of interest (Carareto et al., 1997; Sinkins and Gould, 2006; Windbichler
et al., 2011). Lastly, some types of drive have known genetic behavior, but are not easily
moved between species either because of their specificity to the organism they are found in
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or because the molecular mechanism is completely unknown. Meiotic drive (unpublished),
Medea (Chen et al., 2007), and underdominance (Davis et al., 2001; Magori, 2005) are
drive systems that must be engineered to give the genetic behavior desired without nature’s
molecular blueprint. All of these systems o↵er ways to do population replacement, but
each has a unique set of drive characteristic and the types of concerns the public may have
about them vary as widely. Here I present work on underdominance (UD), and argue that
it represents an important tool in the e↵ort to deliver disease-resistant insect vectors to
needful communities.
UD systems can also address another, only partially satisfied, need in the genetically
modified organism (GMO) community. It is not always desirable for GMOs released into
the environment to interbreed with native organisms. UD can o↵er a tightly reproductively
isolated method of controlling gene flow between engineered and wild organisms. This
means that engineered animals could bear traits which might generate concerns about hy-
bridization with wild animals because no genetic exchange would occur between the wild
and native individuals. While the work here is not done in plants, the plant GMO com-
munity is especially interested in preventing the traits of their products from transferring
into unmodified species and is working on ways of achieving genetic isolation (Kwit et al.,
2011). Hopefully what we learn and the types of systems we are developing here could be
used by that community, and help to reassure the public of the safety of GMOs they would
wish to use in their nations and that the integrity of their ecosystems can be protected.
Conceptual Framework
Underdominance, also called heterozygote disadvantage, is defined by selection against the
heterozygous state. Animals homozygous for either of a pair of alleles is more fit than
an individual heterozygous at that locus in an UD genetic system. It is a genetic behavior
observed in natural populations that can be appropriated for use as a gene drive mechanism.
In an engineered system, the premise is that the two fit homozygous states are represented
by wild type alleles and engineered alleles. When an engineered allele and a wild allele
are carried by the same individual, fitness is compromised, or, in extreme underdominant
systems, eliminated.
The challenge in engineering an UD system lies in the fact that the heterozygous animal
would be the progeny of a wild and engineered mating, and that only one of the parental
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Figure 4.1: (a) Underdominance results when either of two homozygous states is more fit
than the heterozygous state. In extreme underdominance, the heterozygous is unviable.
(b) In the Davis model (left) the toxin remains constant and a pair of promoters and their
suppressors comprise the underdominant system. In the systems described in this work,
a pair of toxins and their antidotes are expressed from a promoter held constant. (c) In
a single locus, extreme underdominant system, outcrosses to wild individuals produce no
viable progeny. When the organisms are crossed to each other, 50% of the progeny survive.
animals (the engineered animal) can have an engineered genome. This means that the allele
generating the fitness disadvantage must somehow interact with the wild genome to enforce
the cost without doing so in the fully engineered background. Davis et al. suggested a way
around this hurdle by using a two allele system to generate a fit ‘homozygous’ engineered
animal, which is really a transheterozygote at the UD locus. The original system proposed
consists of a pair of alleles, each bearing a copy of a toxin driven by a di↵erent repressible
promoter, and the repressor for the complementary promoter (Figure 4.1). In this way,
carrying both alleles results in repression of both promoters, so no toxin is expressed and
the individual is viable. An individual carrying a single allele (as would be the case if
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the engineered transheterozygote mated to a wild organism) results in de-repression of the
promoter driving the toxic transcript. Trying to implement this system is di cult because
promoter/repressor pairs that are tight enough to remain o↵, but strong enough to kill are
a challenging component to identify and work with. Here we propose a simplified system
with toxin and antidote both derive from an expressed transcript, and do not rely on the
repression of promoter activity. This distinction seems small, but really opens up a wide
variety of toxin-antidote systems that can be worked with.
Drive Characteristics
One benefit of an engineered UD system is that due to its two allele functionality, single and
two locus systems can be engineered. These have distinct drive characteristics. Generation
of the single locus system requires site-specific integration via the PhiC31 system (Groth
et al., 2004) which allows the positioning of the two alleles at the same genomic locus.
Extreme underdominance, resulting in the death of individuals carrying only a single
allele, in a single locus system means that no hybrids between engineered animals and
native animals are produced. In e↵ect, the wild population and engineered population are
genetically isolated from one another and no gene flow occurs. As shown in Figure 4.2,
this means that replacing a local population requires a large release compared to the native
population, but also implied is that spread from the release area to neighboring populations
will be slow or non-existent. Additionally, removal of the system is possible through release
of a manageable number of wild-type individuals: A release of wild-type animals will drive
the fraction of engineered animals below the threshold required for population replacement.
If more drive is required due to increased fitness costs, or genetic isolation is not a
requirement for a specific release, a two locus systems o↵ers slightly di↵erent drive charac-
teristics. The initial releases required for population replacement are not as large, the time
to fixation is similar for comparable release and there is still a threshold that would allow
removal of underdominant animals from the wild if necessary.
This type of drive contrasts greatly with Medea’s drive. Medea, when released at low
ratios takes some time to drive, but unless eliminated quickly by stochastic events, will
always e↵ect complete population replacement when fitness costs are low. Medea is a very
aggressive drive system, which also means that once established in an area, it will be di cult,
if not impossible, to remove. Also, if there is significant migration, it will spread beyond
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Figure 4.2: Shown here are three graphs produced by Catherine Ward showing the drive
dynamics of Medea, and Single and Two Locus Underdominance. Each shows the same
parameter space and is a useful framework to compare the aggressiveness of drive and release
ratios required to e↵ect population replacement. The space below the lowest contour on
each graph represents conditions under which no drive can occur. This area is much larger
for both of the underdominant systems than it is for Medea.
the area of initial release.
While replacing all mosquitoes with refractory individuals is attractive in theory, com-
munities may show reluctance about the release of engineered organisms that cannot be
recalled or removed (Marshall et al., 2010). The animals will not respect international bor-
ders, and so releases in one country could upset neighbors who have not agreed to replace
their native populations. Underdominant drive o↵ers a di↵erent profile in that single and
two locus underdominance both have much less aggressive drive profiles. An additional
selling point is that they drive more quickly because of the large initial releases required.
The two locus system is not genetically isolated, but does drive quickly at intermediate
release thresholds, so in e↵ect engineered underdominance contributes two new tools to the
gene drive tool box.
Toxin and Antidote Systems
In the studies that follow, I worked with two distinct classes of toxin and antidote pairs. The
first relies on the use of a protein toxin, specifically the Drosophila cell death protein, Hid,
and miRNAs targeting recoded Hid transcripts as antidote. Other apoptotic proteins such
as Rpr or even exogenous toxins such as Barnase could be imagined in this role, but it is
important that some leak of the toxin be tolerated. Suppression occurs at the mRNA level
and if any protein is produced, its function cannot be suppressed by the miRNA antidote.
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Protein toxins have the advantage that their action is predictable, and several toxin-antidote
pairs are already extant. Their disadvantage lies in their instability on evolutionary time
scales. A single base pair change could ablate function of the toxin, disabling the system.
The second type of system I explore here uses miRNAs to deplete an essential transcript
in a sensitive and essential tissue as the toxin. The restoration through use of miRNA-
insensitive transcripts able to provide the protein when and where it is required serves as
antidote. The challenge in resupplying a necessary transcript is that often dose and timing
are important, however, there are several modes of supplying the antidote between two
cassettes. The first is through use of a split transcription factor, as is used in the yeast
two-hybrid system (Fields and Song, 1989). If each underdominant allele provides half of
the transcription factor, one the activation domain and the other the DNA binding domain,
bringing them together can instigate transcription from the upstream activation sequence.
This approach could likely provide a high dose of rescue, but relies on a tightly o↵ behavior
when the alleles are in isolation.
Another way to resupply a targeted protein is through the expression of the target
itself in two pieces. If the protein has a natural split point, small, charged coiled-coils can
be used to bring the two domains of the proteins together. Even if the protein cannot
tolerate coiled-coil reassembly, reconstitution of two expressed pieces into a single protein
may be possible through the use of inteins (Lockless and Muir, 2009; Schwartz et al., 2007).
If protein splicing is e cient enough, rescue could be e↵ected. The work described here
mostly falls into the transcription factor method of rescue, but the other methods are being
developed as well.
Approaches to UD: Induced Fitness Cost or Lethality
A functional UD system relies on the induction of a fitness cost in a target organism.
Extreme underdominance, the ultimate goal of this project, requires that no animal bearing
only a single engineered chromosome could survive in the wild. One significant challenge in
the construction of these systems is that both underdominant alleles must be introduced into
the genome of the target organism. These chromosomes must be introduced individually,
and tolerated until their compensatory allele can be crossed in.
One way to circumvent this challenge is through the generation of single underdominant
chromosomes that will not kill the individual. The underdominant system then relies on
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the distinction between fitness in the wild and fitness in the laboratory. Drosophila has
been the geneticists’ workhorse for over 100 years, and in that time a multitude of mutants
have been generated, many of which can be maintained in the lab but would not survive
or compete in the wild. This includes all manner of physical deformities including wingless
flies, blind flies and flies without a full complement of, or with too many, appendages. Many
of these mutations result from disruption of control sequences, but some are induced by over
expression or loss of a known transcript, and these can be used in underdominant systems.
If a phenotype that is tolerated in a laboratory system, but would critically compromising in
the wild, can be induced and then rescued, a viable toxin-antidote pair has been identified.
The other approach, a true lethals system, requires the use of an conditional or reversible
rescue. Each allele as it is generated is suppressed in a way that can be either discontinued or
removed from the genome of the animal. The cassette can introduce considerable complexity
to the system, but they are only required in construction stages and not for the function of
any system during or after release.
4.2 Results and Discussion
4.2.1 Protein Toxins
GMR Constructs
A great amount of work has been done in the fly eye with cell death proteins, so our
initial underdominance constructs derived from that work. The expression of the RHG
proteins produce small eye phenotypes when over expressed, and this death can be sup-
pressed through the use of miRNAs (Chun-Hong Chen, unpublished). HidAla3 (Bergmann
et al., 1998) was recoded at the DNA level to allow targeting of its mRNA specifically by
engineered miRNAs. Two version were made that di↵ered from one another so they could
be specifically targeted by synthetic miRNAs, and from the endogenous Hid transcript, so
that the normal function of Hid as part of the cell death machinery was not perturbed.
Three miRNAs were designed to target each version of Hid, with miRNA set 2 (m2) cloned
downstream of Recoded Hid 1 (rH1) and vice-versa, producing GMR-rH1m2 (UD1) and
GMR-rH2m1 (UD2). Each miRNA was located in its own intron. This generated con-
structs each bearing a toxin (Hid) and a rescue (miRNA) that targets the other recoded
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Figure 4.3: (a) Each chromosome bears a toxin, Hid, and a rescue, a set of miRNAs. The
Hids have been recoded at the DNA level to produce mRNAs specifically targeted by the
miRNAs. When a fly bears only a single chromosome, there is death in the eye, but when
it bears both, the eye is restored to its wild-type size, shape and patterning. (b) Cage
experiments investigating drive using the GMR-Hid UD system were conducted. The food
was elevated on a pedestal treated with SigmaCote and unable to be climbed by the flies,
and positioned in either a 12 in2 or 18 in2 cage.
Site-specific integration was used in this project so that single locus systems could be
developed and to be able to compare experiments to one another. Rainbow Transgenics
generated transformants of GMR-UD1 and GMR-UD2 at 86Fa and GMR-UD2 at 96E.
Toxicity from injecting these constructs was significant and GMR-UD1 transformants could
not be generated at 96E. Eye phenotypes at 96E were more severe, and the GMR-UD1 line
was less healthy at 86Fa than the GMR-UD2 line. Generating transformants was di cult,
probably due to leakage o↵ the GMR promoter in the embryo following injections. Many
of the later injections were injected in-house because so few G0s were received from com-
mercial injections. When 86Fa GMR-UD1 was crossed to 96E GMR-UD2, a fully rescued
eye resulted. This indicated that the miRNAs were functioning catalytically because the
expression levels at the two insertion sites di↵er.
I attempted drive experiments with these flies. Conversations with Dr. Michael Dick-
inson indicated that blind flies might not initiate flight, so I constructed a cage with an
elevated food source only able to be reached by flight. The food was positioned on a pedestal.
The pedestal was constructed by fixing a food vial to a glass rod coated with SigmaCote, a
material that makes the glass too slippery for the flies to climb up it. A mixture of Oregon
R, 86Fa-UD1, and 86Fa-UD2 were introduced into the habitat. Within 6 hours, all the
flies had reached the food source and stayed there. Mating, eating and egg laying were all
occurring on the food, so the blind flies were not being selected against and drive could
not be observed. While they might be compromised in the wild, blind Drosophila are not
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greatly disadvantaged in the laboratory.
Essential Tissue Constructs
The Hid system was then moved to essential tissues. Generating transformants carrying
only one of the alleles required for an underdominant system required a conditional or
reversible rescue. The first system I worked with utilized a Tetracycline (Tet) driven rescue.
Using the same tissue-specific promoter as was driving Hid, I drove expression of rtTA2S-
M2 (tTAV), a prokaryotic Tet operon binding domain fused to minimal VP16 activation
domain repeats. The Ptight promoter, which is recognized by tTAV, was cloned upstream
of a GFP open reading frame that carried a set of miRNAs able to suppress the toxin in
the 3’UTR of GFP. When fed Tet or Doxycline (Dox), the flies express a GFP marker and
miRNAs to suppress the Hid transcript. If reared o↵ Tet, no rescue is expressed and Hid
induces apoptosis. A schematic is shown in Figure 4.4a.
The Tet-inducible rescue was tested in a Hid-UD construct with GMR as the driver of
Hid and the tTAV protein. Despite the Clontech and other literature stating that Tet would
not activate tTAV (Gossen et al., 1995), it worked fairly well at high doses in flies. However,
many of the promoters I worked with were on during pupal development, and tests with
GMR-Hid UD constructs showed that Tet’s half-life was too short to e↵ect rescue through
this developmental stage. I also found, however that Dox was not well tolerated during larval
stages. To address these issues, I treated larvae with Tet in the food, and administered a
dose of Dox approximately 24 hours before pupation. This produced complete rescue of the
eye (Figure 4.5). The Tet-then-Dox treatment regimen was used in testing all of the Tet-
inducible cassette constructs. A second generation of the Tet-inducible rescue was tested.
It carried a 5’ intron and Kozak sequence (shown in Appendix C) upstream of the tTAV,
and these constructs are designated ntTAV. This design made no appreciable change to
e↵ectiveness of Tet treatments or degree of rescue.
A set of Hid-UD constructs targeting essential tissues were designed. The original pair
of promoters used were from Drosophila proteins giant (gt) and EDG84a. The gt enhancer
as described in Berman et al. (2002) is expressed significantly only in the early embryo
between 2–8 hours. The SCP was fused at the 3’ end of the enhancer. EDG84a is a cuticle
gene (Kayashima et al., 2005; Murata et al., 1996). The EDG84a enhancer has a short first
exon coding for four amino acids followed by an intron. The initiating ATG was mutated
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Figure 4.4: Shown are three modes of rescue, and how they are positioned in the underdom-
inant constructs. (a) The first conditional rescues (Tet, ntTAV) used were Tet-inducible
rescues. Feeding of Tet-induced expression of GFP and a set of miRNAs able to suppress
the Hid in the construct. (b) A second generation of rescue (FRTs) utilized the same GFP-
miRNA cassette expressed directly o↵ the tissue-specific promoter used to e↵ect killing.
This construct was removable through FLP excision. (c) The last construct shown in this
set (FlpeERT2-ex) operates by estrogen-inducible FLP excision in the germ line so that
parental animals fed estrogen produce progeny not carrying the cassette. This design was
not tested in flies. (d) In isolation, the chromosomes are toxic, but when both are carried,
as in the eye, Hid is suppressed and the animal is viable.
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Figure 4.5: GMR-Hid UD flies with a Tet-inducible rescue were used as a model for the
function of both the Hid underdominant system and the conditional rescue. An untreated
fly has shows the small-eyed phenotype expected from HidAla over-expression. Treatment
with Tet, either as a single dose in the food or repeatedly, gives only partial rescue of the eye
phenotype. Treatment Tet through the larval stages and then Dox shortly before pupation
resulted in complete rescue.
via PCR to prevent tagging of the tTAV and Hid proteins with the first four amino acids
of the EDG84a protein. These two enhancers were tested with the original Tet-inducible
rescue, and gave transformants of both UD alleles when injected in-house, but neither was
toxic when the animals were reared o↵ Tet.
Additional enhancers were tested that targeted various tissue. Other embryonic genes
tested were serendipity-↵ and scute (Deshpande et al., 1995). Several proteins involved
with nervous system development such as nerfin-1, nervy (Kuzin et al., 2009) and Dfd (Lou
et al., 1995) were also tested. In-house injections yielded transformants for at least one
Hid-UD chromosome for all 5 of these enhancers, although only Dfd gave some indication
that expression of Hid was killing. Co-injecting pAc-miRNAs constructs suppressed most
of the toxicity associated with injecting the Hid-UD constructs. Transformants of Dfd-
UD constructs were very hard to generate. Three di↵erent types of rescue, the original
Tet-induced rescue, the ntTAV rescue, and a blocked version like the bottom schematic of
Figure 4.4(a.), were tested. Transformants were only ever generated for one chromosome
of the FLP-excisable rescue, and I was unable to locate this insertion to the attB site I
was targeting. Dfd was revisited later when a final round of Hid constructs were built and
tested.
Two enhancers targeting muscle, mef-2 (Nguyen and Xu, 1998) and paramyosin (Hess
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Hid-based UD Constructs and Flies
Promoter Rescue Type Transformants Killing Rescue
none Both Y Y
Tet UD1 Y Y
GMR
ntTAV UD1 Y Y
FRTs UD1 Y Y
EDG84a Tet Both N
gt-SCP Tet Both N
Nerfin-1 Tet Both N
scute-hsp70 Tet Both N
mef-2-hsp70 Tet UD1 N
Tet N
sry-↵
FRTs UD1 N
Ubq Tet N
Tet UD11
Nervy ntTAV N
FRTs Y N
Tet N3
ntTAV N3
Dfd-hsp70
FRTS UD21 N
↵1-Tub Both N
Tet UD2 N2
hand-hsp70 FRTS UD1 N2
↵1-Tub Both Y N
Fln FRTs Both N
Table 4.1: Fly results
1Insertion was not at attB site.
2Killing was likely partial, and this was before we appreciated that ovo-FLP(8727) had a
variable activity.
3Several vials had dead late pupae.
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et al., 2007; Marco-Ferreres et al., 2005) were designed, although the paramyosin constructs
were never injected. The mef-2-Hid UD transformants were healthy when reared without
Tet. A Ubq-Hid UD construct was built, using a promoter provided by O. Akbari, but
no transformants could be generated. The heart enhancer, hand (Sellin et al., 2006), was
tested preliminarily at 86Fa without much success but was revisited about two years after
the initial phase of this project was put on hold. A comprehensive list of flies generated
and tested is shown in Table 4.1.
Testing of Estrogen-Responsive FLP
FlpeERT2 (Hunter et al., 2005) was tested in S2 tissue culture before generating Drosophila
carrying the estrogen responsive FLP excision cassette. Both FlpeERT2 and a derivative
of one of A. Kumar’s counting constructs, pAc-NoFlpCount were transfected into S2 cells.
The flippable construct is shown in Figure 4.6. When pAc-FlpeERT2 and pAc-NoFlpCount
were co-transfected, a great deal of flipping occurred even in the absence of either Tamox-
ifen (TAM) or Estrogen. I also found both these drugs to be toxic to S2 cells, even in
small amounts compared to recommended dosages (27 µM and 37 µM, respectively), al-
though these doses were derived from mammalian protocols. Heres-Pulido et al. (2004)
have shown some toxicity associated with TAM, and an estrogen responsive system has
been implemented in Drosophila (Thackray et al., 2000), although the literature remains
incredibly sparse. Doses used in these studies were lower than those I used, and toxicity
is not discussed. One concern I had was about the presence of estrogens in the FBS used
to supplement the S2 media. In the Thackary study, charcoal stripped FBS is used and so
I also used it for my studies, but the background rate of flipping was still extremely high.
At this point, I stopped development of the estrogen-responsive FLP because we could not
maintain an unflipped state in tissue culture.
Excision of FLP-Removable Rescues
I also built rescues that were not drug-inducible, and acted as blocking sequences that
separated the tissue specific promoter from the Hid ORF. These had to be excised by
introducing FLP into the germ line of Hid-UD bearing animals. The crossing scheme is
shown in Figure 4.7. Separate male and female germ line FLPs on the X chromosome, ovo-
FLP and  -tubulin-FLP, were obtained from the Bloomington Stock Center (Bloomington,
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Figure 4.6: The construct shown, NoFlpCount, was designed for use in flies and modified
for testing in tissue culture. When no FLP is present, GMR should drive GFP, but in
tissue culture GMR is not active, so there is no fluorescent signal. If flipping occurs, RFP
is expressed from the Actin5C promoter, which is very active in S2 cells. Shown here
are bright-field and RFP-channel photos from a transfection of pAc-FlpeERT2 and pAc-
NoFlpCount without estrogen or TAM applied. There is a great deal of flipping occurring.
IL), and crossed to homozygous Hid-UD lines. FRT flanked rescues that were expressed
from the same promoter as was driving Hid were cloned as well. These are marked and
excised in the same way as the blocking rescues, but are less clever because they are cloned
as a separate cassette and the toxin is still expressed.
The Hid-UD lines were marked with a somatic GFP showing the presence of the FLP-
excisable cassette and the attP site is marked with a 3XP3 (eye) RFP, so the unflipped
flies carry two fluorescent markers, scoreable in two separate tissues. Of the tissue specific
promoters we used, hand and prm gave strong, easily scored GFP phenotypes. For tissues
that did not give a strong GFP expression pattern, prm was used for subsequent sets of
constructs, as was the case with Dfd.
Progeny from the initial cross, F1 individuals, bear a GFP marker in the soma, an RFP
marker in their eyes, and FLP is expressed in the germ line. The F2 flies, if flipping has
occurred, will no longer be marked with GFP, but will still be marked with RFP. They
should only be viable if they carry both UD chromosomes. This crossing scheme allows
analysis of the e ciency of the various FLP lines and e cacy of the toxin. If F1 individuals
bearing a germ line FLP and a Hid-UD chromosome are outcrossed to w- (a wild type
line), no RFP positive, GFP-negative flies should be produced if killing is complete. The
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fraction of GFP-positive flies allows quantification of FLP e ciency, whether or not killing
is complete.
Figure 4.7: (a) GFP expression from the prm-hsp70 (top) and hand-hsp70 promoters at
PhiC31 insertion site 86Fa (b) Crossing scheme carried out to FLP-excise blocking rescues
Enhancers that were tested with FLP-excisable rescues were GMR, sry-↵, nervy, Dfd,
hand and Fln. GMR flies had wild-type eyes when blocked, and FLP excision did result
in a small eye phenotype indicating that the system was sound. Sry-↵ and nervy both
produced animals that were viable when flipped. I found one Dfd transformant from the
non-blocked FRT removable rescue, and flipping did not result in killing, but GFP was not
expressed and I also determined that this insertion was not at 86Fa. This fly was scored
an an inconclusive result. Hand seemed to give partial killing at 86Fa, and later studies
showed that the ovo-FLP line used had variable e ciency resulting in di culty scoring the
lines. The expected phenotype for Fln was the inability to fly, but expression of Hid o↵ this
enhancer did not produce flightless flies.
Final Set of Essential Tissue Constructs
Before this round of flies was generated, studies with miRNA toxin UD constructs began,
and the Hid-UD constructs were set aside. Recently, I generated one final round of Hid-
based constructs. I used the Dfd and hand enhancers to generate a set of Hid-UD alleles
as these two enhancers had given more encouraging results with both the Hid and miRNA
UD constructs. These also had the ↵1-tubulin promoter driving GFP and miRNAS as the
conditional rescue in an e↵ort to have a strong, unambiguous GFP marker and ubiquitous
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expression of miRNAs to suppress any Hid leakiness. DNAs were injected by Rainbow
Transgenics. Dfd insertions were generated at 58A and 86Fa. Hand insertions were achieved
at 51D, 58A, and 86Fa.
Figure 4.8: (a) The architecture of the final Hid-UD constructs tested (b) Killing and
generation of trans-heterozygous underdominant individuals
The ↵1-tubulin promoter did not give a GFP phenotype scoreable on the dissecting
scope, but either there was some expression and the miRNAs were e↵ective in suppressing
toxicity or the blocking sequence worked well because I had no di culty generating trans-
formants. In the F2 generation, some individuals were outcrossed to w- to assess killing
and others were crossed to the complementary UD line to generate transheterozygous indi-
viduals. Results are in Figure 4.8. The Dfd constructs failed to kill. The hand constructs
killed, but could not be rescued. Studies with this architecture are ongoing.
4.2.2 MiRNA Toxins
The miRNA-toxin-based UD system also requires two alleles, but in this case the toxin is
identical in each allele and the rescue is split between the two alleles. I used two archi-
tectures that were very similar to one another, di↵ering only in the placement of CTCF
insulators, designed to suppress genomic influences on expression. A schematic is shown in
Figure 4.10, and the components of the system are explained in detail below. The main
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advantage to this system over the protein toxin system is the robustness of the toxin. The
miRNAs can be multimerized and made to target multiple sites, so a point mutation in the
toxin itself or the targeted transcript should not result in broken alleles. This is desirable for
releases into wild populations where selection agains the system will be strong and diversity
of the population could result in varying sensitivity to any given toxin. There are many
choices for all of the key components in this system, and many of the experiments described
occurred in parallel or partially overlapped.
Split Transcription Factors and Promoter Development
The design of the miRNA-toxin UD system as we envision it is more complicated because
the rescue needs to be distributed between two alleles. The added complexity does not
increase the fragility of the constructs when thinking of a release because as long as the
toxin remains intact, any animals with a compromised rescue will simply die. We decided
to use a split transcription factor as the two component mode of rescue. The two parts of
the transcription factor would associate non-covalently when co-expressed in the targeted
tissue. In these designs, each UD allele bears the miRNA toxin and half of the transcription
factor. The rescue is expressed from an enhancer driving the replacement transcript as part
of each allele only when both halves of the transcription factor are expressed (when the
animal carries both UD alleles).
Before any flies were built, I tested the split transcription factors in tissue culture. A
split version of Gal4::VP16 had been shown to work in vivo in Drosophila (Luan et al.,
2006), but because of the work I had already done using the LexA::VP16 transcription
factor in my studies of the DENV sensors (described in Chapter 3), I tested that system.
The 8LexA enhancer was fused to a fragment of the UASp promoter (the basal piece that
does not bear the Gal4 UAS). This was cloned into the pAc5.1-HisB in place of the Actin
promoter. eGFP was cloned into the resulting plasmid, p8LexUASp, so that co-transfection
with the LexA::VP16 fused transcription factor resulted in eGFP expression. The fusion
worked very well as a control, shown in Figure 4.9.
I tested LexA with coiled-coils located N- and C-termially to the LexA DBD (Moll
et al., 2001; Arndt et al., 2001). I tested both the WinzipA2-WinZipB1 and EE12RR345L-
RR12EE345L coiled-coil pairs. I saw no expression with the WinZip pair, so in this study,
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Figure 4.9: In panel (a) are shown how the LexA::VP16 fusion and the LexA and VP16 with
coiled-coil domains function. (b) The results of a transfection using the split transcription
factor components in isolation, together and with the fusion LexA::VP16 as a control.
CC refers to the EE12RR345L-RR12EE345L coiled-coil pair. I also used Gal4DBD-CC as a
control when testing the LexA split transcription factor. LexA with an N-terminal CC gave
the best expression, better than Gal4DBD-CC with NLS-VP16-CC in my hands. Expression
induced by the CC-LexA and NLS-VP16-CC was similar to that achieved with a fused
transcription factor. One important modification I made to the VP16 was the addition of
the nuclear localization signal (AAPAAKKKKLD). Without it, there is no GFP expression
from the 8LexA promoters in S2 culture.
As fly studies with complete miRNA-toxin UD constructs progressed, leak o↵ the 8LexA-
UASp promoter became a concern. While it was not clear that level of leakiness observed
would compromise the function of the system, it was desirable to have other promoters avail-
able to test. I assembled three more 8LexA promoters. The first used the same fragment
of hsp70 used in the UASt and GMR promoters as both these are broadly and successfully
utilized. The 8LexA-hsp70 promoter was tested in tissue culture and gave a very robust
response to both the fused and split transcription factors. I also cloned two more minimal
promoters, each consisting of the 8LexA repeat, an ⇠ 60 bp spacer that was part of the
yeast 8LexA promoter construct (this was in all the 8LexA promoters tested), and a short
basal fragment. One was a short artificial TATAA segment (Butler, 2001), and the other
derived from the TATA box and downstream promoter element (DPE) from the Drosophila
sex combs reduced gene. Neither of these minimal 8LexA promoters gave GFP expression
in the tissue culture assay (data not shown).
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Figure 4.10: (a) The miRNA-based toxin is driven as part of the split transcription factor
by a tissue specific promoter. Transcription is blocked by a cassette like that in Figure
4.8. Once FLP is introduced, the blocking cassette is excised and the miRNAs are free
to suppress the targeted transcript, resulting in death. Half of the transcription factor is
produced, but alone cannot drive expression of the rescue. (b) When both constructs are
carried and FLP excision has occurred, the two halves of the transcription factor come
together and drive expression of the rescue. The target has been coded so as not to be
targeted by the miRNAs. (c) Shown here is a second architecture varying from that in
panel (b) by the placement of CTCF insulators, depicted as quadruples of small black
ovals.
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Target Selection and MiRNA Design
The use of miRNAs as a toxin allows the selection of any transcript as the target, but
it is necessary to select a transcript whose depletion in a given tissue or set of tissues is
toxic. These studies were commenced after I had had some success with the hand enhancer
in the Hid-UD studies, and so I continued working with the heart specific enhancer. An
RNAi screen in the heart using the tinman enhancer, which has a similar expression pattern,
showed that the depletion of several transcripts resulted in developmental lethality (Neely
et al., 2010). From this study, we selected RpL35a, a ribosomal subunit, and CG5266 a
proteasome subunit as primary targets. RpL35a is known to be haploinsu cient (Marygold
et al., 2007), so it seemed likely that it was a target I would be able to suppress su ciently
using artificial miRNAs. One concern, however, was that it might be di cult to rescue
if tissues were very sensitive to dosage. CG5266 is less well studied, but suppression of
several proteasome subunits by RNAi gave developmental lethality. CG5266 has a single
homologue in Aedes making it a good candidate for translating the system to the mosquito
upon success in Drosophila.
The initial triplets of miRNAs designed to target the RpL35a and CG5266 transcripts
were a compromise between good target sites and minimizing the amount of recoding of the
transcript necessary to render the rescue insensitive to the toxin. Each set had one miRNA
designed to target the 5’ UTR, one targeting the 3’ UTR and the last targeting the start
codon. As in the Hid-UD constructs, the miRNAs were positioned between the end of an
ORF, the split transcription factor, and an endogenous D. melanogaster 3’ UTR. In this
case, rather than each miRNA being positioned in its own intron, the triplet as a whole
was flanked by strong 5’ and 3’ splice sites. This ensures that the split transcription factor
mRNAs will remain stable even if the miRNAs are e ciently processed.
As understanding of miRNA design progressed in the laboratory, and use of the EA
cloning strategy became standard, later sets of miRNAs were designed such that a preference
was given to targeting the CDS exclusively. For the last set of CG5266 miRNAs designed,
we did not even shy away from clustering the targets all in one part of the transcript. A
list of all target sites used in the miRNA-UD constructs is shown in Table 4.2.
Tissue selection is an equally important consideration. In addition to the hand-hsp70
promoter targeting the heart, I also worked with Dfd-hsp70 and prm-hsp70 as the Hid-UD
constructs had seemed to indicate killing would be a major hurdle. prm-hsp70 was an espe-
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miRNA Target Sites
Target Sequence Location Killing Rescue
CGAGGCGGGTTTCTTCTATACA CDS
IAP1
GAAAGGAGCCAGAGAAGAAATT 5’ UTR
Yes1 D.ana ORF
ATACATTCATCGAACAACAAGC 5’UTR
RpL35a AACAACAAGCTAAGCCATGGCC ATG Yes RpL35a
TAAGGCGAGATACCGATTGAAA 3’UTR
CCAACTATTACGATGATGTAAT CDS
Fln
TCAGTATAAACACTATAGTAAA 5’ UTR
No Recode Fln
TCATTTTACACATCAAATCACT 5’UTR
CG5266 CCAGGAAATATGGCTACCGAAC ATG No Recode 5266
CCACAAGCTAAGCTTTCTTAAT 3’UTR
AAACACAAGTCACCGCTGTATG CDS
CG5266 CCATCCTTACGCTGAAAGAAGG CDS Yes2 Recode 5266
GAATCTGCGATCAGAACGGATT CDS
CATGGGCAAGAACGCAGTGAAC CDS
CG5266 CACCGCCATCCTTACGCTGAAA CDS Yes2 Recode 5266
TGAAAGAAGGTTTTGAGGGAAA CDS
Table 4.2: The targeted transcripts and the 22 bp target sites used in miRNA doublets or
triplets
1E↵ectiveness reported by Chun-Hong Chen, but not confirmed by my studies
2These sets of targets results in suppression, with the last set being most e↵ective (A.
Buchman, unpublished)
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cially aggressive choice as it is expressed broadly in muscle tissue throughout development
and into adulthood. I expected that ablation of any of these three tissues would result in
death of the animal.
I also built some non-lethal miRNA-UD constructs. The two tissues I targeted were the
flight muscle and the eye. The intention with the eye was again proof-of-principle, testing
of miRNAs sets, and observation and analysis of modes of rescue. The GMR promoter
expresses for a relatively long window during development, and so is a good model for a
proliferative tissue. The generation of flightless flies o↵ered a fitness deficit that I thought
could be challenged in the lab. A food source that cannot be reached by walking would
allow execution of a drive experiment in a caged environment. The cage we had designed
for the blind flies would o↵er a good habitat in which to observe drive. MiRNA toxins
tested in the eye targeted IAP and RpL35a. The flight muscle promoter, Fln, was used to
target flightin protein itself, in addition to IAP and RpL35a.
Other Construct Components
An additional worry was having the enhancer driving the toxin so close to the rescue,
and so partially artificial CTCF insulators (Kyrchanova et al., 2008) were positioned around
the rescuing portion of the construct. These were intended to limit both precocious rescue
from non-specific genome driven expression and reach-around by the enhancer.
The final major component to this design is the conditional rescue. Having found the
Tet-inducible rescues to be di cult to construct and not any more functional than simply
separating the promoter from the toxin, we decided to work with the FLP excisable rescues
as shown in Figure 4.4b, but without a miRNA suppressor. All of the constructs discussed
here required exogenous FLP to be crossed in as discussed in the previous section, although
a Tet-induced FLP cassette was designed and is still being tested in the lab. It is discussed
in Appendix E. These components were assembled into the Drosophila attB backbone and
injected by Rainbow Transgenics, Inc.
Fly Results
The initial set of flies generated carried RpL35a-targeting constructs driven by the
hands-hsp70, Dfd-hsp70 and prm-hsp70 promoters. As shown in Table E.1, these con-
structs all resulted in good killing. When the flies were crossed to germ line FLP flies and
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then outcrossed to w-, no survival of FLP-excised, UD construct bearing flies was observed.
Unfortunately, when the ovo-FLP/X; UD1/+ flies were crossed to the  -tubulin/Y; UD2/+
flies, no transheterozygous progeny were recovered. The RpL35a rescuing cassette was not
su cient to resupply the protein and rescue.
CG5266 targeting UD constructs were also used to generate flies. Constructs driven
by the hand-hsp70 and prm-hsp70 promoters were injected. Unfortunately, the CG5266
flies were healthy, even after FLP excision of the blocking ORF. This, however, gave us an
opportunity to examine the function of some of the system components.
I began working with the hand-CG5266-LexA and hand-CG5266-VP16 flies because I
noticed that the ovo-FLP/X; UD1/+ X  -tubulin/Y; UD2/+ progeny could be categorized
into two groups: those with wild type wings and those with delicate, fluid filled wings.
Initially, we hypothesized that perhaps suppressing CG5266 in the heart, while not lethal,
did induce a fitness cost (these flies had significantly worse survivorship in addition to the
wing phenotype, but were fertile). I sorted the flies into two groups, the healthy flies and the
sickly flies, and genotyped individuals. If the miRNAs were inducing the sickly phenotype, I
expected to see the healthy winged flies carried both the LexA and the VP16 UD alleles, and
that the sickly flies bore only one UD allele. Instead, I observed that the sickly phenotype
segregated with the LexA allele, as shown in Figure 4.11. This suggested that expression
of the CC-LexA protein in the heart was causing the sickly phenotype. Later experiments
by Anna Buchman indicated that suppression of CG5266 in the heart also produced this
phenotype, so it is likely a result of compromised heart function in Drosophila.
The viable CG5266 flies allowed me to ask two more questions: whether or not the
LexA-VP16 split transcription factor was coming together to activate transcription of the
rescue, and whether the 8LexA-UASp promoter I had constructed leaked. To do this, I
pooled the sickly flies, some of which would carry both LexA and VP16, and the healthy
flies that carried only VP16, and carried out RT-PCR to assess the level of expression of
the rescue transcript. I was able to sample the rescuing transcript without contamination
from the native transcript because the region across the start codon had been recoded so
as to be insensitive to the miRNA toxin.
In flies carrying only the VP16 allele, polyT priming did not give rise to a CG5266 band,
but gene-specific primers (GSPs) gave a faint band. The endogenous hid transcript was used
as a positive control for the RT and PCR reactions. When the mixture of LexA only and
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Figure 4.11: (a) The sickly phenotype segregates very cleanly with the LexA allele. Carrying
both alleles does not alleviate the fitness e↵ects of LexA expression. (b) Expression of the
CG5266 allele is weak, but detectable with gene-specific primers (GSP) in flies carrying
only the VP16 allele. Expression is greatly enhanced when some of the flies in the sample
carry both LexA and VP16 alleles.
1The CG5266 control band is from a plasmid template and gives a larger product than the
RT-PCR bands because the plasmid carries a genomic CG5266, which has introns totaling
approximately 325 bps.
LexA/VP16 flies was assayed, a CG5266 band was visible with both a polyT primer and
GSPs. This is not quantitative, but I felt comfortable concluding that the transcription
factor does assemble in vivo and initiate transcription of the rescuing transcript. There was
some leak occurring from the 8LexA-UASp promoter, however, and it was of concern, so
this lead me to test other 8LexA promoters. As mentioned previously, the minimal TATAA
and DPE promoters did not function in tissue culture, but fly constructs were built using
the 8LexA-hsp70.
Around this time, I also began to notice non-uniform GFP phenotypes and eye colors
from my 86Fa lines. While it is still unclear what the cause of this was, I moved away
from the 86Fa line and began working with the 8621 attB line. Injections of hand-RpL35a
with the 8LexA-hsp70 promoter gave identical results to those achieved at 86Fa with the
8Lex-UASp promoter, but results from other lines indicate that 8621 is not a particularly
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miRNA-based UD Constructs and Flies
Promoter Target Rescue Promoter Injection Site Killing
IAP1 8LexA-UASp 86Fa No
8LexA-UASp 86Fa Yes
hand
RpL35a
8LexA-hsp70 8621 Yes
8LexA-UASp 86Fa Partial1
CG5266
8LexA-hsp70 8621 No
Fln 8LexA-hsp70 8621 Partial2
Fln IAP1 8LexA-UASp 8621 No
RpL35a 8LexA-UASp 8621 No
IAP1 8LexA-UASp 86Fa No
Dfd
RpL35a 8LexA-UASp 86Fa Yes
IAP1 8LexA-UASp 86Fa No3
GMR
RpL35a 8LexA-UASp -4
8LexA-UASp 86Fa Yes
prm
RpL35a
8LexA-hsp70 8621 Yes
CG5266 8LexA-hsp70 8621 No
Table 4.3: Fly results
1Killing was attributed to expression of LexA.
2Only a single LexA line was flightless and had a very dark eye color. This could be due to
over-expression of LexA, an o↵-target insertion, or both.
3A surprising result, as this miRNA pair had been shown to kill previously (Chun-Hong
Chen, unpublished.)
4No transformants were generated.
strong site. A complete list of systems tested is in Table E.1.
With miRNA suppression of RpL35a unable to be rescued, and CG5266 miRNAs unable
to kill, I went back to a protein whose depletion is known to induce apoptosis, IAP1.
Unfortunately, despite the miRNAs against IAP1 having been reported to work, I did not
observe an eye or flight phenotype. Testing with the hand-hsp70 or Dfd-hsp70 promoters
also failed to give lethality.
I built a non-lethal system using the Fln promoter driving miRNAs targeting the Fln
mRNA. I did generate one flightless line, a LexA allele. Many Fln-VP16 and other Fln-
LexA insertions were isolated, but all were able to fly. Given my previous data indicating
that expression of LexA on its own can be toxic, it is possible that the flight muscle was
not compromised due to loss of the Fln transcript, but only due to LexA expression. Also,
the eye color was not as expected for the injection site, so it was likely an ectopic insertion.
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Flight was not was not rescuable by crossing Fln-VP16 line to the flightless Fln-LexA line,
also indicating that the phenotype might not have been due to the action of the miRNAs.
Untested Constructs
I next needed to determine whether the leakiness from the 8LexA promoter was preco-
ciously rescuing the CG5266 constructs or the miRNA toxin was not potent enough to kill.
Two additional sets of miRNAs were designed. For the first set I selected three targets, but
tried to distribute them throughout the transcript. The second set of targets was selected
by Geo↵ Pittman who took the optimal targets which clustered very near each other, with
two of the three actually overlapping. Blocked kill only constructs using the VP16 allele and
each of the three sets of miRNAs were sent out for injections (Figure 4.12), but BestGene
could not generate transformants. At this point, I moved on, but Anna Buchman later
tested the three sets of miRNAs in tissue culture and then in the fly eye. She determed that
the original set gave the weakest killing, and that the clustered, overlapping set gave the
strongest. These miRNAs are now being used to test alternative methods of rescue such as
using inteins to reassemble the rescue protein.
Figure 4.12: This construct bears only the VP16 portion of the split transcription factor
and the miRNA toxin. It is nontoxic until the blocking cassette is excised, and allows the
testing of miRNA killing in the selected tissue.
The final set of constructs that I built (but did not test) were intended to address the
clear fitness cost induced by the expression of CC-LexA. The 8LexA promoter was replaced
by the Gal4-UASt promoter, and CC-Lex replaced by a CC-Gal4DBD. Versions containing
the most potent set of CG5266 miRNAs and the hand promoter were developed, but not
injected and I moved back to working on the Hid-UD chromosomes. If a tissue sensitive to
knockdown of CG5266 can be identified, this Gal4 system should be tested.
4.3 Future Studies
Development of underdominance in Drosophila remains an important goal in the field of
insect engineering. The current tool set is limited, and underdominance o↵ers two di↵erent
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drive profiles each of which is not currently available. Working in Drosophila still o↵ers the
best chance of developing a drive system model which can then be moved into pest insect
genomes.
Protein Toxin Underdominance
When considering the hurdles to protein-based UD development, one important set of tools
that is still being developed are the transcriptional profiling data sets. There is a massive
amount of data available now that did not exist when we carried out our initial enhancer
selections. Some of the choices we made initially in light of this data look very good, like
the hand enhancer. The expression pattern is tight, and it is on during later embryogenesis,
all larval stages and the pupal to adult transition giving a good window for killing. Others,
like EDG84a, show a strong pulse at a single developmental stage that may or may not be
particularly sensitive to killing. A short window with moderate expression levels might not
be the best sort of profile to pursue. With what is now known, the enhancer for ACP65a,
also a cuticle gene, might be a better choice because its overall expression level is higher
and it is on through the pupal-adult transition.
These data sets do not, of course, guarantee that the enhancer selected will give rise
to the desired expression pattern, but they can guide enhancer selection. Eliciting the
expression pattern desired is more likely when starting with an enhancer for a gene that has
the potential to give rise to that pattern. Looking back at the enhancers we screened earlier
could reveal some that warrant more study and new candidates could also be identified.
I also think that a stable, strong PhiC31 site has finally been identified in 51D. Conduct-
ing comparable experiments is important for understanding the function of our components,
and testing enhancers that were previously unable to kill at this site might breathe new life
into some of the constructs that have been set aside. Taking constructs that kill at some
sites, but not others, like the hand-hsp Hid-UD constructs could also help identify other
PhiC31 sites that have strong somatic expression.
As my constructs evolved, refinement of the conditional rescue reduced the overall size
and complexity of the UD-alleles. The ‘doubly-o↵’ system of expressing GFP in place
of the toxin and placing rescuing miRNAs in the 3’UTR expression allowed for the easy
generation of transformants. In future, use of this rescue paradigm will ease the generation
of transformants and speed the experimental cycle.
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The Hid-UD system appears to be on the verge of functioning. It’s unclear why rescue
cannot be e↵ected in the heart when it appears to be so complete in the eye. It is possible
that the long expression window from the hand enhancer allows for enough Hid protein to
be produced that it is toxic. Using a wild-type version of Hid could solve this problem, but
might not prove a potent enough toxin. The miRNAs may also not function well enough
through all the developmental stages of the heart to keep Hid suppressed. Increasing the
number of miRNAs, the number of sites targeted, or the backbone used may all help. Some
of these solutions are already being tested.
MiRNA Toxin Underdominance
The hurdles of the miRNA toxin approach are di↵erent. The studies described here have
revealed a lot about many of the components of the system, but discovering the di culties
is not the same as finding solutions.
It seems target selection must be done empirically. Despite working from an RNAi
study focused on the same tissue I was targeting, killing remained hit or miss. This is
likely due to e↵ectiveness of miRNA targeting, sensitivity of the tissue to depletion of the
transcript, and stability of the protein produced. Reverting to the use of the promoter in
the RNAi study, tinman, did not enhance our killing. Redesign of miRNAs has improved
killing as observed through their suppression of CG5266 in the eye, but all three sets of
miRNAs gave killing in tissue culture. Killing using these miRNAs in the heart, even the
best set, is ambiguous as the sickly phenotype is partially penetrant and the adults are
fertile. Additionally, expression of the RpL35a miRNAs (which kill quite e ciently in vivo)
in tissue culture did not kill S2 cells, indicating tissue culture may not be a reliable test
bed for miRNA e cacy. Ultimately, this means that each system must be tested directly in
flies—a slow and painful process because each set must be blocked by a FLP-excisable rescue
that requires genetic removal, unless the Tet-inducible FLP system can be implemented.
The mode of rescue presents more di culties. It is clear from this work that the LexA-
VP16 transcription factor can induce expression in vivo, but also that the 8LexA promoters
tested so far have significant leak in the heart, and likely other tissues as well. The CC-LexA
used in most of my designs also clearly results in a fitness cost on its own. The Gal4 system
has not been tested, but is likely to give somewhat weaker expression based on tissue culture
experiments, a problem because expression of the rescuing RpL35a transcript already seems
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insu cient. Getting away from split transcription factors would eliminate promoter leakage
and fitness costs from that rescue approach, but the intein rescue, which allows reassembly
of the native protein, is likely to be fairly ine cient. Initial tests in the eye have shown
that it cannot rescue the small eye phenotype induced by miRNA suppression of CG5266.
Since I last worked on this project, the PhiC31 insertion site issues seemed to have been
resolved and expression at 51D using the hand enhancer is very strong. One more e↵ort
with RpL35a seems called for, especially because the constructs needed could be easily
assembled with parts available. The very 5’ end of the RpL35a rescue could be recoded to
be insensitive to the miRNAs with a single primer, and the Gal4-VP16 split transcription
factor could be tested. Use of new translational enhancers could boost protein production
induced by the Gal4-VP16 transcription factor (Pfei↵er et al., 2012).
Ultimately the di culty with the miRNA approach lies in the large number of parts
that must be individually tuned and the fact that observing their behavior in flies requires
a large time investment and a large number of transformants. In-house injections into a
stable, strong PhiC31 site will allow progress at modest cost, but on long time scales.
4.4 Materials and Methods
Protein Toxin Constructs
The first generation underdominance constructs were cloned by traditional methods into the
Drosophila attB vector with an multiple cloning site (MCS) comprised of 8 bp restriction
sites. The 5’ end of HidAla3 was PCRed from BH932 and cloned PmeI/AsiSI. The tubulin
3’ UTR was PCRed from pGMR-D5DD3RT, described in the previous chapter, and cloned
in AscI/SwaI. Two versions of the 3’ end of Hid were recoded and synthesized by GeneArt
(Regensburg, Germany) as were the two triplets of miRNAs that targeted these recoded Hid
fragments. The 3’ Hid fragments were cloned AsiSI/FseI and the miRNAs FseI/AscI. The
GMR promoter was PCRed from pGMR-1N and cloned PacI/PmeI. Annotated versions of
the miRNAs and the recoded Hid 3’ ends are shown in Appendix C. The pair generated
comprises the original set of underdominance constructs, attB-GMR-rH1m2 (UD1) and
attB-GMR-rH2m1 (UD2). UD1 constructs always carry Hid version 1 and miRNA set 2
and vice versa for UD2 constructs.
Conditional rescues were assembled separately. The original Tetracycline-inducible res-
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cuing cassette was assembled in pBSK. Ptight (XhoI/HindIII) and rtTA2S-M2 (SpeI/BamHI)
were PCRed from plasmids that are part of the Tet-On Advanced Inducible Gene Expres-
sion System produced by Clontech (Mountain View, CA).  -tubulin 23c (EcoRI/PstI) and
Actin 88F (BamHI/PstI) 3’ UTRs were PCRed from Drosophila genomic DNA. eGFP
(HindIII/EcoRV) was PCRed from the KHS-GFP construct. The tissue specific promoters
were cloned NotI/SpeI. Each set of miRNAs was cloned via the enzymatic assembly (EA
cloning) procedure (Gibson et al., 2009) into an EcoRV site. This procedure is more fully
documented in Appendix C. Primers for all these components are shown in Table 4.4 and
a schematic in Figure 4.4.
The second generation of UD constructs were made targeting essential tissues. Promot-
ers PCRed from genomic DNA and cloned directly into the attB-UD constructs PacI/PmeI
were Nervy (Kuzin et al., 2009) and Serendipity-↵ (sry-↵) (Ibnsouda et al., 1995). EDG84a
(Kayashima et al., 2005; Murata et al., 1996) was cloned as a complete promoter, but with
its native ATG mutated away via PCR. The super core promoter (SCP) (Juven-Gershon
et al., 2006) was PCRed onto giant (gt) (Berman et al., 2002). Other enhancers were PCRed
from genomic DNA and cloned into pBSK NotI/XbaI. A fragment of the hsp70 promoter
was cloned downstream XbaI/SpeI. Complete promoters were then PCRed and cloned into
the attB-UD backbone and the Tet-inducible rescue. Enhancers cloned in this manner are
scute (sc) (Deshpande et al., 1995), Nerfin-1 (Kuzin et al., 2009), mef-2 (Nguyen and Xu,
1998), hand (Sellin et al., 2006), deformed (Dfd) (Lou et al., 1995), and paramyosin (prm)
(Hess et al., 2007; Marco-Ferreres et al., 2005). The primers that define all these fragments
are in Table 4.4. These promoters were then sub cloned into the attB-UD constructs. A
final promoter, flightin (Fln) (Rider et al., 2011) was cloned as an alternative to essential
tissue targeting into the Hid-UD constructs.
Name Sequence 5’ to 3’
Ptight F GGC ATC GAT GCG ATC TGA CGG TTC ACT AAA CG
Ptight R GGC CTC GAG TTA ATT AAG TAT CAC GAG GCC CTT TCG TCT TCA
Gamma Tubulin UTR F GGC GGA TCC TCG CTT GTG CCA GAA GAA ATG C
Gamma Tubulin UTR R CTG CAG ATT TAA AAA CTG TTT TTT ATT TAA TGT GTC
Actin UTR F (3’ End) GGC CTG CAG AAA ATA TTT AAT AGT TTT AAT GGA AG
Actin UTR R (5’ End) GGC GAA TTC GTC TTT CGC CCG CCG CGA AAG CTC
tTAV F GGC ACT AGT ATG TCT AGA CTG GAC AAG AGC A
tTAV R GGC GGA TCC TTA CCC GGG GAG CAT GTC AAG G
GFP F (EA) ATC GAT AAG CTT GAT ATG GTG AGC AAG GGC GAG GAG CTG T
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Name Sequence 5’ to 3’
GFP R (EA) AAA GAC GAA TTC GAT ATC TTA CTT GTA CAG CTC GTC CAT GCC
miRNA F (EA) AAA GAC GAA TTC GAT ATC ATA TTC TAG AGT TGA TGG ATC CGT AG
miRNA R (EA) CTG TAC AAG TAA GAT ATT AAA AGA TCT ATG GCA TAC CC
Tubulin UTR F GCG GCG CGC CGC GTC ACG CCA CTT CAA CGC TCG AT
Tubulin UTR R GGC GAT ATC ATC GAT GCG GCC GCA TTT AAA TAA AGA AAA ACA GTG
GGG TTT TCT TA
gt F GGC TTA ATT AAA GAA ACT TAC CAT CAC TTC GAG ATG
gt R w/ SCP GCC GTT TAA ACC GGT CCG TAG GCA CGT CTG CTC GGC TCG AGT GTT
CGA TCG C
EDG84a F GGC TTA ATT AAA ATT CTT TTT TAT TAA TTT TAA AGT TAC
EDG84a R I ACT TGT AAA TAA CAC ATG ATA TAC CTT AAC CAA AAT GCT GAT CGA
ATT TTT AGG TTG ATG
EDF84a R II GGC GTT TAA ACA GTC TGT ACG TGG TTA AAG GAT TAG GAT AAA GGC
AAG CCA ACT TGT AAA TAA CAC ATG
hsp70 F GGC TCT AGA ATC CCA AAA CAA ACT GGT TGT TGC GG
hsp70 R GGC ACT AGT GGT GGC GAC CTT AGG AGA TCT GC
Dfd F GGC TTA ATT AAT GAC CTG ACC CAT GTT AGT TCA CAT TTT TC
Dfd R GGC TCT AGA GCA AGG GGA TGG GTT GGT TAC G
Ubq F GGC GCG GCC GCC GCG CAG ATC GCC GAT GGG CGT GGC GC
Ubq R GGC ACT AGT TCT GCG GGT CAA AAT AGA GAT GTG G
Nerfin F GGC TTA ATT AAG TGT CTG CTA GTC TGT TAG TCT G
Nerfin R GGC TCT AGA CTC GAG TGT CCT TTT TCG ACG CCG GC
Nervy F GGC GCG GCC GCC TAA AGC CCT CGA TGT GCC CAT TTC C
Nervy R GGC ACT AGT TCC GAC CAG TCG TAA GTG GCG TTT G
hand F GGC GCG GCC GCG TAA GAG AGT AAT TTA CTT TGT CAT GC
hand R GGC CTG AAA TAT AAA TTG TCA TTA TTA ATT GGA ACA
sc F GGC TTA ATT AAT ATC TGT ATC TTA GCA TCT TTA CCC ATA TCG
sc R GGC TCT AGA TGG ACC ATG GCG ACG CGT GGC AGG TGT ATT
mef2 F GGC GCG GCC GCG AAG AAA CCC CTG CCA AGC AGT TAA
mef2 R GGC TCT AGA ATT CTG ATT CCC GTT TGC AGT GTC C
Sry-↵ F GGC TTA ATT AAG GTA GTC CTT TGC TAG ATT AAT CTA AGA AGC C
Sry-↵ R GGC GTT TAA ACG CTG TTC TAT CAG ATG TGC TCC GGG AAA C
prm F GGC GGC GCG CCT CAA GTA GGC ACA CAC TCT
prm R GGC CCT AGG GTG AAA ATT CTC GTT CGT CTT CGA GCG
Table 4.4: Oligonucleotide primers used to construct the tetracycline-inducible rescue and
to isolate promoter fragments used in protein-kill UD constructs
Additional conditional rescue cassettes, also diagrammed in Figure 4.4, were cloned
using a subset of the above parts and a few others. FLP was PCRed from lab sources,
and contained a glycine at position 5 of the protein (Nern et al., 2011). The FRT sequence
used was GAAGTTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTT
74
C (Zhu and Sadowski, 1995). It was PCRed onto components using a pair of primers
each time. I assembled them as few times as was possible because they were prone to
mutation and the PCRs were di cult to perform because they have a large degree of
self complementarity. These later versions of the rescue were assembled using EA cloning
(Gibson et al., 2009). Primers had 30 bp of sequence overlapping the neighboring fragment
and 30 bps that annealed to the fragment being amplified.
Two other modes of rescuing were also built, but never tested. The first utilized an
RU486 inducible Gal4 that drove GFP and miRNAs, just as in the Tet-inducible system.
This utilizes the canonical Gal4 UAS, PCRed from lab sources and Gal4 from the P{Switch}
system (Roman et al., 2001). These components were cloned into the Tet-inducible rescue
in place of Ptight and tTAV. The second system utilized a FLP modified to function only in
the presence of estrogens to excise the rescuing functionality from the UD construct. This
system used the bag-of-marbles germ line promoter, PCRed from genomic DNA, to drive
FLPe-ERT2 (Hunter et al., 2005). The cassette also carried the tissue-specific promoter
being used to drive the toxin as the driver for a GFP marker and a rescuing set of miRNAs
(Figure 4.4b).
The final set of Hid UD constructs bore the ↵1-tubulin promoter, PCRed from genomic
DNA, driving GFP and a rescuing set of miRNAs between FRTs sites (the first positioned
downstream of the tissue specific promoter, and the second downstream of the UTR of the
GFP-miRNAs cassette). FLP excision required introduction of a germ line FLP via crossing
to a germ-FLP bearing fly.
MiRNA Toxin Constructs
The split transcription factor I used consists of the LexA DNA binding domain (DBD) and
the VP16 activation domain (AD), each tagged with a coiled-coil (Arndt et al., 2001; Luan
et al., 2006). The AD was also tagged with a nuclear localization signal, AAPAAKKKKLD.
The two halves, CC-LexA and NLS-VP16-CC, were cloned into the pAc5.1-HisB backbone
EcoRI/XbaI. The coiled-coils and nuclear localization signal (NLS) were fused to the DBD
and AD by PCR. A short flexible linker (AGSSTGSSTG) was inserted between the coiled-
coil and the DBD or AD. The codon optimized LexA::VP16 described in Chapter 3 was
also cloned into pAc5.1-HisB. The Actin5C promoter was removed from the pAc5.1-HisB
backbone BglII/KpnI and replaced with the LexA UAS (8LexA), PCRed from pSH-18-34,
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fused to one of several basal promoters. Basal promoters tested were UASp, hsp70, the
sexcombs reduce DPE, and a minimal TATAA fragment described by Butler (2001).
Name 30 bps of the 5’ and 3’ ends of each fragment, 5’ to 3’ Source
ATACATATCCATATACATATCCATATCTAA
UASp
GATTAGTTTTTTAGCCTTATTTCTGGGGTA
pSH18-34
TCGATAGCCGAAGCTTACCGAAGTATACAC
8lexA
ACAATAACGTGACTGTGCGTTAGGTCCTGT
pCaSpeR5-UASp
GCGAAAAGAGCGCCGGAGTATAAATAGAGG
hsp70
AACAAGCGCAGCTGAACAAGCTAAACAATC
pGMR
TGCATGCCTGCAGGTCGGAGTACTGTCCTC
UASt
ATTATTGAATACAAGAAGAGAACTCTGAAT
pUASt
TTATTGATGCTCAGAAATTTGAATTATGCC
DPE
TTGGCGCTTCGTGCACGTATCCGCGGATAC
Genomic
GGCTATAAAAGGGGGTGGGGGCGCGTTCGT
TATAA
GACGTGCCAAATCTCATGTCCGCCGCCGCT
PCR Assem.
CCTTGCAGCGCCACCTGGCCGCGAAGAGTT Genomic +
CTCF
ACAACTCACACCTTGCAGCGCCACCTGGCC PCR Add-on
GTCTTTCGCCCGCCGCGAAAGCTCTTCAAA
Actin 3’ UTR
ATATCTTCCATTAAAACTATTAAATATTTT
Genomic
TCGCTTGTGCCAGAAGAAATGCGTGCCATG
 –tubulin 3’ UTR
TGACACATTAAATAAAAAACAGTTTTTAAA
Genomic
ATGGCAAATGTGGTAACCAGCTCGCGGTAT
D.ana IAP
ACCGATGTGATGCGTGTATATTTTTCTTAA
D.ana Genomic
ATGGCCGACACACAAGCCAAGTCCACTACT
RpL35a
TTGCAGATGCTGTACCCATCAAGGATTTAA
Genomic
ATGGCAACTGAGCGATACAGCTTTTCGTTG1
CG5266
ATCAAGGACTACTTGGCCAGCATCCCCTAA
Genomic
ATGGCAGACGAAGAAGATCCATGGGGTTTC
Fln ORF
ATCAACCAAAGGTATGCCAGTGTCCTTTAG
Genomic
CGTTCCCGTGATAGAGTAACGGTTCCTTTT
Fln Promoter
TCAGTGGACCCAATGTCCTAGTTTTAGCTG
Genomic
ATGGCGGCTCCGGCTGCCAAAAAGAAGAAA
NLS-VP16-CC
CAGTATCGGACACGATACGGCCCACTGTAA
pAc-NLS-VP16-CC
ATGTTGGAAATTCGTAGGGCCGCTTTTCTG
CC-LexA
GAGCTCCATCTGGACGGCGAAGACGTTTAA
pAc-CC-LexA
Table 4.5: First and last 30 bps of fragments used in the miRNA-toxin constructs
1The 5’ end is recoded to make it insensitive to the miRNA.
The architecture of the full UD constructs utilizing miRNA-based killing and a split
transcription factor rescue is shown in Figure 4.10. The assembly of all of these constructs
was achieved through EA cloning (Appendix C). They each consist of two halves. One half
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bears the LexA-VP16 responsive promoter driving the rescuing mRNA and a 3’UTR. The
other part of the constructs bears the tissue specific promoter, half the rescuing transcription
factor, the miRNA toxin and a 3’UTR. The first and last 30 bps of each fragment that has
not been previously described are listed in Table 4.5.
The GMR, hand-hsp70, Dfd-hsp70, and prm-hsp70 tissue-specific promoters were gen-
erated as described. Fln was PCRed from genomic DNA. The split transcription factor
components are as described above. The 3’UTR used downstream of the miRNAs is  -
tubulin.
MiRs were cloned as doublets and triplets as described in Appendix D. Identical miR6.1
backbones were used for all miRNAs. Site selection was carried out using rules described by
Chun-Hong Chen or using the Dharmacon siRNA design tool (http://www.dharmacon.com/
designcenter/). A list of the miRNAs used in this study is provided in Table 4.2. Each set
of miRNAs was flanked by splice sites so the doublet or triplet would be spliced from the
transcript as as single unit. The consensus sequence used for the 5’ site was cagGTaagt and
for the 3’ site was tactaattcttcttttcccttttttttAGg with the donor and acceptor highlighted
in capitol letters.
The rescuing mRNA used was matched to the toxin. The RpL35a rescue was PCRed
out of the Drosophila genome. For Fln and the first CG5266 constructs, the recoding
of the mRNA only required a few point mutations around the start codon and could be
accomplished using a single forward primer. Later version of the CG5266 were recoded via
EA cloning techniques. The actin 3’UTR was used downstream of each of the rescuing open
reading frames (ORFs). Partially artificial CTCFs were generated by PCRing a pair out
of the Drosophila genome and adding another pair, one on each primer making a tetramer
roughly as described in Kyrchanova et al. (2008). One CTCF was place between the two
halves of the construct, and the other either 5’ to the rescue or 3’ to the miRNA bearing
section.
RT-PCR
RNA was prepped using Qiagen’s RNeasy Kit (Valencia, CA). RT-PCR was carried out
using SuperScript III First-Strand Synthesis Kit from Invitrogen (Carlsbad, CA) according
to package instructions. The final PCR was conducted using Phusion (Thermo Scientific,
Lafayette, CO).
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Tissue Culture
Drosophila S2 cells were maintained in Schneider’s medium 10% FBS, 1% penicillin and
streptomycin (P/S) at 27.5 C, passaged every 3–4 days. S2 cell transfections were carried
out using the FuGENE6 reagent. The most successful ratio of FuGENE:DNA was 2.5 µl:1
µg. A GFP or RFP marker was often used, and always as 20% of the DNA transfected. Use
of endotoxin-free DNAs was essential for good transfection e ciency. A 2.7 M tamoxifen
stock solution and a 3.7 M estradiol stock solution (both from Sigma) were made in EtOH
and stored at -20 C. Dilutions were made in ethanol and amounts not greater than 2 µl were
added to wells containing 500 µl culturing media. Mock treatments of EtOH containing no
drug were used as controls.
Fly Culture and Strains
Fly crosses were carried out under standard conditions at 25 C. Injections were carried
out both in-house according to standard methods with Hay lab particulars described in
Appendix C, and by several companies including Rainbow Transgenics (Camarillo, CA),
BestGene (Chino Hills, CA), Genetic Services Inc. (Sudbury, MA) and Genetivision (Hous-
ton, TX). Rainbow Transgenics and Genetivision provided the most reliable transformation
results.
A saturated solution of tetracycline (Tet) in 70% EtOH or 50 mg/m doxycycline-hyclate
(Dox) in PBS was added directly to our standard fly food at a ratio of 1:100. Fly food was
liquefied by microwaving and allowed to cool to ⇠ 50 C. The concentrate was added directly
to the food and mixed, and the food was allowed to resolidify. Because Tet degrades rapidly
in the light, food is stored in the dark at 4 C. For rearing, repeated Tet treatments were
carried out by adding 10 µl of the drug solutions directly to the food the flies were cultured
in and on.
Additional strains used in these studies were ovo-FLP (Bloomington Stock Center #
8727, 8728, 8729),  -tubulin-FLP (# 7196), and PhiC-31 lines 86Fa (# 24486) and 96E (#
24487).
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Chapter 5
Conclusions
Engineering Insects is Hard
This is an outrageous oversimplification and poor final conclusion for this body of work, but
it summarizes many of the lessons I have learned. Drosophila is one of the best understood
organisms on the planet, having been studied for over one hundred years. The cell death
pathway, one of the systems I primarily worked with, has been intensively investigated (Hay
and Guo, 2006). Much of the work has been done in the eye —a non-essential tissue that
tolerates a great deal of disruption—using a well-characterized enhancer (see Bergmann
et al. (2003, 1998); Hawkins et al. (2000); Hay et al. (1994); Yoo et al. (2002) as examples).
Thus, this cell pathway and tissue target was almost an ideal choice for our model drive
experiment. Perhaps unsurprisingly, the proof-of-principle system in the eye worked as
predicted. Despite the fact that the cell pathway is known to be active in numerous tissues
throughout the organism, we were often unable to produce expected phenotypes when the
system was moved to other essential tissues, even when other carefully evaluated enhancers
were used. While more data is continually being generated that describes expression levels
and patterns, we now know that each enhancer will have to be tested empirically. When I
did elicit expected phenotypes, suppressing the apoptotic activities was unsuccessful, which
implies that miRNA machinery is also not the same in the eye as in all other tissues.
My other studies also encountered similar problems of components not working uni-
formly from one set of conditions to another. The work on viral sensors utilizing cell death
proteins was complicated not by the inability to kill, but by di culties in keeping the death-
inducing proteins from carrying out their activities. Literature reporting success in tethering
proteins to membranes (Browman et al., 2006; Op De Beeck et al., 2004; Szczesna-Skorupa
79
and Kemper, 2000) was not as translatable to the mosquito tissue culture system as we had
hoped. The signaling and localization sequences derived from other systems, and studied
in various tissues, could not reprise their functions in mosquito tissue culture. Function of
the UAS promoters also showed variability when moved between S2 culture, C6/36 culture,
and Drosophila. My work also highlights the concern that models created in tissue culture
may require additional and unpredictable adjustments when implemented in animals.
The overarching challenge is the staggering complexity of cellular metabolism, of inter-
actions between cells, within tissues, and in whole organisms. Carefully designed inputs can
interact with thousands of other components in the cellular milieu, and it is impossible to
predict exactly how they will behave. We are still largely engineering in a black box, and
future progress will rely on empirical results and direct testing of systems in vivo.
Progress is Possible
Despite these challenges, we have learned a great deal from my e↵orts here. Many compo-
nents of the viral sensors have been tested and refined. I have identified a split-transcription
factor that works in both Drosophila and C6/36 culture. Tests of cell death proteins from
Drosophila in C6/36 culture indicate that, in some cases, those components can be moved
from one species to another. Experiments investigating the fate of protease-based sensor
components will identify the point at which failure is occurring and, hopefully, allow comple-
tion of that project. In light of the new information about the mosquito cell lines, work can
be resumed on the RdRp-base approaches. Testing of the RdRp substrates, in some ways,
never began, so testing of those sensors is a great next step in relaunching that project.
The underdominant systems also need more diagnostic work, but the functioning proof-
of-principle system in the eye demonstrates that the protein-based system is viable. Iden-
tification of a suitable essential tissue and improvement of miRNA function are the two
remaining variables that will allow completion of the lethal system. The miRNA-based
system has many more tunable parts, and once an appropriate tissue, or two, are selected,
components can be tested individually to identify weak points in the design. Working on
one component at a time will be slow, but should allow steady advancement of the project
and hopefully the building of a functioning underdominant system suitable for testing in
vector species.
Improved genome manipulation techniques in C. elegans o↵er a chance to revisit the
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transitive RNAi project. Work on miRNAs in many systems including C. elegans will be
able to better inform target selection. The systematic perturbations of genes and expression
patterns that are carried out in the worm may o↵er a treasure trove of genes and tissues to
work with when trying to genetically isolate one line from another.
Engineering Insects is Important
Despite the challenging and ambitious nature of this work, I am confident that engineered
insects can play an important role in reducing the burden of vector-borne disease. As with
the development of any new technology, early days have been fraught with setbacks, but
the ultimate product makes it worth the time and energy invested. Reduction in e cacy
of pesticides and anti-malaria medications (Shah et al., 2011; Trape et al., 2011) means an
increasing disease burden where disease is already endemic. As temperatures rise and the
ranges of these insects broaden, exposure to these diseases will only rise (Lambrechts et al.,
2010). Working to address this problem now is part of our responsibility to the future.
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Appendix A
Transitive RNAi
A.1 Bombardment Protocol, S. Kuntz
Materials
Growth of Bacteria
Per liter of Terrific Broth (TB) (Tartof and Hobbs, 1987):
To 900 mL of dI H2O add:
12 g tryptone
24 g yeast extract
4 mL glycerol
Mix until the solutes dissolve.
Autoclave.
To 90 mL of dI H2O add:
2.31 g KH2PO4
12.54 g K2HPO4
Adjust to 100 mL with dI H2O.
Autoclave.
Once the two solutions have cooled to 60 C or cooler, combine.
Per 500 mL culture you will need:
1 2800 mL Fernbach flask
1 5 mL O/N culture of HB101
1000 X Streptomycin solution (300 mg Streptomycin in 10 mL ddH2O)
2 tared 250 mL centrifuge bottles
37 C shaker & Sorval centrifuge
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Growth of Worms in Liquid Culture
Per ⇠ 1 L of Complete S-medium (Sulston and Brenner, 1974):
1 M potassium phosphate, pH 6.0:
136 g KH2PO4
Add DI H2O to 900 mL. Adjust to pH 6.0 with KOH.
Add DI H2O to 1 L and autoclave.
1 M potassium citrate, pH 6.0:
268.8 g tripotassium citrate
26.3 g citric acid monohydrate
Add DI H2O to 900 mL. Adjust to pH 6.0 with KOH.
Add DI H2O to 1 L and autoclave.
Trace metals solution:
1.86 g Na2EDTA
0.69 g FeSO4·7H22O
0.20 g MnCl2·4H2O
0.29 g ZnSO4·7H2O
0.016 g CuSO4
Add DI H2O to 1 L, autoclave, and store in the dark.
S-basal medium:
5.9 g NaCl
50 mL of 1 M potassium phosphate, pH 6.0 (above)
1 mL 5 mg/mL cholesterol in EtOH
Add dI H2O to 1 L and autoclave.
S-complete medium:
1 L S-basal medium (above)
10 mL of 1 M potassium citrate, pH 6.0 (above)
10 mL of trace metals solution (above)
3 mL of 1 M CaCl2 (autoclaved)
3 mL of 1 M MgSO4 (autoclaved)
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1 1 L flask
3 Nearly cleared NGM Special plates of gravid unc-119 worms
Concentrated HB101 bacteria from above
20 C shaker
Gold Microparticle Cleaning
One-time Preparation of beads:
60 mg gold microparticles
70% ethanol
ddH2O
50% glycerol
Platform vortexer
Keep prepared beads at 4 C.
Gold Microparticle Coating
Coating Beads:
70 µL of 60 mg/mL gold microparticles in 50% glycerol
7–14 µg of DNA
3.5 µg of control DNA (such as unc-119 rescue vector)
3.5 µg of experimental DNA (such as PCR-products or GFP-markers)
315 µL of 2.5 M CaCl2
Stock made by 138.75 g of CaCl2 with H2O up to 500 mL
112 µL of 0.1 M spermidine
800 µL of 70% EtOH
800 µL of 100% EtOH (fresh)
70 µL of 100% EtOH (fresh)
7 Macrocarriers (large orange discs) [Bio-Rad #: 1652263]
Platform vortexer
99
Biolistic Gun Setup
1 tank of UHP Helium (99.999%)
7 macrocarriers seeded with the DNA-coated beads (as described above)
1 2200 psi Rupture Disc (small dark orange-red discs)
1 Hepta Stopping Screen (metal grid)
Post-Bombardment Care of Worms
25 small (5 cm) NGM lite plates liberally seeded with OP-50 24 hours in advance
13 9 cm NG plates seeded with OP-50
Methods
Growth of Bacteria for Food
1. Inoculate 5 mL HB101 culture in LB and streptomycin. Streptomycin final concen-
tration at 30 µg/mL.
2. Grow 10–12 hours at 37 C.
3. Inoculate 500 mL TB and streptomycin culture with the 5 mL culture. Use a 2800
mL Fernbach flask (with ba✏ing if available).
4. Grow 24 hours at 37 C, 250 rpm.
5. Spin at 4000 g in 2 500 mL tared centrifuge bottles for 10 min. 6500 rpm with the
GSA rotor.
6. Remove supernatant.
7. Resuspend bacteria in LB to a 50% w/w concentration.
8. Store at 4 C.
Growth of Worms in Liquid Culture
1. Wash o↵ the plates with M9 into 2 15-mL falcon tubes, spin down the worms, remove
all but 1 mL of supernatant and then bleach with 7 mL water, 2 mL bleach, and 1
mL 5M KOH in each tube.
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2. Divide into aliquots of 1 million eggs. Use serial dilutions and count the number of
eggs in 10 µL of solution.
3. Place each aliquot in 100 mL of S-complete medium in a covered 1 L flask.
4. Shake for 24 hours at 20 C at 150–200 rpm.
5. Add 6 mL of concentrated HB101 solution. This is approximately 3 g of bacterial
mass.
6. Shake for 48 hours at 20 C at 150–200 rpm. 24 hours into shaking 1 mL of solution
should be extracted and the worms checked for contamination and progress of growth.
7. Harvest worms. The exact time of harvest is flexible within a 4 hour bu↵er, thus 48
hours ± 4 hours should be observed.
Purification of Worms from Liquid Culture
To purify 100 mL of worms:
1. Pour worm culture into 2 50-mL centrifuge tubes. Check that the worms are L4s or
young adults.
2. Gravity sediment the worms for 10 minutes. Only gravity sediment as centrifugation
packs the worms too tightly.
3. Remove supernatant to culture flask. Be careful to not disturb the pellet, as it may
be very loose.
4. Plate 1–1.5 mL of the worm pellet per 9 cm NG plate. Keep most of the worms at
the center, they will naturally spread out.
5. Place NG plates on ice and allow to dry. Placing on ice prevents the worms from
clumping together. Failure of the plate to dry completely is not a problem, but it
should be fairly dry. If placed at 4 C they should be fine for several hours.
6. Shake supernatant culture for 24 hours to starve it out.
Cyclic Liquid Culture of Worms
1. Pour starved supernatant worm culture into 2 50-mL centrifuge tubes. This is the
worm culture from above.
2. Spin down worms and remove supernatant. Using a clinical centrifuge, spin at level 4
for 5 minutes.
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3. Aliquot at 1 million worms per 100 mL solution. Use a fresh 1 L flask and fresh
S-complete.
4. Add 6 mL HB101 solution.
5. Shake for 48 hours at 20 C at 150–200 rpm.
6. Bleach worms and continue with next cycle. The bleached eggs will be used in the
next round of growth, step 2 of the Growth of Worms in Liquid Culture section.
Cleaning Gold Microparticles
One-time preparation of gold microcarrier beads, good for 14 hepta bombardments:
1. Weigh 60 mg of gold in a 1.5 mL microfuge tube. The gold is the consistency of clay,
but can be a↵ected by static electricity.
2. Add 1 mL 70% EtOH.
3. Vortex 5 min, settle 15 min, spin 15 seconds.
4. Discard supernatant. The supernatant should be clear. If not, centrifuge longer.
5. Repeat three times:
(a) Add 1 mL ddH2O.
(b) Settle 1 min.
(c) Centrifuge 15 seconds, discard supernatant. The supernatant should be clear. If
not, centrifuge longer.
6. Add 1 mL 50% glycerol.
7. Store at 4 C.
The solution should be good for two months. After two months, re-clean the beads.
Coating Gold Microparticles
All numbers are for hepta-shots. For single shots, divide all figures by seven, except for on
step 13. Coating the beads with DNA (performed every time):
1. Vortex gold solution for 10 min.
2. Mix 7–14 µg DNA in fresh microfuge tube. Avoid doing more than a few sets of
hepta-shots at a time, as the steps should be performed as quickly as possible. For
thorough mixing, vortex and pipette up and down.
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3. Place macrocarriers in hepta-adapter macrocarrier holder. Use the red macrocarrier
plug to help place the macrocarriers.
4. Add 70 µL gold beads to DNA, vortex 10 seconds. The gold solution should be a
homogenous brown solution. Vortex it immediately before removing the 70 µL.
5. Add 315 µL 2.5M CaCl2, vortex 10 seconds.
6. Add 112 µL 0.1M spermidine.
7. Vortex 3 min, settle 1 min, spin 15 sec.
8. Discard supernatant. The supernatant should be clear. If not, spin longer.
9. Resuspend in 800 µL 70% EtOH.
10. Settle 1 min, spin 15 sec, discard supernatant. The supernatant should be clear. If
not, spin longer.
11. Add 800 µL fresh 100% EtOH, remove supernatant. The EtOH must be fresh, as
non-denatured 100% EtOH quickly becomes < 100% after being opened.
12. Resuspend in 70 µL 100% EtOH. Mix well, both vortexing at low speed and pipetting
up and down.
13. Plate 10 µL on each macrocarrier, allow to dry. Be certain that the solution is well
mixed while taking aliquots. Always use 10 µL per macrocarrier, regardless of the
number of shots. Once dry the gold should appear as a white powder if well-mixed
and distributed. The macrocarriers may be stored for up to 12 hours at 4 C, though
immediate use is recommended.
Biolistic Gun Setup
1. Turn on helium tank (top valve). Only UHP (ultra-high purity or 99.999%) helium
should be used.
2. Remove the hepta-adaptor pressure disc holder.
3. Place 2200 psi rupture disc in hepta-adapter pressure disc holder.
4. Screw in and tighten pressure disc holder (nozzle). Tighten securely, but do not bend
in any other direction. The torque wrench may be used but no orthogonal torque
should be applied.
5. Add stopping screen to macrocarrier holder, put in macrocarrier holder. Be certain
the gold microparticles are facing downward.
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6. Line up air-flow pathways.
7. Put in plate of worms immediately below macrocarrier holder. Place the worm plate
on the plastic target shelf and remove the plate lid.
8. Close door tightly.
Biolistic Gun Firing
1. Turn on the gun.
2. Turn on the vacuum pump.
3. Switch regulator to Vacuum, pull vacuum past 20. Rocker in the top position. The
Fire light should turn on.
4. Switch regulator to Hold. Rocker in the bottom position.
5. Press and hold Fire until the disc pops. The gun pressure should raise until the disc
ruptures above 1500 psi.
6. Switch regulator to Vent. Rocker in the middle position. This is necessary for the
door to be opened.
7. Remove all disposable components, clean o↵ macrocarrier holder.
8. Switch regulator to Vacuum and allow the vacuum pump to run before shutting down.
This step is necessary to not damage the vacuum pump. Leave the door open during
this step.
9. Shut o↵ the helium tank (top valve) and turn o↵ the gun.
Post-Bombardment Care of Worms
1. Add 8 mL of M9 to worms.
2. Let sit for 1 hour. Between 45 minutes and 2 hours is acceptable.
3. Distribute worms on 25 seeded 5 cm NGM lite plates. Additional M9 may be added
to assist in the distribution. Be sure to label each plate.
4. Dry plates. During the next 2 days additional food may be added if the worms appear
to be starving. After that, starvation is encouraged.
5. Seed 13 9 cm NG plates.
6. Check for transgenics after 3 days and chunk small plates onto large plates. If using
unc-119 worms, large plates are a crawling assay. Each F1 is an independent line.
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Timeline
Day 0 (Sunday): Prepare all media.
Inoculate overnight HB101 culture.
Day 1 (Monday): Bleach worms.
Inoculate 500 mL HB101 culture.
Add worms to S-complete (cultures A and B).
Day 2 (Tuesday): Harvest bacteria.
Culture A:
Add bacteria to worm culture.
Day 3 (Wednesday): Culture A: Check on worm growth.
Seed 25 5-cm NGM lite plates.
Culture B: Add bacteria to worm culture.
Day 4 (Thursday): Culture A:
Harvest worms.
Coat beads.
Inoculate extra worms in cyclic culture.
Bombard worms.
Replate worms on NGM plates.
Seed 13 9-cm NG plates.
Culture B:
Check on worm growth
Seed 25 5-cm NGM lite plates
Day 5 (Friday): Culture B: Harvest worms.
Coat beads.
Inoculate extra worms for cyclic culture (mix with cyclic culture A).
Bombard worms.
Replate worms on NGM plates.
Seed 13 9-cm NGM plates.
Day 6 (Saturday): Add food to cyclic worm culture.
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Day 7 (Sunday): Culture A:
Chunk worms to NG plates.
Begin scoring.
Day 8 (Monday): Start over with bleaching.
Culture B:
Chunk worms to NG plates.
Begin scoring.
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Appendix B
Viral Sensing and Killing
B.1 Immunostaining for DENV2 Infection in S2 and C6/36
Cells
Concanavalin A Treatment of Slides
1. Cleaning the slip covers
(a) Prepare Cleaning Solution:
i. Dissolve 70 g NaOH in 280 mL ddH2O.
ii. Add 420 mL 95% ethanol. Total volume is 700 mL; stir until completely
mixed.
iii. If solution remains cloudy, add ddH2O until clear.
(b) Pour solution into container with slip covers; cover chambers with glass lids. Mix
on orbital shaker for 2 hr.
(c) Once slides are clean, they should be exposed to air as little as possible. Dust
particles will interfere with coating.
(d) Quickly transfer slips to a fresh container filled with ddH2O. Rinse vigorously by
agitation.
(e) Repeat rinses 4X with fresh ddH2O each time. It is critical to remove all traces
of NaOH-ethanol.
2. Concanavalin A Solution
(a) Measure 0.0625 g of Concanavalin A (ConA).
(b) In a graduated cylinder, add ConA to 200 mL nuclease-free water.
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(c) Mix by inversion.
(d) After ConA is dissolved, bring volume to 250 mL.
(e) Pour ConA into a 250 mL jar. Add a sterilized stir bar to jar, seal top of jar and
stir ConA on a stir plate for 4 hours at a speed that creates a su cient vortex
in the solution.
(f) After 4 hours of stirring, filter solution into a new, sterilized container with 0.22
µm vacuum filter.
3. Slide Coating (Performed in tissue culture hood. Use powder free gloves when man-
ually handling slides)
(a) In a tissue culture hood, array small circular coverslips that will fit in the bottom
of the wells in 24-well tissue culture dishes on Kimwipes.
(b) Spray the fingertips of the gloves used to handle the slides with 100% ethanol.
(c) Clean slides with 100% ethanol.
(d) Cover the coverslips with the solution. It has good surface tension and nearly
the whole surface can be covered without it spilling o↵.
(e) Allow to sit for 2–3 minutes.
(f) Pipette o↵ and allow to dry for 1 hour.
(g) Rinse 2–3 times with nuclease free, autoclaved H2O. Usually I hold them with
forceps and rinse with a spray bottle.
(h) Dry slides for 1 hour as before.
4. Slide Storage
(a) Normally I use them immediately.
(b) I have stored them in the fridge for up to about 2 weeks without a noticible
decline in quality.
Immunostaining of S2 Cells
This can be carried out in the wells containing treated coverslips. There is no need to
remove the slips, although they are better observed outside of wells.
1. Remove media and fix cells in 4% formaldehyde.
2. Wash 5 times with 1XPBS.
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3. Incubate 20 minutes in PBT.
4. Wash twice with 1XPBT.
5. Wash twice times with 1XPBS.
6. Incubate 15 minutes in 1XPBS with 10% BSA and 10% PBT.
7. Wash four times with 1XPBS.
8. Incubate 1 hour with 150 µl of primary (DENV2, MAB8702) antibody, diluted 1:400.
9. Wash 3 times with 1XPBS.
10. Incubate 1 hour with 150 µl of secondary (anti-mouse) antibody, diluted 1:200.
11. Wash 3 times with 1XPBS.
12. Observe on an inverted fluorescence scope.
Immunostaining of C6/36 Cells
1. Wash with ice-cold 1XPBS
2. Remove media and fix cells in -20  MeOH.
3. Wash 3 times with ice-cold 1XPBS.
4. Incubate 1 hour with 150 µl of primary (DENV2, MAB8702) antibody, diluted 1:400.
5. Wash 3 times with ice-cold 1XPBS.
6. Incubate 1 hour with 150 µl of secondary (anti-mouse) antibody, diluted 1:200.
7. Wash 3 times with ice-cold 1XPBS.
8. Observe on an inverted fluorescence scope.
B.2 Transmembrane-Targeted Proteins
PrM-Cleave
A portion of the DENV2 poly protein comprising amino acids 102-264 which encompasses
a small C-terminal portion of the capsid, the entire prM and a small piece of the M pro-
teins (lowercase) which includes a transmembrane domain is fused to a set of NS2B/NS3
target sites (uppercase). Restriction sites, EcoRI and BglII, are underlined and the Kozak
sequence is italicized. This is meant to be in-frame fused to either Flp, Gal4 or LexA::VP16.
gaattc caaaccaaa atggggtctg caggcatgat cattatgctg attccaacag tgatggcgtt ccatttaacc acacg-
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taacg gagaaccaca catgatcgtc agcagacaag agaaagggaa aagtcttctg tttaaaacag aggatggcgt gaa-
catgtgt accctcatgg ccatggacct tggtgaattg tgtgaagaca caatcacgta caagtgtccc cttctcaggc agaat-
gagcc agaagacata gactgttggt gcaactctac gtccacgtgg gtaacttatg ggacgtgtac caccatggga gaa-
catagaa gagaaaaaag atcagtggca ctcgttccac atgtgggaat gggactggag acacgaactg aaacatggat
gtcatcagaa ggggcctgga aacatgtcca gagaattgaa acttggatct tgagacatcc aggcttcacc atgatggcag
caatcctggc atacaccata ggaacgacac atttccaaag aGGCG GCGGA GGCGG TGGCG GGGGC
GGACT GAAGC GCCGC TCCGG CTCCG GCTTC GCCGC CGGCC GCAAG TCCCT
GACCC TGAAC CTGCT TAAAA GACGT TCGGG GAGCG GTaga tct
P450-Cleave
An artificial protein with an N-terminal signal sequence and ER localization signal (upper-
case) fused to a set of C-terminal NS2B/NS3 cleavage sites (bold) via a polyglycine linker.
The signal sequence and ER localization domains are taken from a cytochrome p450, which
is presumed to be conserved. Restriction sites, EcoRI and BglII, are underlined and the
Kozak sequence is italicized. This is meant to be in-frame fused to either Flp, Gal4 or
LexA::VP16.
Protein Sequence
mdpvvvlglclscllllslw KQSYGGGK gggggggg lkrrsgsg-faagrk-sltlnl-lkrrsgsg
DNA Sequence
gaattc caaaccaaa atggac cccgtg gtggta ctgggc ctgtgc ctgtcc tgcctg ctgctc ctgtcc ctgtgg
AAGCAG TCCTAC GGCGGC GGCAAG GGCggc ggaggc ggtggc gggggc ggactg aagcgc
cgctcc ggctcc ggcttc gccgcc ggccgc aagtcc ctgacc ctgaac ctgctt aaaaga cgttcg
gggagc ggt agatct
CD4-E-Link
This construct consists of the N-terminal, transmembrane section of CD4 (aa 1-371) which
is not shown, a fragment of the DENV envelope (italics), a flexible linker containing viral
cleavage sites (in bold), and a LexA::VP16 fusion transcription factor. Note that upstream
of the NotI site an extra nucleotide, a, is added in to maintain the open reading frame. This
DNA carries the original LV used, but the final constructs carry the recoded LV because
110
a point mutation when cloning necessitated replacing the part and I used the newer LV to
replace it.
Protein sequence: GAIYGAAFSGVSWTMKILIGVIITWIGMNSRSEFGGGGGGGGG
LKRRSGSFAAGRKSLTLNLLKRRSGSGSGRMKALTARQQEVFDLIRDHISQT
GMPPTRAEIAQRLGFRSPNAAEEHLKALARKGVIEIVSGASRGIRLLQEEEEGLPLV
GRVAAGEPLLAQQHIEGHYQVDPSLFKPNADFLLRVSGMSMKDIGIMDGDLLAVH
KTQDVRNGQVVVARIDDEVTVKRLKKQGNKVELLPENSEFKPIVVDLRQQSFTIEG
LAVGVIRNGDWLEFPGIRRPAGIPGDLAPPTDVSLGDELHLDGEDVAMAHADALD
DFDLDMLGDGDSPGPGFTPHDSAPYGALDMADFEFEQMFTDALGIDEYGG
(SpeI site) ACTAGT –
(Envelope fragment) GGAGCAATCTATGGAGCTGCCTTCAGTGGGGTTTCATGGA
CTATGAAAATCCTCATAGGAGTCATTATCACATGGATAGGAATGAATTCACGC
AGC –
(EcoRI site) GAATTC –
(Linker) GGCGGCGGAGGCGGTGGCGGGGGCGGACTGAAGCGCCGCTCCGGCTC
CGGCTTCGCCGCCGGCCGCAAGTCCCTGACCCTGAACCTGCTTAAAAGACGTT
CGGGGAGCGGTa –
(NotI site) GCGGCCGC –
(LexA::VP16 fusion) ATGAAAGCGTTAACGGCCAGGCAACAAGAGGTGTTTGATC
TCATCCGTGATCACATCAGCCAGACAGGTATGCCGCCGACGCGTGCGGAAATC
GCGCAGCGTTTGGGGTTCCGTTCCCCAAACGCGGCTGAAGAACATCTGAAGG
CGCTGGCACGCAAAGGCGTTATTGAAATTGTTTCCGGCGCATCACGCGGGATT
CGTCTGTTGCAGGAAGAGGAAGAAGGGTTGCCGCTGGTAGGTCGTGTGGCTG
CCGGTGAACCACTTCTGGCGCAACAGCATATTGAAGGTCATTATCAGGTCGAT
CCTTCCTTATTCAAGCCGAATGCTGATTTCCTGCTGCGCGTCAGCGGGATGTC
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GATGAAAGATATCGGCATTATGGATGGTGACTTGCTGGCAGTGCATAAAACT
CAGGATGTACGTAACGGTCAGGTCGTTGTCGCACGTATTGATGACGAAGTTA
CCGTTAAGCGCCTGAAAAAACAGGGCAATAAAGTCGAACTGTTGCCAGAAAA
TAGCGAGTTTAAACCAATTGTCGTAGATCTTCGTCAGCAGAGCTTCACCATTG
AAGGGCTGGCGGTTGGGGTTATTCGCAACGGCGACTGGCTGGAATTCCCGGG
GATCCGTCGACCTGCAGGAATTCCCGGGGATCTGGCCCCCCCGACCGATGTCA
GCCTGGGGGACGAGCTCCACTTAGACGGCGAGGACGTGGCGATGGCGCATGC
CGACGCGCTAGACGATTTCGATCTGGACATGTTGGGGGACGGGGATTCCCCG
GGTCCGGGATTTACCCCCCACGACTCCGCCCCCTACGGCGCTCTGGATATGGC
CGACTTCGAGTTTGAGCAGATGTTTACCGATGCCCTTGGAATTGACGAGTACG
GTGGGTAG –
(SacII site) CCGCGG
CD4-M-Link
This construct is the same as the previous except that a section of the prM protein is sub-
stituted in place of the envelope fragment.
actagtagaattgaaacttggatcttgagacatccaggcttcaccatgatggcagcaatcctggcatacaccataggaacgacac
atttccaaaga
Protein Sequence
TSRIETWILRHPGFTMMAAILAYTIGTTHFQR
Erlin-Link-nLV
In place of the CD4 and viral fragments is a short N-terminal fragment from Erlin1, codon
optimized for insects during gene synthesis. The linker is also updated and the LexA::VP16
has also been recoded.
Protein Sequence
EFQTKMTQARVLVAAVVGLVAVLLYASIHKIEEGGGGGGGGGGLKRRSGSG
FAAGRKSLTLNLLKRRSGSGMKALTARQQEVFDLIRDHISQTGMPPTRAEIAQ
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RLGFRSPNAAEEHLKALARKGVIEIVSGASRGIRLLQEEEEGLPLVGRVAAGEPLLA
QQHIEGHYQVDPSLFKPNADFLLRVSGMSMKDIGIMDGDLLAVHKTQDVRNGQVV
VARIDDEVTVKRLKKQGNKVELLPENSEFKPIVVDLRQQSFTIEGLAVGVIRNGDW
LEFPGIRRPAGIPGDLAPPTDVSLGDELHLDGEDVAMAHADALDDFDLDMLGDGD
SPGPGFTPHDSAPYGALDMADFEFEQMFTDALGIDEYGG
(Erlin 1–29) ATGACTCAAGCACGTGTTTTGGTTGCAGCTGTAGTAGGATTGGTT
GCGGTCTTGTTGTACGCCAGCATCCACAAAATCGAAGAAGGC –
(Linker) GGCGGTGGCGGTGGTGGTGGCGGCGGACTCAAGCGTCGCTCCGGCTC
CGGTTTCGCTGCCGGTCGCAAGTCGCTTACGCTGAACCTGCTGAAACGTCGCA
GCGGTTCCGGT –
(Recoded LexA::VP16) ATGAAGGCTTTGACTGCTCGGCAGCAAGAGGTGTTCGA
CCTGATCCGCGATCACATAAGCCAGACGGGAATGCCACCAACGCGAGCCGAGA
TTGCTCAGCGGCTGGGCTTCCGGTCGCCCAATGCTGCTGAGGAACACCTGAAG
GCACTTGCCCGAAAGGGCGTAATCGAGATCGTCTCGGGTGCCTCGCGGGGCA
TCCGCCTCTTGCAGGAAGAGGAGGAGGGCCTGCCCCTGGTTGGCCGCGTTGC
CGCCGGAGAGCCGCTGCTGGCCCAGCAACATATAGAGGGCCATTACCAGGTC
GATCCATCCTTGTTCAAGCCGAACGCTGACTTCCTCCTGCGAGTATCCGGCAT
GAGTATGAAAGATATTGGCATAATGGATGGCGACCTGCTGGCGGTGCACAAG
ACTCAAGATGTGCGCAATGGCCAGGTTGTAGTGGCCCGTATAGATGATGAGG
TCACTGTGAAGCGGCTGAAGAAGCAGGGTAATAAGGTGGAGCTGCTGCCCGA
GAACAGCGAATTTAAACCTATTGTGGTGGATCTGAGGCAGCAATCCTTCACTA
TCGAGGGACTCGCCGTCGGTGTCATTCGCAACGGCGACTGGTTGGAATTTCCC
GGCATACGACGCCCGGCCGGCATCCCGGGCGACCTGGCGCCACCCACCGATGT
GTCGTTGGGCGACGAGCTCCATCTGGACGGCGAAGACGTTGCCATGGCCCAC
GCAGATGCATTGGATGATTTTGATCTGGATATGTTGGGCGATGGCGACAGTC
CTGGCCCCGGATTCACTCCCCACGACTCCGCCCCGTATGGAGCTCTTGATATG
GCTGATTTTGAGTTCGAGCAGATGTTCACAGACGCACTGGGCATCGACGAGT
ACGGAGGATAA
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B.3 Chun-Hong’s Flip-Based Killer
This was designed by Chun-Hong Chen as half of an underdominant system. We adapted
it for use as a viral sensor. When expressed, the transcript codes for a miRNA that self tar-
gets and is flanked by FRT sites. Downstream of the FRT sites and the miR is a Rpr open
reading frame. If no flp is present, the miR is expressed, targets the transcript downstream
and cleaves it leaving an uncapped Rpr transcript that is degraded. Once flip excision has
occurred, Rpr is expressed and cell death occurs. The sequence of each component is shown
below and a schematic is in Figure B.1
(PacI site) ATTTAAAT –
(FRT) GAAGTTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC –
(miR)CACGGCCAATTCCAACGATTTGTCATTTGTGGCACGCATTTGTGTCACC
TCAGTGCGAAAATTGAAAATTGTATTTAATGTATACGCACGATCAACAAAACT
CTAAGTTAATATACCATATCTAGATTTTTGTTGATCGTGCGTATGTACCTAAA
GCAATCGATCTACGTTCAGTGGTTTGCCAGGACATGAAACAGAAATATTTTCC
GTCAACAGACTTCTGATTGCACAAATTCCTC –
(FRT) GAAGTTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC –
(2X miR Target) CATACGCACGATCAACAAAAATCaaaaaaaaaaCATACGCACGATC
AACAAAAATC –
(FseI site) GGCCGGCC –
(Rpr) ATGGCAGTGGCATTCTACATACCCGATCAGGCGACTCTGTTGCGGGAGG
CGGAGCAGAGGGAGCAGCAGATTCTCCGCTTGCGGGAGTCACAGTGGAGATT
CCTGGCCACCGTCGTCCTGGAAACCCTGCGCCAGTACACTTCATGTCATCCGA
GGACCGGAAGAAGGTCCGGCAGATATCGCAGGCCATCGCAATGA –
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(NotI site) GCGGCCGC
Figure B.1: If flp is tethered to the ER and only released by NS2B/NS3 cleavage when cells
are infected with dengue, then viral infection will trigger the cell death cascade.
B.4 RdRp Designs
Titraton Sca↵old
The titration sca↵old was designed to resist degradation of unstructured, noncoding RNAs
in tissue culture experiments. The Dengue 3’ and Kunjin 3’ sequences that are naturally ex-
onuclease resistant were synthesized, and between them a space was left for cloning. Other
features include an intron to help promote export to the cytoplasm, and external cloning
sites so the entire sca↵old can be moved as one piece once modified.
(EcoRI – PacI – spacer ) GAATTC TTAATTAA GAATACAAGCTCACGA –
(Kunjin 3’ sequence) ATATTGTTATTATGTGTAGAAGTTTAGCTTTATAATAGTG
TTTAGTGTGTTTAGAGTTAGAAAAATTTTAGTGAGGAAGTCAGGCCGGAAAA
TTCCCGCCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGACTCAACCCCAGGA
GGACTGGGTGAACAAAGCTGCGAAGTGATCCATGTAAGCCCTCAGAACCGTC
TCGGAAAGAGGACCCCACATGTTGTAGCTTCAAGGCCCAATGTCAGACCACGC
CATGGCGTGCCACTCTGCGGAGAGTGCAGTCTGCGACAGTGCCCCAGGAGGA
CTGGGTGAACAAAGGCGAATCAACGTCCCACGCGGCCCTAGCTCTGGCAATG
115
GTGTTAACCAGAGTGAAAGGACTAGAGGTTAGAGGAGACCCCGCGTTCTGAA
GTGCACGGCCCAGCCTGGCTGAAGCTGTAGGTCAGGGGAAGGACTAGAGGTT
AGTGGAGACCCCGTGCCGCAAAACACCACAACAACACAGCATATTGACACCTG
GGATAGACTAGGAGTCTTCTGCTCTGCACAACCAGCCACACGGCACAGTGCGC
CGACAATGGTGGCTGGTGGTGCGAGAACACAGGATCT –
(Cloning Site Rich Linker) ACGACTTGAACGTTAGCGTTTAAACTTCCAGGCTGCA
GATCTACTCGATGCGGCCGCAGGTTCTCCGGCCGCTTGGG –
(Dengue 2 3’ Sequence) TTGGCAATGAGGAATACACAGATTACATGCCATCCATGA
AAAGATTCAGAAGAGAAGAGGAAGAGGCAGGAGTTTTGTGGTAGAAAAACAT
GAAACAAAACAGAAGTCAGGTCGGATTAAGCCATAGTACGGGAAAAACTATG
CTACCTGTGAGCCCCGTCCAAGGACGTTAAAAGAAGTCAGGCCACTTTGATGC
CATAGCTTGAGCAAACTGTGCAGCCTGTAGCTCACCTGAGAAGGTGTAAAAAA
TCCGGGAGGCCACAAACCATGGAAGCTGTACGCATGGCGTAGTGGACTAGCG
GTTAGAGGAGACCCCTCCCTTACAGATCGCAGCAACAATGGGGGCCCAAGGT
GAGATGAAGCTGTAGTCTCACTGGAAGGACTAGAGGTTAGAGGAGACCCCCC
CAAAACAAAAAACAGCATATTGACGCTGGGAAAGACCAGAGATCCTGCTGTCT
CCTCAGCATCATTCCAGGCACAGGACGCCAGAAAATGGAATGGTGCTGTTGAA
TCAACAGGTTCT –
(KpnI) GGTACC –
(Intron) TACCCATACGACGTTCCGGACTACGCTGTTAAGGTAGGCTGGCACACG
AATAACCATGCCGTTTTCAAATCTAATCCCTTTAGTAAAACTGTTTTAATTTC
TTTTCTTTTTTCAGCCA –
(SalI – AscI – XhoI) GTCGAC GGCGCGCC CTCGAG
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Appendix C
Underdominance
C.1 Enzymatic Assembly Cloning Method
Traditional cloning methods allow the cloning of one, or at most two, fragments at once.
Each step requires at least one restriction enzyme, two to control the direction of insertion.
As constructs become large and complicated, finding restriction sites to assemble them
can be di cult. In 2009, technology was published that allowed the cloning of multiple
fragments at a time into a single restriction site (which could be destroyed or regenerated
as desired) in a directionally controlled manner with additional bases between components
if desired (Gibson et al., 2009). Clontech also produced the “In-Fusion Dry-Down PCR
Cloning Kit,” which I tried, but it was orders of magnitude more expensive and produced
identical results to the in-house prep based on Gibson et al.’s method. I made the 5X ISO
bu↵er in 2009 and this supply lasted until the end of 2011. Stocks of DTT and NAD made
at the same time were used to make the second batch of ISO Bu↵er which worked perfectly,
indicating the components are stable for years at -20 C.
I prepped the necessary materials in-house and followed the recipe provided in the
article:
1. 320 µl 5X isothermal (ISO) reaction bu↵er:
(a) 3 ml of 1 M Tris-HCl pH 7.5
(b) 150 µl of 2 M MgCl2
(c) 60 µl of 100 mM dGTP
(d) 60 µl of 100 mM dATP
(e) 60 µl of 100 mM dTTP
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(f) 60 µl of 100 mM dCTP
(g) 300 µl of 1 M DTT
(h) 1.5 g PEG-8000
(i) 300 µl of 100 mM NAD
(j) Add water to 6 ml
(k) Aliquot and store at -20 C.
2. 0.64 µl T5 exonuclease (Epicentre)
3. 20 µl Phusion DNA polymerase (New England Biolabs)
4. 160 µl Taq DNA ligase (New England Biolabs)
5. Add H2O to 1.2 ml.
6. Aliquot 15 µl into PCR tubes and store at -20 C.
The total volume of DNA added into each reaction is 5 µl. Each fragment to be assem-
bled and the backbone are combined in 1:1 molar ratios.
Each PCRed fragment was designed to have 30 bp of overlap to the backbone if it was
to overlap the backbone. When overlapping adjacent PCR fragments, the primer carried
30 bp to anneal for annealing during PCR and 30 bps matching the fragment it would be
fused to (Figure C.1). This overlap distance was a compromise between maximizing overlap
and minimizing cost. PCR products were generated nearly exclusively using Phusion which
tolerates fairly significantly di↵erent annealing temperatures between the primers in a pair.
It would be acceptable and likely just as successful to use backbone overlaps of 20 bps and
between PCR fragments, however I think keeping the overlaps to at least 30 bps is advisable.
Whenever possible, I cloned into backbones linearized with a single blunt-cutting restriction
enzyme because this eases primer design.
Figure C.1: This is a schematic where three PCR fragments are inserted into a linearized
backbone. Overlaps between inserts and the backbone are 30 bp and overlaps between PCR
fragments is 60 bp.
118
C.2 attB Injections
There are a multitude of injection protocols available, so the notes here are intended to help
with steps specific to Hay lab equipment and conditions.
Needle Puller Kopf Instruments Model 720 Needle/Pipette Puller. Heater set to ⇠ 12.0
and solenoid ⇠ 4. These settings worked well, but it is advisable to play around
with them to achieve a needle shape that works well for each set of injections. Avoid
touching the filament. Spare parts are available from the company.
Capillaries Drummond 1-000-0500, 50 µl volume. The fit the needle puller and injection
apparatus. The larger sizes will fit the needle puller but will not fit into the micro
injector. The glass also has the right composition for injection of Drosophila embryos
still in their chorion. It is not an appropriate glass for the injection of mosquito
embryos.
Dye Blue food dye is used. It should be spun twice at 13 K RPM for 30 minutes each
time. Each time keep the top half and discard the rest. Stable at 4 C for years.
Approximately 1 µl dye per 20 µl DNA solution should be su cient.
DNA EtOH precipitate, resuspend in nuclease-free H2O. Spin 30’ after resuspension. Total
concentration for attB injection 200–250 µl. Any co-inject should be co-precipitated.
Sticky/clog-prone DNA is not recoverable. Begin by reprecipitating a new sample and
if it is also bad, reprep from a new culture. The Machery-Nagle kits seem to give very
clean DNA, good for injections.
Flies Flies should be reared in healthy bottles set less than two weeks before adults will
first be collected. Adults should be transferred to grape plates and kept at 25 C for
at least 3 days before injections will begin. Adults should be given fresh yeast and
plates approximately every 12 hrs for at least 3 days before egg collections begin. Two
dense cages should be su cient for injections.
Embryos Collections should be approximately 45 minutes long. Two one-hour collections
should be made and discarded before embryos for injection are collected. It is easy to
kill embryos that are too old. The yeast paste is removed with a cotton swab and the
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rest of the embryos are loosened from the plate using a cotton swab and PBT (1%
TritonX100 in 1XPBS). They are then rinsed very thoroghly through a silk screening
mesh in the top of a falcon tube.
Figure C.2: Shown are a few of the materials used for injection in the lab.
Tape The tape used in the lab is ScotchTM 137 Double-Sided O ce Tape. It is available
in the stockroom and the packaging is yellow.
Oil We use two oils for injection. The first is Halocarbon Oil 700 and is used as the
medium for breaking needles. Halocarbon Oil 27 is used for covering embryos just
prior to injection.
Mounting the Needle The needle should be placed into the needle holder and tightened
firmly but not severely as this wears on the gaskets. Needle should not move when
pressure is applied through the syringe. If the needle breaks o↵ during insertion or
removal, disassemble the needle holder and carefully remove all traces of glass to
preserve the gaskets.
Breaking Needles Several needles can be opened prior to injections starting, but may dry
closed if not used within an hour or two as the oil slides away from the tip. Needles
are broken on the edge of a glass slide that has been broken in half and mounted
on another glass slide. The hole should be as small as possible for DNA that flows
reliably but not freely. DNA will travel back up the needle like beads on a string with
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a good break. Trial and error is the only way to achieve a break that works for you
reproducibly. If debris is visibly clogging the needle, DNA should be reprepped.
Temperatures Flies should be reared at 25 C. Injections should occur in a room at 18 C
and immediately after injection, embryos should be returned to a grape plate at 25 C.
If constructs carry a HS promoter and may be toxic, post-injection embryos can be
kept at 18 C.
Embryo Alignment This is carried out on a strip of grape plate agar. Thin grape plates
are poured in 10 cm petri dishes, allowed to set normally and then allowed to dry on
the bench top over night. Cracking of the agar along the edges is fine and an indication
the plate has dried significantly. Strips are cut and then blotted thoroughly to remove
additional water. A strip that has not dried su ciently will make picking up the eggs
on the tape di cult or impossible.
Post-Injection Oil should be removed from embryos by vacuum until no more oil can be
removed. A grape plate is spread with a tiny amount of yeast paste all over its surface.
Embryos on tape are cut from the slide to minimize tape larva must crawl across to
reach yeast and grape plate, and this tape strip is applied to the grape plate. I usually
divide a full morning’s injected embryos between two plates. Plates are placed top up
in a pipette tip box with a wet, but not dripping, paper towel to maintain moisture.
C.3 Recoding of Hid & Hid MiRNAs
The regions targeted by miRs are highlighted in bold. The sequences below are those syn-
thesized by GeneArt.
Hid 1
TACGACAACTTTACGGCGGGCCGGGAGCGTCTGCAGGAGTTCAATGGACGCA
TCCCGCCCCGGAAGAAGAAGTCGAGCAACTCGCATAGCTCCTCCTCCAAC
AACCCAGTCTGCCATACCGATAGCCAGCCCGGTGGTACATCCCAGGCTGAA
TCCGGAGCTATTCATGGCCACATCAGTCAGCAGCGACAGGTGGAGCGAGA
ACGACAAAAGGCGAAGGCCGAGAAGAAGAAACCACAGAGCTTCACTTGGCCT
ACAGTAGTTACGGTATTTGTTTTGGCCATGGGCTGTGGCTTCTTTGCGGC
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GCGATGA
Hid 2
TACGACAACTTTACGGCGGGCCGGGAGCGTCTGCAGGAGTTCAATGGACGCA
TCCCGCCCCGGAAGAAGAAGTCCAGTAATTCCCACTCCTCGAGTTCGAAC
AATCCAGTCTGCCATACCGATAGCCAGCCCGGTGGTACATCCCAAGCAGAG
AGTGGCGCAATACATGGCCACATCAGTCAGCAGCGACAGGTGGAGCGAGA
ACGACAAAAGGCGAAGGCCGAGAAGAAGAAACCACAGAGCTTCACTTGGCCG
ACCGTCGTAACAGTCTTTGTTTTGGCCATGGGCTGTGGCTTCTTTGCGGC
GCGATGA
These are the miRs synthesised to target the Hids shown above. MiR set 1 targets Hid 1 and
miR2 set 2 targets Hid 2. Splice junctions are underlined and stem-loops highlighted in bold.
MiR set 1
ATTAAAAGATCTATGGCATACCCATACGACGTTCCGGACTACGCTGTTAAGGT
AGGCATTAACTATTTAAAGTCCACAACTCATCAAGGAAAATGAAAGTCAAAGT
TGGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTGCATAGCTCCTCCT
CCAACCACTAAGTTAATATACCATATCTAGTTGTTGGAGGAGGAGC
TATGCGTACCTAAAGTGCCTAACATCATTATTTAATTTTTATTTTTATTGGCA
CACGAATAACCATGCCGTTTTCAATACTAATCCCTTTAGTAAAACTGTTTTAA
TTTCTTTTCTTTTTTCAGCCAAGGACACCCAGCGCTTCATCATGTATGGTGAG
CAAGGGCGAGGAGCTGTTCACCGGGGTAACGTAGCCAATATCTTTTTGAAAT
CAACAACCCAACACGGGAAGTGTAAGTCTAAGTTAGCAGCTTAGTTTAACTTG
ATTACAGCCTTTAATGTAGGCTGAATCCGGAGCTATCCATAAGTTTCA
AAATCATATCTATGAATAGCTCCGGATTCAGCCTGTACCTAAAGTGCA
TAGCAGCAGTACTTAATCTTATTATTCTTTGGTACTCGCATCACTATGCCCTT
GTCATTACTAATCAATTAAGAAACACTGTTATACTATATTTTTCTTTTACAGA
TGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAG
CGTGTCCGGAAGGTAAGTTTTCAATATTTAGAGCCCTCATCTCATTAACGATA
ATGATAGGCAGAGTTGTCAGCTTACATATACTTAATCCCAGCCTTTAATGTCT
ACAGTAGTTACGGTATTCGTTAAGTTTGTTTTTCATTTCTAACAAAT
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ACCGTAACTACTGTAGGTACCTAAAGTGCCAACATCATAATCTAGTTCTTT
TTATTGTTTGCCCATGAGTAGCCTTGCCGCTTCGGTCACAACTAACCCCTTTA
CTAACACTGTCTTACTTATATTTCTTCTGTCAGGACGAGGGCGAGGGCGATGC
CACCTACGGATCCATCAACTCTAGAATAT
MiR set 2
ATTAAAAGATCTATGGCATACCCATACGACGTTCCGGACTACGCTGTTAAGGT
AGGCATTAACTATTTAAAGTCCACAACTCATCAAGGAAAATGAAAGTCAAAGT
TGGCAGCTTACTTAAACTTAATCACAGCCTTTAATGTCCACTCCTCGAGTT
CGAACCATTAAGTTAATATACCATATCTAATTGTTCGAACTCGAGG
AGTGGGTACCTAAAGTGCCTAACATCATTATTTAATTTTTATTTTTATTGGC
ACACGAATAACCATGCCGTTTTCAATACTAATCCCTTTAGTAAAACTGTTTTA
ATTTCTTTTCTTTTTTCAGCCAAGGACACCCAGCGCTTCATCATGTATGGTGA
GCAAGGGCGAGGAGCTGTTCACCGGGGTAACGTAGCCAATATCTTTTTGAAA
TCAACAACCCAACACGGGAAGTGTAAGTCTAAGTTAGCAGCTTAGTTTAACTT
GATTACAGCCTTTAATGTAAGCAGAGAGTGGCGCAATCCATAAGTTTC
AAAATCATATCTATGTATTGCGCCACTCTCTGCTTGTACCTAAAGTGC
ATAGCAGCAGTACTTAATCTTATTATTCTTTGGTACTCGCATCACTATGCCCT
TGTCATTACTAATCAATTAAGAAACACTGTTATACTATATTTTTCTTTTACAG
ATGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCA
GCGTGTCCGGAAGGTAAGTTTTCAATATTTAGAGCCCTCATCTCATTAACGAT
AATGATAGGCAGAGTTGTCAGCTTACATATACTTAATCCCAGCCTTTAATGTC
GACCGTCGTAACAGTCTTCGTTAAGTTTGTTTTTCATTTCTAACAAA
GACTGTTACGACGGTCGGTACCTAAAGTGCCAACATCATAATCTAGTTCT
TTTTATTGTTTGCCCATGAGTAGCCTTGCCGCTTCGGTCACAACTAACCCCTT
TACTAACACTGTCTTACTTATATTTCTTCTGTCAGGACGAGGGCGAGGGCGAT
GCCACCTACGGATCCATCAACTCTAGAATAT
tTAV 5’ Intron & Kozak
Splice sites are underlined.
123
5’ Intron: CACTGGGCAGGTAAGTATCAAGGTTACAAGACAGGTTTAAGGAGAC
CAATAGAAACTGGGCTTGTCGAGACAGAGAAGACTCTTGCGTTTCTGATAGG
CACCTATTGGTCTTACTGACATCCACTTTGCCTTTCTCTCCACAGGTGTCCAC
TCCC
Kozak: CAACCAAA
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Appendix D
Synthetic MicroRNA Assembly
D.1 Primer Design
There are a variety of arguments made of how targets and backbones should be selected,
but assuming a target and backbone have been selected, this is how primers are designed for
the construction of a single stem loop. In this example, the Drosophila microRNA miR6.1
will be used as the backbone, and it is designed to target the open reading frame of the
Drosophila melanogaster Flightin gene. This microRNA has been designed to mimic the
natural structure of 6.1.
First, two outside primers are designed which are not specific to the gene being targeted
and can be used in any scheme requiring the same cloning sites and backbone. These are
shown in Figure D.1a. The first three bases on each primer serve as a tail to make sure
once both rounds of PCR are complete, the restriction enzymes will have enough double
stranded DNA to allow digestion. In red are shown the pair of restriction sites on each
primer. Between the restriction sites, in blue, are consensus sequences for the 5’ and 3’
splice sites so that microRNA will be spliced out of any transcript it is part of. This allows
the inclusion of microRNAs in UTRs of transcripts containing open reading frames without
the truncation of these transcripts. The splice sites themselves are underlined. Recall the
3’ end is reverse-complemented. This outer pair can be used in the construct of any miR6.1
backbone that uses the same restriction sites in its cloning scheme. The primers can be
easily modified to accommodate any restriction sites required or to remove the splice sites.
The inner primers are shown in Figure D.1b. This pair is self annealing, and is made
specific by the four bases shown in orange. The dark and light purple sections are the
step and the green represents the loop. To preserve the natural loop in the miR6.1stem, a
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mismatch at position 20 of the stem has been included. The guide strand pairs perfectly
with the target, however. I have also shown a schematic of the assembled microRNA after
both rounds of PCR can be carried out.
Figure D.1: (a) Outer primer pair. Each primer contains two restriction sites (red), a splice
site (blue), and a portion of the microRNA flanking sequence (black). (b) Inner primer
pair. These primers anneal to one another. The dark purple sequence corresponds to the
sequence targeted apart from an A-to-C base pair substitution at position 20 to preserve
a mismatch in the native stem. The light purple sequence is exactly the sequence to be
targeted. The four orange bases make this pair specific to one another and help catch
mistakes in PCR setup by only allowing the correct pair to be annealed. (c) A schematic
of the miR6.1 architecture color coded to match the primers used to construct it.
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D.2 MicroRNA Multimerization
The microRNA design above allows for easy cloning and multimerization. This protocol
was designed by Haixia Huang and Chun-Hong Chen and was originally carried out through
a three piece ligation. Our current standard is to ligate the miRs separately, and then clone
in a second step.
For this example, the four enzymes used are EcoRI, NotI, BamHI, and BglII. EcoRI and
NotI serve as the outer restriction sites and are used for cloning into the plasmid backbone.
BamHI and BglII have compatible ends are are used as the inner pair. First, two aliquots of
the microRNA are generated. These may be the same stem-loop or two di↵erent stem-loops
with the same flanks. One is digested with BamHI and then EcoRI, and the other BglII
then NotI. BamHI and BglII digestions leave compatible ends, so the two microRNAs can
be ligated together. Phosophatase treatment of one (but not both!) before digesting with
the outer enzyme, either NotI or EcoRI, reduces the number of ligations of the microRNAs
to themselves. Even if two BamHI or BglII sites do ligate to one another, however, this will
not result in background because those fragments will not be able to be ligated in the next
step.
Following the initial ligation, we gel excise to isolate the pair which can then be ligated
into a backbone digested with the outer enzymes, EcoRI and NotI. This creates the initial
vector containing a pair of microRNAs flanked by the full complement of restriction sites
that each of the singles had within an intron. If only a pair is desired, cloning is complete.
If further multimerization is required, additional stem-loops can be cloned in by opening
this vector with either EcoRI/BamHI and cloning in a microRNA digested EcoRI/BglII or
the opposite: The backbone is cut BglII/NotI and the microRNA BamHI/NotI. Because
the BamHI/BglII ligation results in a fused site that is recognized by neither of the en-
zymes, there is no multiplication of the BamHI or BglII cut sites and this procedure can
be repeated as necessary. Exponential growth of the number of stem-loops is limited only
by the tolerance of the plasmid and cells with respect to repetitive DNAs. A schematic
showing this example is shown in Figure D.2.
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Figure D.2: (a) MicroRNAs are digested with a pair of restriction enzymes such that one
over-hang matches the opposite microRNA, but when they are ligated neither restriction
site will be recovered. This pair is ligated together making a covalently linked pair. (b)
This product also has a pair of ends that allow ligation into a doubly digested plasmid. (c)
The newly constructed plasmid can now can be redigested and another set of microRNAs
cloned in.
General Protocol
1. Run a 10 cycle PCR with the inner primer pair.
2. Run a second PCR using the first round as template and the outer primer pair.
3. Clean and concentrate the reactions.
4. Digest one microRNA with BglII and the second with BamHI.
5. Phosphatase treat one of these reactions.
6. Heat inactive the phosphatase.
7. Clean an concentrate both reactions.
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8. Ligate entire volume of both reactions together.
9. Gel purify (the band may be faint).
10. Digest the gel-purified ligation and backbone EcoRI/NotI.
11. Phosphatase treat backbone.
12. Clean and concentrate both reactions.
13. Ligate, transform, and plate.
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Appendix E
FLP Excision
E.1 FLP Excision Lines
All of the FLP excisions carried out genetically in this work were done using lines ordered
from the Bloomington Stock Center.
The three ovo-FLP lines I ordered were:
#8727 P[ovo-FLP.]M1A, w[*]
#8728 w[*]; P[ovo-FLP.R]F1B, wgSp-1/CyO; MKRS/TM2
#8729 w[*]; Povo-FLP.RM1B; MKRS/TM2
The  -tubulin line used was:
#7196 P[ry[+t7.2]=betaTub85D-FLP]1; ry[506]
Flipping of all three ovo-FLP lines were tested, but I had trouble maintaining #8728
because it gave nearly all male progeny. I attempted to segregate what was giving rise to
the sex ratio distortion, but I could not easily identify even the chromosome causing it and
so I opted to not use it.
I used the  -tubulin-FLP line and the 8727 ovo-FLP lines in the excision crossing
schemes with the UD flies because of their reasonable flipping e ciencies and position
on the X chromosome. The 8727 line sometimes gave very e cient flipping and other times
barely flipped at all. I was unable to determine what was influencing this variability. Some
of the e↵ect may have been due to the size of the fragment to be excised, but even this did
not seem to be consistent. We tried to develop other germ line FLPs with greater and more
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Assessment of FLP Lines
FLP line Chromosome/PhiC31 Site Percentage Flipped
ovo-FLP (8727) X ⇠ 95%1, 60%
ovo-FLP (8729) II ⇠ 5%?
ovo-FLP (8728) II -
ExuMed-FLP X/9753 ⇠ 4%
ExuMed-FLP II/9724 ⇠ 36%
 -tubulin FLP(7196) X ⇠ 90%1, 60%,
ExuLong-FLP X/9753 ⇠ 52%
ExuLong-FLP II/9724 ⇠ 52%
vasa-FLP X/9753 0%
vasa-FLP II/9724 0%
Table E.1: Lines were tested for the percentage flipping in their germ line. 1These two
counts were done using a GMR-Hid UD construct. The other assessments were done using
a GMR RFP/GFP assay with nothing toxic involved.
repeatable FLP e ciency.
First I worked with a vasa fragment, hoping to get FLP expression in both male and
female germ lines, but at two di↵erent PhiC31 insertion sites no flipping was observed. It
also came to our attention that there are two FLP versions used in the Drosophila literature
and our constructs bore the one which had a very low flipping e ciency (Nern et al., 2011).
The next round of germ line FLP constructs used the more e cient FLP allele and
were constructed using two di↵erent Exu promoter fragments—one meant to express in
the female germ line (ExuMed) and the other the male germ line (ExuLong). These two
fragments were identified by O. Akbari in his survey of maternal gene promoters. Flipping
is still not very e cient.
E.2 Tet-Induced Excision
If generating an UD system in mosquitos for release, removing the conditional rescue
through feeding of a drug would be very desirable. This would allow introgression of the UD
chromosomes into a genetically diverse background and would alleviate the need to develop
e cient germ line FLPs in the mosquito.
To accomplish this, I built up a cassette that could excise itself upon the feeding of
tetracycline. Between two FRT sites are the blocking ORF and its 3’ UTR (usually GFP,
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although anything could be used), a germ-line-promoter driven tTAV and a Ptight-driven
FLP. In the soma of animals fed Tet, the GFP is expressed from the tissue-specific promoter
as usual. In the germ line, tTAV is expressed in both the presence or absence of drug. If the
animal is fed Tet, however, tTAV binds to the Ptight promoter, driving expression of FLP
and excising the cassette. The progeny that grow from germ cells that have undergone FLP
excision bear an UD chromosome without the blocking sequence and express the toxin.
Figure E.1: The blocking cassette is flanked by FRT sites. Also between the sites is a germ
line driven tTAV and a Ptight driven FLP.
This system was tested using vasa as the germ line promoter and the less e cient FLP,
and no flipping was observed. New versions using other germ line promoters and the more
e cient allele of FLP are being tested.
